MODEL,DESCRIPTOR,MEDIA,DETACHMENT MEDIA,ATTACHMENT,SPECIFIC NOTES,DIAGNOSIS/REPLASE,PHASE,PRIOR TREATMENT(S),SOURCE OF CULTURE,1p,3p,11q,17q,ALK STATUS,MYCN STATUS,P53 STATUS,1:2,1:3 ,1:4 ,1:5,1:6,1:7,1:8,1:9,1:10,1:20,NOTES,RACK LOCATION:,LOCATION: BOX,LOCATION: ROW,LOCATION: POSITION,PASSAGE #,FREEZE DATE,INITIALS,LINEAGE,MYCO DATE,STR DATE,STR RESULT,AMELOGENIN (ALLELE 1),AMELOGENIN (ALLELE 2),D3S1358 (ALLELE 1),D3S1358 (ALLELE 2),,D1S1656 (ALLELE 1),D1S1656 (ALLELE 2),,D2S441 (ALLELE 1),D2S441 (ALLELE 2),D10S1248 (ALLELE 1),D10S1248 (ALLELE 2),,D13S317 (ALLELE 1),D13S317 (ALLELE 2),D13S317 (ALLELE 2),PENTA E (ALLELE 1),PENTA E (ALLELE 2),PENTA E (ALLELE 3),D16S539 (ALLELE 1),D16S539 (ALLELE 2),D18S51 (ALLELE 1),D18S51 (ALLELE 2),,D2S1338 (ALLELE 1),D2S1338 (ALLELE 2),D2S1338 (ALLELE 3),CSF1PO (ALLELE 1),CSF1PO (ALLELE 2),,PENTA D (ALLELE 1),PENTA D (ALLELE 2),PENTA D (ALLELE 3),TH01 (ALLELE 1),TH01 (ALLELE 2),vWA (ALLELE 1),vWA (ALLELE 2),vWA (ALLELE 3),D21S11 (ALLELE 1),D21S11 (ALLELE 2),,D7S820 (ALLELE 1),D7S820 (ALLELE 2),D5S818 (ALLELE 1),D5S818 (ALLELE 2),TPOX (ALLELE 1),TPOX (ALLELE 2),,DYS391 (ALLELE 1),D8S1179 (ALLELE 1),D8S1179 (ALLELE 2),D8S1179 (ALLELE 3),D12S391 (ALLELE 1),D12S391 (ALLELE 2),,D19S433 (ALLELE 1),D19S433 (ALLELE 2),,FGA (ALLELE 1),FGA (ALLELE 2),,D22S1045 (ALLELE 1),D22S1045 (ALLELE 2),,,Lab 
CHP-134,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Progressing,"Cisplatin, carboplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Sample was collected after bone marrow transplant.",Bone Marrow,LOH p32.3-pterm; Gain p34.3-p36.22; Loss p36.22-pterm,GaiNAl p26.3,None,Gain q12-qterm,WT,Amplified,WT,NA,1,NA,1,NA,NA,2,NA,3,NA,,7,1,1,1,5,03/31/2017,LS,,03/31/2017,,Good,X,Y,16,,,11,,,11.3,,14,,,8,11,,5,7,,11,13,15,18,,20,27,,9,13,,9,,,9,9.3,18,19,,28,29,,9,,11,12,8,,,10,8,14,,17,18,,12,13,,21,25,,15,18,,,Maris
CHP-134,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Progressing,"Cisplatin, carboplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Sample was collected after bone marrow transplant.",Bone Marrow,LOH p32.3-pterm; Gain p34.3-p36.22; Loss p36.22-pterm,GaiNAl p26.3,None,Gain q12-qterm,WT,Amplified,WT,NA,1,NA,1,NA,NA,2,NA,3,NA,,7,1,1,2,5,03/31/2017,LS,,03/31/2017,,Good,X,Y,16,,,11,,,11.3,,14,,,8,11,,5,7,,11,13,15,18,,20,27,,9,13,,9,,,9,9.3,18,19,,28,29,,9,,11,12,8,,,10,8,14,,17,18,,12,13,,21,25,,15,18,,,Maris
CHP-134,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Progressing,"Cisplatin, carboplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Sample was collected after bone marrow transplant.",Bone Marrow,LOH p32.3-pterm; Gain p34.3-p36.22; Loss p36.22-pterm,GaiNAl p26.3,None,Gain q12-qterm,WT,Amplified,WT,NA,1,NA,1,NA,NA,2,NA,3,NA,,7,1,1,3,6,07/27/2017,klc,"thawed from LS, P5 03/31/2017",07/28/2017,,Good,X,Y,16,,,11,,,11.3,,14,,,8,11,,5,7,,11,13,15,18,,20,27,,9,13,,9,,,9,9.3,18,19,,28,29,,9,,11,12,8,,,10,8,14,,17,18,,12,13,,21,25,,15,18,,,Maris
CHP-134,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Progressing,"Cisplatin, carboplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Sample was collected after bone marrow transplant.",Bone Marrow,LOH p32.3-pterm; Gain p34.3-p36.22; Loss p36.22-pterm,GaiNAl p26.3,None,Gain q12-qterm,WT,Amplified,WT,NA,1,NA,1,NA,NA,2,NA,3,NA,,7,1,1,4,6,07/27/2017,klc,"thawed from LS, P5 03/31/2017",07/28/2017,,Good,X,Y,16,,,11,,,11.3,,14,,,8,11,,5,7,,11,13,15,18,,20,27,,9,13,,9,,,9,9.3,18,19,,28,29,,9,,11,12,8,,,10,8,14,,17,18,,12,13,,21,25,,15,18,,,Maris
CHP-134,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Progressing,"Cisplatin, carboplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Sample was collected after bone marrow transplant.",Bone Marrow,LOH p32.3-pterm; Gain p34.3-p36.22; Loss p36.22-pterm,GaiNAl p26.3,None,Gain q12-qterm,WT,Amplified,WT,NA,1,NA,1,NA,NA,2,NA,3,NA,,7,1,1,5,6,07/27/2017,klc,"thawed from LS, P5 03/31/2017",07/28/2017,,Good,X,Y,16,,,11,,,11.3,,14,,,8,11,,5,7,,11,13,15,18,,20,27,,9,13,,9,,,9,9.3,18,19,,28,29,,9,,11,12,8,,,10,8,14,,17,18,,12,13,,21,25,,15,18,,,Maris
CHP-134,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Progressing,"Cisplatin, carboplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Sample was collected after bone marrow transplant.",Bone Marrow,LOH p32.3-pterm; Gain p34.3-p36.22; Loss p36.22-pterm,GaiNAl p26.3,None,Gain q12-qterm,WT,Amplified,WT,NA,1,NA,1,NA,NA,2,NA,3,NA,,7,1,1,6,6,07/27/2017,klc,"thawed from LS, P5 03/31/2017",07/28/2017,,Good,X,Y,16,,,11,,,11.3,,14,,,8,11,,5,7,,11,13,15,18,,20,27,,9,13,,9,,,9,9.3,18,19,,28,29,,9,,11,12,8,,,10,8,14,,17,18,,12,13,,21,25,,15,18,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,1,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,1,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHP-134,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Progressing,"Cisplatin, carboplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Sample was collected after bone marrow transplant.",Bone Marrow,LOH p32.3-pterm; Gain p34.3-p36.22; Loss p36.22-pterm,GaiNAl p26.3,None,Gain q12-qterm,WT,Amplified,WT,NA,1,NA,1,NA,NA,2,NA,3,NA,,7,1,2,10,7,09/19/2017,JLH,,,08/22/2018,Good,X,Y,16,,,11,,,11.3,,14,,,8,11,,5,7,,11,13,15,18,,20,27,,9,13,,9,,,9,9.3,18,19,,28,29,,9,,11,12,8,,,10,8,14,,17,18,,12,13,,21,25,,15,18,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,2,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,2,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,2,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,2,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,2,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
IMR-05,Cell Bank,"RPMI 1640 w/ 10 % FBS, 1% of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection ,Solid Tumor Same patient as IMR-32 Subclone of IMR-3,Gain + LOH p32.3-pter,GaiNAl p24.3-26.3,Loss q22.1-qter,Gain q21.2-qter,WT,Amplified,WT,NA,NA,NA,1-2,NA,NA,NA,NA,3,4,,7,1,3,1,,01/27/2016,LSH,,07/28/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
IMR-05,Cell Bank,"RPMI 1640 w/ 10 % FBS, 1% of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection ,Solid Tumor Same patient as IMR-32 Subclone of IMR-3,Gain + LOH p32.3-pter,GaiNAl p24.3-26.3,Loss q22.1-qter,Gain q21.2-qter,WT,Amplified,WT,NA,NA,NA,1-2,NA,NA,NA,NA,3,4,,7,1,3,3,4,03/27/2017,LS,,03/31/2017,08/22/2018,Good (Drop out of 7 at PENTA E; STR of subsequent freeze is good (KLC P7 10/31/17)),X,Y,16,,,17,17.3,,10,11,13,14,,9,,,7 (DO),15,,8,,12,15,,23,24,,11,12,,11,12,,7,9.3,15,,,30,31,,9,10,11,12,11,,,11,13,,,19.3,23,,14,15,,21,24,,16,19,,,Maris
IMR-05,Cell Bank,"RPMI 1640 w/ 10 % FBS, 1% of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection ,Solid Tumor Same patient as IMR-32 Subclone of IMR-3,Gain + LOH p32.3-pter,GaiNAl p24.3-26.3,Loss q22.1-qter,Gain q21.2-qter,WT,Amplified,WT,NA,NA,NA,1-2,NA,NA,NA,NA,3,4,,7,1,3,4,5,03/27/2017,LS,,03/31/2017,08/22/2018,Good (Drop out of 7 at PENTA E; STR of subsequent freeze is good (KLC P7 10/31/17)),X,Y,16,,,17,17.3,,10,11,13,14,,9,,,7 (DO),15,,8,,12,15,,23,24,,11,12,,11,12,,7,9.3,15,,,30,31,,9,10,11,12,11,,,11,13,,,19.3,23,,14,15,,21,24,,16,19,,,Maris
IMR-05,Cell Bank,"RPMI 1640 w/ 10 % FBS, 1% of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection ,Solid Tumor Same patient as IMR-32 Subclone of IMR-3,Gain + LOH p32.3-pter,GaiNAl p24.3-26.3,Loss q22.1-qter,Gain q21.2-qter,WT,Amplified,WT,NA,NA,NA,1-2,NA,NA,NA,NA,3,4,,7,1,3,5,6,12/09/2019,KU,"From LS, P5, 03/27/2017 (STR from thaw is good)",12/10/2019,08/22/2018,Good (Drop out of 7 at PENTA E; STR of subsequent freeze is good (KLC P7 10/31/17)),X,Y,16,,,17,17.3,,10,11,13,14,,9,,,7 (DO),15,,8,,12,15,,23,24,,11,12,,11,12,,7,9.3,15,,,30,31,,9,10,11,12,11,,,11,13,,,19.3,23,,14,15,,21,24,,16,19,,,Maris
IMR-05,Cell Bank,"RPMI 1640 w/ 10 % FBS, 1% of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection ,Solid Tumor Same patient as IMR-32 Subclone of IMR-3,Gain + LOH p32.3-pter,GaiNAl p24.3-26.3,Loss q22.1-qter,Gain q21.2-qter,WT,Amplified,WT,NA,NA,NA,1-2,NA,NA,NA,NA,3,4,,7,1,3,6,6,12/09/2019,KU,"From LS, P5, 03/27/2017 (STR from thaw is good)",12/10/2019,08/22/2018,Good (Drop out of 7 at PENTA E; STR of subsequent freeze is good (KLC P7 10/31/17)),X,Y,16,,,17,17.3,,10,11,13,14,,9,,,7 (DO),15,,8,,12,15,,23,24,,11,12,,11,12,,7,9.3,15,,,30,31,,9,10,11,12,11,,,11,13,,,19.3,23,,14,15,,21,24,,16,19,,,Maris
IMR-05,Cell Bank,"RPMI 1640 w/ 10 % FBS, 1% of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection ,Solid Tumor Same patient as IMR-32 Subclone of IMR-3,Gain + LOH p32.3-pter,GaiNAl p24.3-26.3,Loss q22.1-qter,Gain q21.2-qter,WT,Amplified,WT,NA,NA,NA,1-2,NA,NA,NA,NA,3,4,,7,1,3,7,6,12/09/2019,KU,"From LS, P5, 03/27/2017 (STR from thaw is good)",12/10/2019,08/22/2018,Good (Drop out of 7 at PENTA E; STR of subsequent freeze is good (KLC P7 10/31/17)),X,Y,16,,,17,17.3,,10,11,13,14,,9,,,7 (DO),15,,8,,12,15,,23,24,,11,12,,11,12,,7,9.3,15,,,30,31,,9,10,11,12,11,,,11,13,,,19.3,23,,14,15,,21,24,,16,19,,,Maris
IMR-05,Cell Bank,"RPMI 1640 w/ 10 % FBS, 1% of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection ,Solid Tumor Same patient as IMR-32 Subclone of IMR-3,Gain + LOH p32.3-pter,GaiNAl p24.3-26.3,Loss q22.1-qter,Gain q21.2-qter,WT,Amplified,WT,NA,NA,NA,1-2,NA,NA,NA,NA,3,4,,7,1,3,8,6,12/09/2019,KU,"From LS, P5, 03/27/2017 (STR from thaw is good)",12/10/2019,08/22/2018,Good (Drop out of 7 at PENTA E; STR of subsequent freeze is good (KLC P7 10/31/17)),X,Y,16,,,17,17.3,,10,11,13,14,,9,,,7 (DO),15,,8,,12,15,,23,24,,11,12,,11,12,,7,9.3,15,,,30,31,,9,10,11,12,11,,,11,13,,,19.3,23,,14,15,,21,24,,16,19,,,Maris
IMR-05,Cell Bank,"RPMI 1640 w/ 10 % FBS, 1% of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection ,Solid Tumor Same patient as IMR-32 Subclone of IMR-3,Gain + LOH p32.3-pter,GaiNAl p24.3-26.3,Loss q22.1-qter,Gain q21.2-qter,WT,Amplified,WT,NA,NA,NA,1-2,NA,NA,NA,NA,3,4,,7,1,3,9,6,12/09/2019,KU,"From LS, P5, 03/27/2017 (STR from thaw is good)",12/10/2019,08/22/2018,Good (Drop out of 7 at PENTA E; STR of subsequent freeze is good (KLC P7 10/31/17)),X,Y,16,,,17,17.3,,10,11,13,14,,9,,,7 (DO),15,,8,,12,15,,23,24,,11,12,,11,12,,7,9.3,15,,,30,31,,9,10,11,12,11,,,11,13,,,19.3,23,,14,15,,21,24,,16,19,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,3,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,4,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,4,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,4,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,4,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,4,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,4,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,4,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,4,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
KELLY,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,NA,3,NA,4,NA,NA,NA,NA,5,NA,,7,1,5,1,4,02/06/2015,LSH,,11/06/2014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
KELLY,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,NA,3,NA,4,NA,NA,NA,NA,5,NA,,7,1,5,2,11,11/3/16,JLH,,,3/3/20,Good,X,,14,16,,11,13,,10,14,13,14,,10,14,,12,16,,12,13,14,17,,17,20,,12,,,9,14,,9.3,,16,18,,28,30,,9,,11,13,8,10,,-,14,,,19,20,,12,15.2,,20,21,,16,,,,Maris
KELLY,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,NA,3,NA,4,NA,NA,NA,NA,5,NA,,7,1,5,3,11,11/3/16,JLH,,,3/3/20,Good,X,,14,16,,11,13,,10,14,13,14,,10,14,,12,16,,12,13,14,17,,17,20,,12,,,9,14,,9.3,,16,18,,28,30,,9,,11,13,8,10,,-,14,,,19,20,,12,15.2,,20,21,,16,,,,Maris
KELLY,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,NA,3,NA,4,NA,NA,NA,NA,5,NA,,7,1,5,4,12,02/19/2020,KU,"From JLH, P11, 11/03/2016",02/07/2020,3/3/20,Good,X,,14,16,,11,13,,10,14,13,14,,10,14,,12,16,,12,13,14,17,,17,20,,12,,,9,14,,9.3,,16,18,,28,30,,9,,11,13,8,10,,-,14,,,19,20,,12,15.2,,20,21,,16,,,,Maris
KELLY,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,NA,3,NA,4,NA,NA,NA,NA,5,NA,,7,1,5,5,12,02/19/2020,KU,"From JLH, P11, 11/03/2016",02/07/2020,3/3/20,Good,X,,14,16,,11,13,,10,14,13,14,,10,14,,12,16,,12,13,14,17,,17,20,,12,,,9,14,,9.3,,16,18,,28,30,,9,,11,13,8,10,,-,14,,,19,20,,12,15.2,,20,21,,16,,,,Maris
KELLY,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,NA,3,NA,4,NA,NA,NA,NA,5,NA,,7,1,5,6,12,02/19/2020,KU,"From JLH, P11, 11/03/2016",02/07/2020,3/3/20,Good,X,,14,16,,11,13,,10,14,13,14,,10,14,,12,16,,12,13,14,17,,17,20,,12,,,9,14,,9.3,,16,18,,28,30,,9,,11,13,8,10,,-,14,,,19,20,,12,15.2,,20,21,,16,,,,Maris
KELLY,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,NA,3,NA,4,NA,NA,NA,NA,5,NA,,7,1,5,7,3,6/9/2017,KLC,ATCC stock bought june 2015,6/9/2017,10/19/2018,Good,X,,14,16,,11,13,,10,14,13,14,,10,14,,12,16,,12,13,14,17,,17,20,,12,,,9,14,,9.3,,16,18,,28,30,,9,,11,13,8,10,,-,14,,,19,20,,12,15.2,,20,21,,16,,,,Maris
KELLY,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,NA,3,NA,4,NA,NA,NA,NA,5,NA,,7,1,5,8,3,6/9/2017,KLC,ATCC stock bought june 2015,6/9/2017,10/19/2018,Good,X,,14,16,,11,13,,10,14,13,14,,10,14,,12,16,,12,13,14,17,,17,20,,12,,,9,14,,9.3,,16,18,,28,30,,9,,11,13,8,10,,-,14,,,19,20,,12,15.2,,20,21,,16,,,,Maris
KELLY,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,NA,3,NA,4,NA,NA,NA,NA,5,NA,,7,1,5,9,3,6/9/2017,KLC,ATCC stock bought june 2015,6/9/2017,10/19/2018,Good,X,,14,16,,11,13,,10,14,13,14,,10,14,,12,16,,12,13,14,17,,17,20,,12,,,9,14,,9.3,,16,18,,28,30,,9,,11,13,8,10,,-,14,,,19,20,,12,15.2,,20,21,,16,,,,Maris
KELLY,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,NA,3,NA,4,NA,NA,NA,NA,5,NA,,7,1,5,10,12,02/19/2020,KU,"From JLH, P11, 11/03/2016",02/07/2020,3/3/20,Good,X,,14,16,,11,13,,10,14,13,14,,10,14,,12,16,,12,13,14,17,,17,20,,12,,,9,14,,9.3,,16,18,,28,30,,9,,11,13,8,10,,-,14,,,19,20,,12,15.2,,20,21,,16,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,6,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,6,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,6,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,6,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,6,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,6,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,6,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,6,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
KELLY,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,NA,3,NA,4,NA,NA,NA,NA,5,NA,,7,1,6,10,12,02/19/2020,KU,"From JLH, P11, 11/03/2016",02/07/2020,3/3/20,Good,X,,14,16,,11,13,,10,14,13,14,,10,14,,12,16,,12,13,14,17,,17,20,,12,,,9,14,,9.3,,16,18,,28,30,,9,,11,13,8,10,,-,14,,,19,20,,12,15.2,,20,21,,16,,,,Maris
LA-N-5,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p33-pterm,None,None,Gain q21.2-qterm,R1275Q,Amplified,WT,NA,NA,4,NA,NA,NA,NA,NA,7,8,,7,1,7,1,5,11/14/2014,PK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,7,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
LA-N-5,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p33-pterm,None,None,Gain q21.2-qterm,R1275Q,Amplified,WT,NA,NA,4,NA,NA,NA,NA,NA,7,8,,7,1,7,3,7,09/05/2019,KU,From P6 LSH 02/18/2016 (STR from thaw good),09/06/2019,3/3/20,Good,X,Y,15,16,,15,,,11,14,15,,,9,12,,11,12,,9,12,17,22,,19,25,,10,,,11,13,,6,9.3,15,16,,29,31,,10,,11,,8,,,11,11,13,,20,,,13,15,,21,27,,11,16,,,Maris
LA-N-5,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p33-pterm,None,None,Gain q21.2-qterm,R1275Q,Amplified,WT,NA,NA,4,NA,NA,NA,NA,NA,7,8,,7,1,7,4,8,09/11/2019,KU,From P6 LSH 02/18/2016 (STR from thaw good),09/06/2019,12/10/2019,(Good (STR of thaw is good),X,Y,15,16,,15,,,11,14,15,,,9,12,,11,12,,9,12,17,22,,19,25,,10,,,11,13,,6,9.3,15,16,,29,31,,10,,11,,8,,,11,11,13,,20,,,13,15,,21,27,,11,16,,,Maris
LA-N-5,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p33-pterm,None,None,Gain q21.2-qterm,R1275Q,Amplified,WT,NA,NA,4,NA,NA,NA,NA,NA,7,8,,7,1,7,5,8,09/11/2019,KU,From P6 LSH 02/18/2016 (STR from thaw good),09/06/2019,12/10/2019,(Good (STR of thaw is good),X,Y,15,16,,15,,,11,14,15,,,9,12,,11,12,,9,12,17,22,,19,25,,10,,,11,13,,6,9.3,15,16,,29,31,,10,,11,,8,,,11,11,13,,20,,,13,15,,21,27,,11,16,,,Maris
LA-N-5,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p33-pterm,None,None,Gain q21.2-qterm,R1275Q,Amplified,WT,NA,NA,4,NA,NA,NA,NA,NA,7,8,,7,1,7,6,8,09/11/2019,KU,From P6 LSH 02/18/2016 (STR from thaw good),09/06/2019,12/10/2019,(Good (STR of thaw is good),X,Y,15,16,,15,,,11,14,15,,,9,12,,11,12,,9,12,17,22,,19,25,,10,,,11,13,,6,9.3,15,16,,29,31,,10,,11,,8,,,11,11,13,,20,,,13,15,,21,27,,11,16,,,Maris
LA-N-5,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p33-pterm,None,None,Gain q21.2-qterm,R1275Q,Amplified,WT,NA,NA,4,NA,NA,NA,NA,NA,7,8,,7,1,7,7,8,09/11/2019,KU,From P6 LSH 02/18/2016 (STR from thaw good),09/06/2019,12/10/2019,(Good (STR of thaw is good),X,Y,15,16,,15,,,11,14,15,,,9,12,,11,12,,9,12,17,22,,19,25,,10,,,11,13,,6,9.3,15,16,,29,31,,10,,11,,8,,,11,11,13,,20,,,13,15,,21,27,,11,16,,,Maris
LA-N-5,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p33-pterm,None,None,Gain q21.2-qterm,R1275Q,Amplified,WT,NA,NA,4,NA,NA,NA,NA,NA,7,8,,7,1,7,8,8,09/11/2019,KU,From P6 LSH 02/18/2016 (STR from thaw good),09/06/2019,12/10/2019,(Good (STR of thaw is good),X,Y,15,16,,15,,,11,14,15,,,9,12,,11,12,,9,12,17,22,,19,25,,10,,,11,13,,6,9.3,15,16,,29,31,,10,,11,,8,,,11,11,13,,20,,,13,15,,21,27,,11,16,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,7,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,7,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,8,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
LA-N-5,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p33-pterm,None,None,Gain q21.2-qterm,R1275Q,Amplified,WT,NA,NA,4,NA,NA,NA,NA,NA,7,8,,7,1,8,3,5,09/13/2019,KU,"From KU, P4, 08/10/2018 (STR from thaw good)",09/06/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
LA-N-5,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p33-pterm,None,None,Gain q21.2-qterm,R1275Q,Amplified,WT,NA,NA,4,NA,NA,NA,NA,NA,7,8,,7,1,8,4,4,07/30/2018,KU,"From KLC, P3, 11/11/2016 (STR from thaw and freeze good)",08/10/2018,12/10/2019,Good,X,Y,15,16,,15,,,11,14,15,,,9,12,,11,12,,9,12,17,22,,19,25,,10,,,11,13,,6,9.3,15,16,,29,31,,10,,11,,8,,,11,11,13,,20,,,13,15,,21,27,,11,16,,,Maris
LA-N-5,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p33-pterm,None,None,Gain q21.2-qterm,R1275Q,Amplified,WT,NA,NA,4,NA,NA,NA,NA,NA,7,8,,7,1,8,5,7,12/27/2018,KU,"From KU, P4, 08/10/2018",12/11/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
LA-N-5,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p33-pterm,None,None,Gain q21.2-qterm,R1275Q,Amplified,WT,NA,NA,4,NA,NA,NA,NA,NA,7,8,,7,1,8,6,7,12/27/2018,KU,"From KU, P4, 08/10/2018",12/11/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
LA-N-5,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p33-pterm,None,None,Gain q21.2-qterm,R1275Q,Amplified,WT,NA,NA,4,NA,NA,NA,NA,NA,7,8,,7,1,8,7,7,12/27/2018,KU,"From KU, P4, 08/10/2018",12/11/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
LA-N-5,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p33-pterm,None,None,Gain q21.2-qterm,R1275Q,Amplified,WT,NA,NA,4,NA,NA,NA,NA,NA,7,8,,7,1,8,8,7,12/27/2018,KU,"From KU, P4, 08/10/2018 ",12/11/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
LA-N-5,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p33-pterm,None,None,Gain q21.2-qterm,R1275Q,Amplified,WT,NA,NA,4,NA,NA,NA,NA,NA,7,8,,7,1,8,9,7,12/27/2018,KU,"From KU, P4, 08/10/2018",12/11/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
LA-N-5,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p33-pterm,None,None,Gain q21.2-qterm,R1275Q,Amplified,WT,NA,NA,4,NA,NA,NA,NA,NA,7,8,,7,1,8,10,9,08/21/2017,KU,,07/30/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,9,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
LA-N-6,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Growth rate is faster the closer in proximity it is to other cells. Thaw in 60 mm plate, rather than 100 mm plate.",Relapse (4),Progressing,Patient received chemotherapy prior to sample collection. 5 cycles of cyclophosphamide and doxorubicin.,Bone Marow,p36.12-pterm; cnLOH p35.3-p36.11,Loss p14.3-qterm,Loss q13.4-qterm,Gain q12-qterm,WT,Non-amplified,WT,NA,12,NA,15,NA,NA,NA,NA,NA,NA,,7,1,9,2,4,03/08/2016,LSH,,11/26/2014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
LA-N-6,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Growth rate is faster the closer in proximity it is to other cells. Thaw in 60 mm plate, rather than 100 mm plate.",Relapse (4),Progressing,Patient received chemotherapy prior to sample collection. 5 cycles of cyclophosphamide and doxorubicin.,Bone Marow,p36.12-pterm; cnLOH p35.3-p36.11,Loss p14.3-qterm,Loss q13.4-qterm,Gain q12-qterm,WT,Non-amplified,WT,NA,12,NA,15,NA,NA,NA,NA,NA,NA,,7,1,9,3,4,03/08/2016,LSH,,11/26/2014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,9,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
LA-N-6,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Growth rate is faster the closer in proximity it is to other cells. Thaw in 60 mm plate, rather than 100 mm plate.",Relapse (4),Progressing,Patient received chemotherapy prior to sample collection. 5 cycles of cyclophosphamide and doxorubicin.,Bone Marow,p36.12-pterm; cnLOH p35.3-p36.11,Loss p14.3-qterm,Loss q13.4-qterm,Gain q12-qterm,WT,Non-amplified,WT,NA,12,NA,15,NA,NA,NA,NA,NA,NA,,7,1,9,5,7,07/17/2019,KU,From P6 LSH 12/02/2014 (STR from thaw good),07/12/2019,3/3/20,Good (STR of subsequent freeze is good),X,,15,,,16,17,,10,15,14,16,,12,,,7,12,,10,12,16,,,18,19,,11,12,,13,,,6,,14,16,,30,32.2,,11,12,10,12,8,,,-,13,14,,15,23,,14,,,18,21,,16,,,,Maris
LA-N-6,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Growth rate is faster the closer in proximity it is to other cells. Thaw in 60 mm plate, rather than 100 mm plate.",Relapse (4),Progressing,Patient received chemotherapy prior to sample collection. 5 cycles of cyclophosphamide and doxorubicin.,Bone Marow,p36.12-pterm; cnLOH p35.3-p36.11,Loss p14.3-qterm,Loss q13.4-qterm,Gain q12-qterm,WT,Non-amplified,WT,NA,12,NA,15,NA,NA,NA,NA,NA,NA,,7,1,9,6,7,07/17/2019,KU,From P6 LSH 12/02/2014 (STR from thaw good),07/12/2019,3/3/20,Good (STR of subsequent freeze is good),X,,15,,,16,17,,10,15,14,16,,12,,,7,12,,10,12,16,,,18,19,,11,12,,13,,,6,,14,16,,30,32.2,,11,12,10,12,8,,,-,13,14,,15,23,,14,,,18,21,,16,,,,Maris
LA-N-6,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Growth rate is faster the closer in proximity it is to other cells. Thaw in 60 mm plate, rather than 100 mm plate.",Relapse (4),Progressing,Patient received chemotherapy prior to sample collection. 5 cycles of cyclophosphamide and doxorubicin.,Bone Marow,p36.12-pterm; cnLOH p35.3-p36.11,Loss p14.3-qterm,Loss q13.4-qterm,Gain q12-qterm,WT,Non-amplified,WT,NA,12,NA,15,NA,NA,NA,NA,NA,NA,,7,1,9,7,7,07/17/2019,KU,From P6 LSH 12/02/2014 (STR from thaw good),07/12/2019,3/3/20,Good (STR of subsequent freeze is good),X,,15,,,16,17,,10,15,14,16,,12,,,7,12,,10,12,16,,,18,19,,11,12,,13,,,6,,14,16,,30,32.2,,11,12,10,12,8,,,-,13,14,,15,23,,14,,,18,21,,16,,,,Maris
LA-N-6,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Growth rate is faster the closer in proximity it is to other cells. Thaw in 60 mm plate, rather than 100 mm plate.",Relapse (4),Progressing,Patient received chemotherapy prior to sample collection. 5 cycles of cyclophosphamide and doxorubicin.,Bone Marow,p36.12-pterm; cnLOH p35.3-p36.11,Loss p14.3-qterm,Loss q13.4-qterm,Gain q12-qterm,WT,Non-amplified,WT,NA,12,NA,15,NA,NA,NA,NA,NA,NA,,7,1,9,8,10,02/04/2020,KU,"From KU, P7, 7/17/2019",12/17/2019,3/3/20,Good,X,,15,,,16,17,,10,15,14,16,,12,,,7,12,,10,12,16,,,18,19,,11,12,,13,,,6,,14,16,,30,32.2,,11,12,10,12,8,,,-,13,14,,15,23,,14,,,18,21,,16,,,,Maris
LA-N-6,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Growth rate is faster the closer in proximity it is to other cells. Thaw in 60 mm plate, rather than 100 mm plate.",Relapse (4),Progressing,Patient received chemotherapy prior to sample collection. 5 cycles of cyclophosphamide and doxorubicin.,Bone Marow,p36.12-pterm; cnLOH p35.3-p36.11,Loss p14.3-qterm,Loss q13.4-qterm,Gain q12-qterm,WT,Non-amplified,WT,NA,12,NA,15,NA,NA,NA,NA,NA,NA,,7,1,9,9,10,02/04/2020,KU,"From KU, P7, 7/17/2019",12/17/2019,3/3/20,Good,X,,15,,,16,17,,10,15,14,16,,12,,,7,12,,10,12,16,,,18,19,,11,12,,13,,,6,,14,16,,30,32.2,,11,12,10,12,8,,,-,13,14,,15,23,,14,,,18,21,,16,,,,Maris
LA-N-6,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Growth rate is faster the closer in proximity it is to other cells. Thaw in 60 mm plate, rather than 100 mm plate.",Relapse (4),Progressing,Patient received chemotherapy prior to sample collection. 5 cycles of cyclophosphamide and doxorubicin.,Bone Marow,p36.12-pterm; cnLOH p35.3-p36.11,Loss p14.3-qterm,Loss q13.4-qterm,Gain q12-qterm,WT,Non-amplified,WT,NA,12,NA,15,NA,NA,NA,NA,NA,NA,,7,1,9,10,10,02/04/2020,KU,"From KU, P7, 7/17/2019",12/17/2019,3/3/20,Good,X,,15,,,16,17,,10,15,14,16,,12,,,7,12,,10,12,16,,,18,19,,11,12,,13,,,6,,14,16,,30,32.2,,11,12,10,12,8,,,-,13,14,,15,23,,14,,,18,21,,16,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,10,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,10,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,10,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,10,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,10,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
LA-N-6,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Growth rate is faster the closer in proximity it is to other cells. Thaw in 60 mm plate, rather than 100 mm plate.",Relapse (4),Progressing,Patient received chemotherapy prior to sample collection. 5 cycles of cyclophosphamide and doxorubicin.,Bone Marow,p36.12-pterm; cnLOH p35.3-p36.11,Loss p14.3-qterm,Loss q13.4-qterm,Gain q12-qterm,WT,Non-amplified,WT,NA,12,NA,15,NA,NA,NA,NA,NA,NA,,7,1,10,6,9,05/03/2017,LS,,04/18/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
LA-N-6,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Growth rate is faster the closer in proximity it is to other cells. Thaw in 60 mm plate, rather than 100 mm plate.",Relapse (4),Progressing,Patient received chemotherapy prior to sample collection. 5 cycles of cyclophosphamide and doxorubicin.,Bone Marow,p36.12-pterm; cnLOH p35.3-p36.11,Loss p14.3-qterm,Loss q13.4-qterm,Gain q12-qterm,WT,Non-amplified,WT,NA,12,NA,15,NA,NA,NA,NA,NA,NA,,7,1,10,7,9,05/03/2017,LS,,04/18/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,10,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,1,10,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
LA-N-6,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Growth rate is faster the closer in proximity it is to other cells. Thaw in 60 mm plate, rather than 100 mm plate.",Relapse (4),Progressing,Patient received chemotherapy prior to sample collection. 5 cycles of cyclophosphamide and doxorubicin.,Bone Marow,p36.12-pterm; cnLOH p35.3-p36.11,Loss p14.3-qterm,Loss q13.4-qterm,Gain q12-qterm,WT,Non-amplified,WT,NA,12,NA,15,NA,NA,NA,NA,NA,NA,,7,1,10,10,10,02/04/2020,KU,"From KU, P7, 7/17/2019",12/17/2019,3/3/20,Good,X,,15,,,16,17,,10,15,14,16,,12,,,7,12,,10,12,16,,,18,19,,11,12,,13,,,6,,14,16,,30,32.2,,11,12,10,12,8,,,-,13,14,,15,23,,14,,,18,21,,16,,,,Maris
NB-1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Loosely adherent; Combination of adherent and non-adherent ,"Be careful when washing cells as they are loosely adherent and can detach. Growth rate is faster the closer in proximity it is to other cells. Thaw in 60 mm plate, rather than 100 mm plate.",Unknown,Unknown,Unknown,Unknown,Loss p32.2-pterm,Gain p24.1-pterm,cnLOH q23.1,Gain q22-qterm,WT; Amplified,Amplified,WT,NA,6,NA,10,NA,NA,NA,NA,NA,NA,,7,2,1,1,4,11/2/2012,LSH,,11/02/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Loosely adherent; Combination of adherent and non-adherent ,"Be careful when washing cells as they are loosely adherent and can detach. Growth rate is faster the closer in proximity it is to other cells. Thaw in 60 mm plate, rather than 100 mm plate.",Unknown,Unknown,Unknown,Unknown,Loss p32.2-pterm,Gain p24.1-pterm,cnLOH q23.1,Gain q22-qterm,WT; Amplified,Amplified,WT,NA,6,NA,10,NA,NA,NA,NA,NA,NA,,7,2,1,2,6,12/05/2014,LSH,,11/26/2014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Loosely adherent; Combination of adherent and non-adherent ,"Be careful when washing cells as they are loosely adherent and can detach. Growth rate is faster the closer in proximity it is to other cells. Thaw in 60 mm plate, rather than 100 mm plate.",Unknown,Unknown,Unknown,Unknown,Loss p32.2-pterm,Gain p24.1-pterm,cnLOH q23.1,Gain q22-qterm,WT; Amplified,Amplified,WT,NA,6,NA,10,NA,NA,NA,NA,NA,NA,,7,2,1,3,9,11/16/15,JLH,,,12/10/2019,Good (STR of subsequent freeze is good),X,,15,17,,12,16,,10,11,14,15,,10,13,,17,18,,9,,14,,,17,28,,10,12,,8,9,,7,,16,19,20,31,31.2,,8,12,9,11,11,,,-,12,16,,19,20,,13.2,15.2,,19,22,,15,17,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Loosely adherent; Combination of adherent and non-adherent ,"Be careful when washing cells as they are loosely adherent and can detach. Growth rate is faster the closer in proximity it is to other cells. Thaw in 60 mm plate, rather than 100 mm plate.",Unknown,Unknown,Unknown,Unknown,Loss p32.2-pterm,Gain p24.1-pterm,cnLOH q23.1,Gain q22-qterm,WT; Amplified,Amplified,WT,NA,6,NA,10,NA,NA,NA,NA,NA,NA,,7,2,1,5,5,07/10/2017,KLC,"thawed from JLH, p9
 , 11/16/2015",07/05/2017,12/10/2019,Good,X,,15,17,,12,16,,10,11,14,15,,10,13,,17,18,,9,,14,,,17,28,,10,12,,8,9,,7,,16,19,20,31,31.2,,8,12,9,11,11,,,-,12,16,,19,20,,13.2,15.2,,19,22,,15,17,,,Maris
NB-1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Loosely adherent; Combination of adherent and non-adherent ,"Be careful when washing cells as they are loosely adherent and can detach. Growth rate is faster the closer in proximity it is to other cells. Thaw in 60 mm plate, rather than 100 mm plate.",Unknown,Unknown,Unknown,Unknown,Loss p32.2-pterm,Gain p24.1-pterm,cnLOH q23.1,Gain q22-qterm,WT; Amplified,Amplified,WT,NA,6,NA,10,NA,NA,NA,NA,NA,NA,,7,2,1,6,5,07/10/2017,KLC,"thawed from JLH, p9, 11/16/2015",07/05/2017,12/10/2019,Good,X,,15,17,,12,16,,10,11,14,15,,10,13,,17,18,,9,,14,,,17,28,,10,12,,8,9,,7,,16,19,20,31,31.2,,8,12,9,11,11,,,-,12,16,,19,20,,13.2,15.2,,19,22,,15,17,,,Maris
NB-1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Loosely adherent; Combination of adherent and non-adherent ,"Be careful when washing cells as they are loosely adherent and can detach. Growth rate is faster the closer in proximity it is to other cells. Thaw in 60 mm plate, rather than 100 mm plate.",Unknown,Unknown,Unknown,Unknown,Loss p32.2-pterm,Gain p24.1-pterm,cnLOH q23.1,Gain q22-qterm,WT; Amplified,Amplified,WT,NA,6,NA,10,NA,NA,NA,NA,NA,NA,,7,2,1,7,7,03/12/2019,KU,"thawed from KLC, P4, 06/30/2017",02/26/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Loosely adherent; Combination of adherent and non-adherent ,"Be careful when washing cells as they are loosely adherent and can detach. Growth rate is faster the closer in proximity it is to other cells. Thaw in 60 mm plate, rather than 100 mm plate.",Unknown,Unknown,Unknown,Unknown,Loss p32.2-pterm,Gain p24.1-pterm,cnLOH q23.1,Gain q22-qterm,WT; Amplified,Amplified,WT,NA,6,NA,10,NA,NA,NA,NA,NA,NA,,7,2,1,8,8,07/19/2019,KU,thawed from P5 KLC 7/10/2017,07/02/2019,12/10/2019,Good,X,,15,17,,12,16,,10,11,14,15,,10,13,,17,18,,9,,14,,,17,28,,10,12,,8,9,,7,,16,19,20,31,31.2,,8,12,9,11,11,,,-,12,16,,19,20,,13.2,15.2,,19,22,,15,17,,,Maris
NB-1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Loosely adherent; Combination of adherent and non-adherent ,"Be careful when washing cells as they are loosely adherent and can detach. Growth rate is faster the closer in proximity it is to other cells. Thaw in 60 mm plate, rather than 100 mm plate.",Unknown,Unknown,Unknown,Unknown,Loss p32.2-pterm,Gain p24.1-pterm,cnLOH q23.1,Gain q22-qterm,WT; Amplified,Amplified,WT,NA,6,NA,10,NA,NA,NA,NA,NA,NA,,7,2,1,9,8,07/19/2019,KU,thawed from P5 KLC 7/10/2017,07/02/2019,12/10/2019,Good,X,,15,17,,12,16,,10,11,14,15,,10,13,,17,18,,9,,14,,,17,28,,10,12,,8,9,,7,,16,19,20,31,31.2,,8,12,9,11,11,,,-,12,16,,19,20,,13.2,15.2,,19,22,,15,17,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-619,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,2,1,5,11/05/2018,KU,"new batch from CCCR, P4 NR 06/11/2018",,12/10/2019,Good (Y dropout in Amelogenin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-619,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,2,2,5,11/05/2018,KU,"new batch from CCCR, P4 NR 06/11/2018",,12/10/2019,Good (Y dropout in Amelogenin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-619,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,2,3,5,11/05/2018,KU,"new batch from CCCR, P4 NR 06/11/2018",,12/10/2019,Good (Y dropout in Amelogenin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-619,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,2,4,5,11/05/2018,KU,"new batch from CCCR, P4 NR 06/11/2018",,12/10/2019,Good (Y dropout in Amelogenin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-619,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,2,5,6,11/12/2018,KU,"new batch from CCCR, P4 NR 06/11/2018",,12/10/2019,Good (Y dropout in Amelogenin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-619,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,2,6,6,11/12/2018,KU,"new batch from CCCR, P4 NR 06/11/2018",,12/10/2019,Good (Y dropout in Amelogenin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-619,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,2,7,6,11/05/2018,KU,"new batch from CCCR, P4 NR 06/11/2018",,12/10/2019,Good (Y dropout in Amelogenin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-619,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,2,8,6,11/05/2018,KU,"new batch from CCCR, P4 NR 06/11/2018",,12/10/2019,Good (Y dropout in Amelogenin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,2,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,2,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-618,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,3,1,5,10/30/2018,KU,"new batch from CCCR, P4 NR 04/25/2018",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-618,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,3,2,5,10/30/2018,KU,"new batch from CCCR, P4 NR 04/25/2018",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-618,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,3,3,5,10/30/2018,KU,"new batch from CCCR, P4 NR 04/25/2018",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-618,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,3,4,5,10/30/2018,KU,"new batch from CCCR, P4 NR 04/25/2018",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-618,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,3,5,6,11/05/2018,KU,"new batch from CCCR, P4 NR 04/25/2018",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-618,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,3,6,6,11/05/2018,KU,"new batch from CCCR, P4 NR 04/25/2018",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-618,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,3,7,6,11/05/2018,KU,"new batch from CCCR, P4 NR 04/25/2018",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-618,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,3,8,6,11/05/2018,KU,"new batch from CCCR, P4 NR 04/25/2018",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,3,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,3,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-623,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,4,1,9,03/21/2019,KU,"new batch from CCCR, P6 JN 08/331/2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-623,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,4,2,9,03/21/2019,KU,"new batch from CCCR, P6 JN 08/331/2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-623,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,4,3,9,03/21/2019,KU,"new batch from CCCR, P6 JN 08/331/2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-623,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,4,4,9,03/21/2019,KU,"new batch from CCCR, P6 JN 08/331/2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-623,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,4,5,8,03/13/2019,KU,"new batch from CCCR, P6 JN 08/331/2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-623,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,4,6,8,03/13/2019,KU,"new batch from CCCR, P6 JN 08/331/2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-623,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,4,7,8,03/13/2019,KU,"new batch from CCCR, P6 JN 08/331/2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-623,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,4,8,8,03/13/2019,KU,"new batch from CCCR, P6 JN 08/331/2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,4,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,4,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-1691,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,Loss p26.1,LOH q11-qter; Loss q22.1-q24.3,None,WT,Amplified,WT,6,10,NA,NA,NA,NA,20,NA,NA,NA,,7,2,5,1,4,01/22/2015,LSH,,2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-1691,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,Loss p26.1,LOH q11-qter; Loss q22.1-q24.3,None,WT,Amplified,WT,6,10,NA,NA,NA,NA,20,NA,NA,NA,,7,2,5,2,6,02/19/2020,KU,"From KLC, p4, 3/01/17",02/04/2020,3/3/20,Good (Drop out of Y at Amelogenin),X,Y (DO),16,,,16,17.3,,10,,13,14,,8,12,,15,,,9,12,16,21,,17,,,10,14,,13,,,9,,19,,,31.2,,,11,,12,,8,,,-,13,15,,20,,,14,16,,21,22,,16,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-1691,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,Loss p26.1,LOH q11-qter; Loss q22.1-q24.3,None,WT,Amplified,WT,6,10,NA,NA,NA,NA,20,NA,NA,NA,,7,2,5,4,6,02/19/2020,KU,"From KLC, P4, 03/01/2017",02/04/2020,3/3/20,Good (Drop out of Y at Amelogenin),X,Y (DO),16,,,16,17.3,,10,,13,14,,8,12,,15,,,9,12,16,21,,17,,,10,14,,13,,,9,,19,,,31.2,,,11,,12,,8,,,-,13,15,,20,,,14,16,,21,22,,16,,,,Maris
NB-1691,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,Loss p26.1,LOH q11-qter; Loss q22.1-q24.3,None,WT,Amplified,WT,6,10,NA,NA,NA,NA,20,NA,NA,NA,,7,2,5,5,6,02/19/2020,KU,"From KLC, P4, 03/01/2017",02/04/2020,3/3/20,Good (Drop out of Y at Amelogenin),X,Y (DO),16,,,16,17.3,,10,,13,14,,8,12,,15,,,9,12,16,21,,17,,,10,14,,13,,,9,,19,,,31.2,,,11,,12,,8,,,-,13,15,,20,,,14,16,,21,22,,16,,,,Maris
NB-1691,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,Loss p26.1,LOH q11-qter; Loss q22.1-q24.3,None,WT,Amplified,WT,6,10,NA,NA,NA,NA,20,NA,NA,NA,,7,2,5,6,4,03/01/2017,KLC,,12/16/2014,3/3/20,Good (Drop out of Y at Amelogenin),X,Y (DO),16,,,16,17.3,,10,,13,14,,8,12,,15,,,9,12,16,21,,17,,,10,14,,13,,,9,,19,,,31.2,,,11,,12,,8,,,-,13,15,,20,,,14,16,,21,22,,16,,,,Maris
NB-1691,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,Loss p26.1,LOH q11-qter; Loss q22.1-q24.3,None,WT,Amplified,WT,6,10,NA,NA,NA,NA,20,NA,NA,NA,,7,2,5,7,4,03/01/2017,KLC,,12/16/2014,3/3/20,Good (Drop out of Y at Amelogenin),X,Y (DO),16,,,16,17.3,,10,,13,14,,8,12,,15,,,9,12,16,21,,17,,,10,14,,13,,,9,,19,,,31.2,,,11,,12,,8,,,-,13,15,,20,,,14,16,,21,22,,16,,,,Maris
NB-1691,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,Loss p26.1,LOH q11-qter; Loss q22.1-q24.3,None,WT,Amplified,WT,6,10,NA,NA,NA,NA,20,NA,NA,NA,,7,2,5,8,4,03/01/2017,KLC,,12/16/2014,3/3/20,Good (Drop out of Y at Amelogenin),X,Y (DO),16,,,16,17.3,,10,,13,14,,8,12,,15,,,9,12,16,21,,17,,,10,14,,13,,,9,,19,,,31.2,,,11,,12,,8,,,-,13,15,,20,,,14,16,,21,22,,16,,,,Maris
NB-1691,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,Loss p26.1,LOH q11-qter; Loss q22.1-q24.3,None,WT,Amplified,WT,6,10,NA,NA,NA,NA,20,NA,NA,NA,,7,2,5,9,4,08/11/2017,KLC,"from LSH, p3, 03/09/2015",07/28/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-1691,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,Loss p26.1,LOH q11-qter; Loss q22.1-q24.3,None,WT,Amplified,WT,6,10,NA,NA,NA,NA,20,NA,NA,NA,,7,2,5,10,6,02/19/2020,KU,"From KLC, P4, 03/01/2017",02/04/2020,3/3/20,Good (Drop out of Y at Amelogenin),X,Y (DO),16,,,16,17.3,,10,,13,14,,8,12,,15,,,9,12,16,21,,17,,,10,14,,13,,,9,,19,,,31.2,,,11,,12,,8,,,-,13,15,,20,,,14,16,,21,22,,16,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,6,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,6,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,6,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,6,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,6,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,6,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-1691,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,Loss p26.1,LOH q11-qter; Loss q22.1-q24.3,None,WT,Amplified,WT,6,10,NA,NA,NA,NA,20,NA,NA,NA,,7,2,6,8,6,02/19/2020,KU,"From KLC, P4, 03/01/2017",02/04/2020,3/3/20,Good (Drop out of Y at Amelogenin),X,Y (DO),16,,,16,17.3,,10,,13,14,,8,12,,15,,,9,12,16,21,,17,,,10,14,,13,,,9,,19,,,31.2,,,11,,12,,8,,,-,13,15,,20,,,14,16,,21,22,,16,,,,Maris
NB-1691,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,Loss p26.1,LOH q11-qter; Loss q22.1-q24.3,None,WT,Amplified,WT,6,10,NA,NA,NA,NA,20,NA,NA,NA,,7,2,6,9,6,02/19/2020,KU,"From KLC, P4, 03/01/2017",02/04/2020,3/3/20,Good (Drop out of Y at Amelogenin),X,Y (DO),16,,,16,17.3,,10,,13,14,,8,12,,15,,,9,12,16,21,,17,,,10,14,,13,,,9,,19,,,31.2,,,11,,12,,8,,,-,13,15,,20,,,14,16,,21,22,,16,,,,Maris
NB-1691,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,Loss p26.1,LOH q11-qter; Loss q22.1-q24.3,None,WT,Amplified,WT,6,10,NA,NA,NA,NA,20,NA,NA,NA,,7,2,6,10,6,02/19/2020,KU,"From KLC, P4, 03/01/2017",02/04/2020,3/3/20,Good (Drop out of Y at Amelogenin),X,Y (DO),16,,,16,17.3,,10,,13,14,,8,12,,15,,,9,12,16,21,,17,,,10,14,,13,,,9,,19,,,31.2,,,11,,12,,8,,,-,13,15,,20,,,14,16,,21,22,,16,,,,Maris
NB-69,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Unknown,Loss p13.3-pterm,None,"cnLOH q23.1, q23.3",Gain q12-qterm,WT,Non-amplified,WT,NA,NA,NA,5-6,NA,NA,NA,NA,7-8,12,,7,2,7,1,4,10/28/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-69,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Unknown,Loss p13.3-pterm,None,"cnLOH q23.1, q23.3",Gain q12-qterm,WT,Non-amplified,WT,NA,NA,NA,5-6,NA,NA,NA,NA,7-8,12,,7,2,7,2,4,07/26/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-69,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Unknown,Loss p13.3-pterm,None,"cnLOH q23.1, q23.3",Gain q12-qterm,WT,Non-amplified,WT,NA,NA,NA,5-6,NA,NA,NA,NA,7-8,12,,7,2,7,3,8,02/12/2020,KU,"From KLC, P6, 11/04/2016",02/04/2020,03/03/2020,Good (Y Drop out at Amelogenin),X,Y (DO),16,17,,12,17.3,,11,11.3,14,15,,8,,,10,13,,9,11,15,16,,17,23,,11,12,,7,12,,8,,17,18,,30.2,31.2,,10,,11,12,8,11,,-,14,15,,19,23,,14,15,,21,25,,16,,,,Maris
NB-69,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Unknown,Loss p13.3-pterm,None,"cnLOH q23.1, q23.3",Gain q12-qterm,WT,Non-amplified,WT,NA,NA,NA,5-6,NA,NA,NA,NA,7-8,12,,7,2,7,4,6,11/04/2016,KLC,"From LSH, p4, 7/26/2014",,03/03/2020,Good (Y Drop out at Amelogenin),X,Y (DO),16,17,,12,17.3,,11,11.3,14,15,,8,,,10,13,,9,11,15,16,,17,23,,11,12,,7,12,,8,,17,18,,30.2,31.2,,10,,11,12,8,11,,-,14,15,,19,23,,14,15,,21,25,,16,,,,Maris
NB-69,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Unknown,Loss p13.3-pterm,None,"cnLOH q23.1, q23.3",Gain q12-qterm,WT,Non-amplified,WT,NA,NA,NA,5-6,NA,NA,NA,NA,7-8,12,,7,2,7,5,8,02/12/2020,KU,"From KLC, P6, 11/04/2016",02/04/2020,03/03/2020,Good (Y Drop out at Amelogenin),X,Y (DO),16,17,,12,17.3,,11,11.3,14,15,,8,,,10,13,,9,11,15,16,,17,23,,11,12,,7,12,,8,,17,18,,30.2,31.2,,10,,11,12,8,11,,-,14,15,,19,23,,14,15,,21,25,,16,,,,Maris
NB-69,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Unknown,Loss p13.3-pterm,None,"cnLOH q23.1, q23.3",Gain q12-qterm,WT,Non-amplified,WT,NA,NA,NA,5-6,NA,NA,NA,NA,7-8,12,,7,2,7,6,8,02/12/2020,KU,"From KLC, P6, 11/04/2016",02/04/2020,03/03/2020,Good (Y Drop out at Amelogenin),X,Y (DO),16,17,,12,17.3,,11,11.3,14,15,,8,,,10,13,,9,11,15,16,,17,23,,11,12,,7,12,,8,,17,18,,30.2,31.2,,10,,11,12,8,11,,-,14,15,,19,23,,14,15,,21,25,,16,,,,Maris
NB-69,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Unknown,Loss p13.3-pterm,None,"cnLOH q23.1, q23.3",Gain q12-qterm,WT,Non-amplified,WT,NA,NA,NA,5-6,NA,NA,NA,NA,7-8,12,,7,2,7,7,2,11/15/2016,JLH,,07/11/2017,08/22/2018,Good (Y Drop out at Amelogenin),X,Y (DO),16,17,,12,17.3,,11,11.3,14,15,,8,,,10,13,,9,11,15,16,,17,23,,11,12,,7,12,,8,,17,18,,30.2,31.2,,10,,11,12,8,11,,,14,15,,19,23,,14,15,,21,25,,,,,,Maris
NB-69,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Unknown,Loss p13.3-pterm,None,"cnLOH q23.1, q23.3",Gain q12-qterm,WT,Non-amplified,WT,NA,NA,NA,5-6,NA,NA,NA,NA,7-8,12,,7,2,7,8,2,11/15/2016,JLH,,07/11/2017,08/22/2018,Good (Y Drop out at Amelogenin),X,Y (DO),16,17,,12,17.3,,11,11.3,14,15,,8,,,10,13,,9,11,15,16,,17,23,,11,12,,7,12,,8,,17,18,,30.2,31.2,,10,,11,12,8,11,,,14,15,,19,23,,14,15,,21,25,,,,,,Maris
NB-69,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Unknown,Loss p13.3-pterm,None,"cnLOH q23.1, q23.3",Gain q12-qterm,WT,Non-amplified,WT,NA,NA,NA,5-6,NA,NA,NA,NA,7-8,12,,7,2,7,9,2,11/15/2016,JLH,,07/11/2017,08/22/2018,Good (Y Drop out at Amelogenin),X,Y (DO),16,17,,12,17.3,,11,11.3,14,15,,8,,,10,13,,9,11,15,16,,17,23,,11,12,,7,12,,8,,17,18,,30.2,31.2,,10,,11,12,8,11,,,14,15,,19,23,,14,15,,21,25,,,,,,Maris
NB-69,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Unknown,Loss p13.3-pterm,None,"cnLOH q23.1, q23.3",Gain q12-qterm,WT,Non-amplified,WT,NA,NA,NA,5-6,NA,NA,NA,NA,7-8,12,,7,2,7,10,8,02/12/2020,KU,"From KLC, P6, 11/04/2016",02/04/2020,03/03/2020,Good (Y Drop out at Amelogenin),X,Y (DO),16,17,,12,17.3,,11,11.3,14,15,,8,,,10,13,,9,11,15,16,,17,23,,11,12,,7,12,,8,,17,18,,30.2,31.2,,10,,11,12,8,11,,-,14,15,,19,23,,14,15,,21,25,,16,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,8,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,8,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,8,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,8,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,8,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,8,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,8,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,8,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-69,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Unknown,Loss p13.3-pterm,None,"cnLOH q23.1, q23.3",Gain q12-qterm,WT,Non-amplified,WT,NA,NA,NA,5-6,NA,NA,NA,NA,7-8,12,,7,2,8,10,8,02/12/2020,KU,"From KLC, P6, 11/04/2016",02/04/2020,03/03/2020,Good (Y Drop out at Amelogenin),X,Y (DO),16,17,,12,17.3,,11,11.3,14,15,,8,,,10,13,,9,11,15,16,,17,23,,11,12,,7,12,,8,,17,18,,30.2,31.2,,10,,11,12,8,11,,-,14,15,,19,23,,14,15,,21,25,,16,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,9,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-EBC1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"If EBC1 becomes overly confluent, their morphology will change from round and cloud like, to smaller with thorn like spikes. Morphology will return to normal after 2-3 passages. Experiments should not be done if the cells are in the stressed morphology. 
",Relapse,Progressing,Unknown,Solid Tumor,Loss p35.2-pterm,Gain p26.1-pter,Loss q21-24.2,Gain q21.31-qterm,WT,Non-amplified,WT,NA,3,4-5,NA,NA,NA,NA,NA,NA,NA,,7,2,9,2,6,06/16/2017,KLC,,06/09/2017,08/22/2018,Good,X,Y,17,,,15,17.3,,11.3,14,14,,,11,12,,11,,,12,,15,20,,19,20,,12,,,9,,,6,9.3,17,19,,27,32.2,,12,14,10,12,8,,,11,11,13,,18.3,,,14,15,,24,25,,14,15,,,Maris
NB-EBC1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"If EBC1 becomes overly confluent, their morphology will change from round and cloud like, to smaller with thorn like spikes. Morphology will return to normal after 2-3 passages. Experiments should not be done if the cells are in the stressed morphology. 
",Relapse,Progressing,Unknown,Solid Tumor,Loss p35.2-pterm,Gain p26.1-pter,Loss q21-24.2,Gain q21.31-qterm,WT,Non-amplified,WT,NA,3,4-5,NA,NA,NA,NA,NA,NA,NA,,7,2,9,3,6,06/16/2017,KLC,,06/09/2017,08/22/2018,Good,X,Y,17,,,15,17.3,,11.3,14,14,,,11,12,,11,,,12,,15,20,,19,20,,12,,,9,,,6,9.3,17,19,,27,32.2,,12,14,10,12,8,,,11,11,13,,18.3,,,14,15,,24,25,,14,15,,,Maris
NB-EBC1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"If EBC1 becomes overly confluent, their morphology will change from round and cloud like, to smaller with thorn like spikes. Morphology will return to normal after 2-3 passages. Experiments should not be done if the cells are in the stressed morphology. 
",Relapse,Progressing,Unknown,Solid Tumor,Loss p35.2-pterm,Gain p26.1-pter,Loss q21-24.2,Gain q21.31-qterm,WT,Non-amplified,WT,NA,3,4-5,NA,NA,NA,NA,NA,NA,NA,,7,2,9,4,6,06/16/2017,KLC,,06/09/2017,08/22/2018,Good,X,Y,17,,,15,17.3,,11.3,14,14,,,11,12,,11,,,12,,15,20,,19,20,,12,,,9,,,6,9.3,17,19,,27,32.2,,12,14,10,12,8,,,11,11,13,,18.3,,,14,15,,24,25,,14,15,,,Maris
NB-EBC1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"If EBC1 becomes overly confluent, their morphology will change from round and cloud like, to smaller with thorn like spikes. Morphology will return to normal after 2-3 passages. Experiments should not be done if the cells are in the stressed morphology. 
",Relapse,Progressing,Unknown,Solid Tumor,Loss p35.2-pterm,Gain p26.1-pter,Loss q21-24.2,Gain q21.31-qterm,WT,Non-amplified,WT,NA,3,4-5,NA,NA,NA,NA,NA,NA,NA,,7,2,9,5,6,06/16/2017,KLC,,06/09/2017,08/22/2018,Good,X,Y,17,,,15,17.3,,11.3,14,14,,,11,12,,11,,,12,,15,20,,19,20,,12,,,9,,,6,9.3,17,19,,27,32.2,,12,14,10,12,8,,,11,11,13,,18.3,,,14,15,,24,25,,14,15,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,9,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-EBC1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"If EBC1 becomes overly confluent, their morphology will change from round and cloud like, to smaller with thorn like spikes. Morphology will return to normal after 2-3 passages. Experiments should not be done if the cells are in the stressed morphology. 
",Relapse,Progressing,Unknown,Solid Tumor,Loss p35.2-pterm,Gain p26.1-pter,Loss q21-24.2,Gain q21.31-qterm,WT,Non-amplified,WT,NA,3,4-5,NA,NA,NA,NA,NA,NA,NA,,7,2,9,7,9,07/05/2019,KU,From P6 KLC 06/20/2017 (STR from thaw is good),07/02/2019,03/03/2020,Good,X,Y,17,,,15,17.3,,11.3,14,14,,,11,12,,11,,,12,,15,20,,19,20,,12,,,9,,,6,9.3,17,19,,27,32.2,,12,14,10,12,8,,,11,11,13,,18.3,,,14,15,,24,25,,14,15,,,Maris
NB-EBC1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"If EBC1 becomes overly confluent, their morphology will change from round and cloud like, to smaller with thorn like spikes. Morphology will return to normal after 2-3 passages. Experiments should not be done if the cells are in the stressed morphology. 
",Relapse,Progressing,Unknown,Solid Tumor,Loss p35.2-pterm,Gain p26.1-pter,Loss q21-24.2,Gain q21.31-qterm,WT,Non-amplified,WT,NA,3,4-5,NA,NA,NA,NA,NA,NA,NA,,7,2,9,8,9,07/05/2019,KU,From P6 KLC 06/20/2017 (STR from thaw is good),07/02/2019,03/03/2020,Good,X,Y,17,,,15,17.3,,11.3,14,14,,,11,12,,11,,,12,,15,20,,19,20,,12,,,9,,,6,9.3,17,19,,27,32.2,,12,14,10,12,8,,,11,11,13,,18.3,,,14,15,,24,25,,14,15,,,Maris
NB-EBC1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"If EBC1 becomes overly confluent, their morphology will change from round and cloud like, to smaller with thorn like spikes. Morphology will return to normal after 2-3 passages. Experiments should not be done if the cells are in the stressed morphology. 
",Relapse,Progressing,Unknown,Solid Tumor,Loss p35.2-pterm,Gain p26.1-pter,Loss q21-24.2,Gain q21.31-qterm,WT,Non-amplified,WT,NA,3,4-5,NA,NA,NA,NA,NA,NA,NA,,7,2,9,9,9,12/27/2019,KU,From P6 KLC 06/20/2017 (STR from thaw is good),12/20/2019,03/03/2020,Good,X,Y,17,,,15,17.3,,11.3,14,14,,,11,12,,11,,,12,,15,20,,19,20,,12,,,9,,,6,9.3,17,19,,27,32.2,,12,14,10,12,8,,,11,11,13,,18.3,,,14,15,,24,25,,14,15,,,Maris
NB-EBC1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"If EBC1 becomes overly confluent, their morphology will change from round and cloud like, to smaller with thorn like spikes. Morphology will return to normal after 2-3 passages. Experiments should not be done if the cells are in the stressed morphology. 
",Relapse,Progressing,Unknown,Solid Tumor,Loss p35.2-pterm,Gain p26.1-pter,Loss q21-24.2,Gain q21.31-qterm,WT,Non-amplified,WT,NA,3,4-5,NA,NA,NA,NA,NA,NA,NA,,7,2,9,10,9,12/27/2019,KU,From P6 KLC 06/20/2017 (STR from thaw is good),12/20/2019,03/03/2020,Good,X,Y,17,,,15,17.3,,11.3,14,14,,,11,12,,11,,,12,,15,20,,19,20,,12,,,9,,,6,9.3,17,19,,27,32.2,,12,14,10,12,8,,,11,11,13,,18.3,,,14,15,,24,25,,14,15,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,10,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-EBC1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"If EBC1 becomes overly confluent, their morphology will change from round and cloud like, to smaller with thorn like spikes. Morphology will return to normal after 2-3 passages. Experiments should not be done if the cells are in the stressed morphology. 
",Relapse,Progressing,Unknown,Solid Tumor,Loss p35.2-pterm,Gain p26.1-pter,Loss q21-24.2,Gain q21.31-qterm,WT,Non-amplified,WT,NA,3,4-5,NA,NA,NA,NA,NA,NA,NA,,7,2,10,2,11,02/19/2020,KU,"From KU, P9, 12/19/2019",02/14/2020,03/03/2020,Good,X,Y,17,,,15,17.3,,11.3,14,14,,,11,12,,11,,,12,,15,20,,19,20,,12,,,9,,,6,9.3,17,19,,27,32.2,,12,14,10,12,8,,,11,11,13,,18.3,,,14,15,,24,25,,14,15,,,Maris
NB-EBC1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"If EBC1 becomes overly confluent, their morphology will change from round and cloud like, to smaller with thorn like spikes. Morphology will return to normal after 2-3 passages. Experiments should not be done if the cells are in the stressed morphology. 
",Relapse,Progressing,Unknown,Solid Tumor,Loss p35.2-pterm,Gain p26.1-pter,Loss q21-24.2,Gain q21.31-qterm,WT,Non-amplified,WT,NA,3,4-5,NA,NA,NA,NA,NA,NA,NA,,7,2,10,3,11,02/19/2020,KU,"From KU, P9, 12/19/2019",02/14/2020,03/03/2020,Good,X,Y,17,,,15,17.3,,11.3,14,14,,,11,12,,11,,,12,,15,20,,19,20,,12,,,9,,,6,9.3,17,19,,27,32.2,,12,14,10,12,8,,,11,11,13,,18.3,,,14,15,,24,25,,14,15,,,Maris
NB-EBC1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"If EBC1 becomes overly confluent, their morphology will change from round and cloud like, to smaller with thorn like spikes. Morphology will return to normal after 2-3 passages. Experiments should not be done if the cells are in the stressed morphology. 
",Relapse,Progressing,Unknown,Solid Tumor,Loss p35.2-pterm,Gain p26.1-pter,Loss q21-24.2,Gain q21.31-qterm,WT,Non-amplified,WT,NA,3,4-5,NA,NA,NA,NA,NA,NA,NA,,7,2,10,4,11,02/19/2020,KU,"From KU, P9, 12/19/2019",02/14/2020,03/03/2020,Good,X,Y,17,,,15,17.3,,11.3,14,14,,,11,12,,11,,,12,,15,20,,19,20,,12,,,9,,,6,9.3,17,19,,27,32.2,,12,14,10,12,8,,,11,11,13,,18.3,,,14,15,,24,25,,14,15,,,Maris
NB-EBC1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"If EBC1 becomes overly confluent, their morphology will change from round and cloud like, to smaller with thorn like spikes. Morphology will return to normal after 2-3 passages. Experiments should not be done if the cells are in the stressed morphology. 
",Relapse,Progressing,Unknown,Solid Tumor,Loss p35.2-pterm,Gain p26.1-pter,Loss q21-24.2,Gain q21.31-qterm,WT,Non-amplified,WT,NA,3,4-5,NA,NA,NA,NA,NA,NA,NA,,7,2,10,5,11,02/19/2020,KU,"From KU, P9, 12/19/2019",02/14/2020,03/03/2020,Good,X,Y,17,,,15,17.3,,11.3,14,14,,,11,12,,11,,,12,,15,20,,19,20,,12,,,9,,,6,9.3,17,19,,27,32.2,,12,14,10,12,8,,,11,11,13,,18.3,,,14,15,,24,25,,14,15,,,Maris
NB-EBC1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"If EBC1 becomes overly confluent, their morphology will change from round and cloud like, to smaller with thorn like spikes. Morphology will return to normal after 2-3 passages. Experiments should not be done if the cells are in the stressed morphology. 
",Relapse,Progressing,Unknown,Solid Tumor,Loss p35.2-pterm,Gain p26.1-pter,Loss q21-24.2,Gain q21.31-qterm,WT,Non-amplified,WT,NA,3,4-5,NA,NA,NA,NA,NA,NA,NA,,7,2,10,6,11,02/19/2020,KU,"From KU, P9, 12/19/2019",02/14/2020,03/03/2020,Good,X,Y,17,,,15,17.3,,11.3,14,14,,,11,12,,11,,,12,,15,20,,19,20,,12,,,9,,,6,9.3,17,19,,27,32.2,,12,14,10,12,8,,,11,11,13,,18.3,,,14,15,,24,25,,14,15,,,Maris
NB-EBC1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"If EBC1 becomes overly confluent, their morphology will change from round and cloud like, to smaller with thorn like spikes. Morphology will return to normal after 2-3 passages. Experiments should not be done if the cells are in the stressed morphology. 
",Relapse,Progressing,Unknown,Solid Tumor,Loss p35.2-pterm,Gain p26.1-pter,Loss q21-24.2,Gain q21.31-qterm,WT,Non-amplified,WT,NA,3,4-5,NA,NA,NA,NA,NA,NA,NA,,7,2,10,7,11,02/19/2020,KU,"From KU, P9, 12/19/2019",02/14/2020,03/03/2020,Good,X,Y,17,,,15,17.3,,11.3,14,14,,,11,12,,11,,,12,,15,20,,19,20,,12,,,9,,,6,9.3,17,19,,27,32.2,,12,14,10,12,8,,,11,11,13,,18.3,,,14,15,,24,25,,14,15,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,2,10,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-628,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,2,10,9,4,02/09/2018,NR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-SH,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Two distinct morphologies ,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,None,None,LOH 23.1,Gain q21.31-qterm,F1174L,Non-amplified,WT,NA,NA,NA,NA,5,NA,6,NA,NA,NA,,7,2,10,10,LOT # 5105351,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NBL-S,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Unknown,None,None,Loss q14.1-qterm,None,WT,Non-amplified,WT,NA,3,NA,6-7,NA,NA,NA,NA,9,NA,,7,3,1,1,5,07/10/2017,KLC,"from klc, p3, 11/11/16",07/11/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NBL-S,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Unknown,None,None,Loss q14.1-qterm,None,WT,Non-amplified,WT,NA,3,NA,6-7,NA,NA,NA,NA,9,NA,,7,3,1,2,4,10/07/2014,LSH,,10/10/2014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NBL-S,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Unknown,None,None,Loss q14.1-qterm,None,WT,Non-amplified,WT,NA,3,NA,6-7,NA,NA,NA,NA,9,NA,,7,3,1,3,4,10/07/2014,LSH,,10/10/2014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NBL-S,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Unknown,None,None,Loss q14.1-qterm,None,WT,Non-amplified,WT,NA,3,NA,6-7,NA,NA,NA,NA,9,NA,,7,3,1,4,3,11/11/2016,klc,,10/10/2014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NBL-S,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Unknown,None,None,Loss q14.1-qterm,None,WT,Non-amplified,WT,NA,3,NA,6-7,NA,NA,NA,NA,9,NA,,7,3,1,6,6,09/24/2018,KU,"From KLC, P5, 7/10/17 ",09/21/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NBL-S,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Unknown,None,None,Loss q14.1-qterm,None,WT,Non-amplified,WT,NA,3,NA,6-7,NA,NA,NA,NA,9,NA,,7,3,1,7,6,07/24/2018,KU,"From KLC, P5, 7/10/17",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NBL-S,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Unknown,None,None,Loss q14.1-qterm,None,WT,Non-amplified,WT,NA,3,NA,6-7,NA,NA,NA,NA,9,NA,,7,3,1,9,5,12/04/2019,KU,"From KLC , P3 11/11/2016",11/26/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NBL-S,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Unknown,None,None,Loss q14.1-qterm,None,WT,Non-amplified,WT,NA,3,NA,6-7,NA,NA,NA,NA,9,NA,,7,3,1,10,5,12/04/2019,KU,"From KLC , P3 11/11/2016",11/26/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NBL-S,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Unknown,None,None,Loss q14.1-qterm,None,WT,Non-amplified,WT,NA,3,NA,6-7,NA,NA,NA,NA,9,NA,,7,3,2,5,4,11/27/2019,KU,"From KLC , P3 11/11/2016",11/26/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NBL-S,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Unknown,None,None,Loss q14.1-qterm,None,WT,Non-amplified,WT,NA,3,NA,6-7,NA,NA,NA,NA,9,NA,,7,3,2,6,4,11/27/2019,KU,"From KLC , P3 11/11/2016",11/26/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,2,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NBL-S,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Unknown,None,None,Loss q14.1-qterm,None,WT,Non-amplified,WT,NA,3,NA,6-7,NA,NA,NA,NA,9,NA,,7,3,2,8,5,12/04/2019,KU,"From KLC , P3 11/11/2016",11/26/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,2,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,2,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-SD,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will grow and make a honeycomb like pattern and then grow into the honeycomb space as the plate becomes more confluent. 
",Relapse,Progressing,Unknown,Bone Marrow,Loss p21.3-pterm,Loss p13-pterm,cnLOH q23.2-23.3,Gan q12-qter,F1174L,Amplified,C176F,NA,3,NA,5,NA,NA,NA,NA,6,8,,7,3,3,1,6,02/21/2014,LSH,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-SD,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will grow and make a honeycomb like pattern and then grow into the honeycomb space as the plate becomes more confluent. 
",Relapse,Progressing,Unknown,Bone Marrow,Loss p21.3-pterm,Loss p13-pterm,cnLOH q23.2-23.3,Gan q12-qter,F1174L,Amplified,C176F,NA,3,NA,5,NA,NA,NA,NA,6,8,,7,3,3,2,4,08/02/2016,LSH,,11/06/2014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-SD,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will grow and make a honeycomb like pattern and then grow into the honeycomb space as the plate becomes more confluent. 
",Relapse,Progressing,Unknown,Bone Marrow,Loss p21.3-pterm,Loss p13-pterm,cnLOH q23.2-23.3,Gan q12-qter,F1174L,Amplified,C176F,NA,3,NA,5,NA,NA,NA,NA,6,8,,7,3,3,3,4,08/02/2016,LSH,,11/06/2014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,3,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,3,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-SD,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will grow and make a honeycomb like pattern and then grow into the honeycomb space as the plate becomes more confluent. 
",Relapse,Progressing,Unknown,Bone Marrow,Loss p21.3-pterm,Loss p13-pterm,cnLOH q23.2-23.3,Gan q12-qter,F1174L,Amplified,C176F,NA,3,NA,5,NA,NA,NA,NA,6,8,,7,3,3,6,8,12/04/2019,KU,"From KLC, P7, 04/06/2018 (STR from thaw is good)",11/26/2019,3/3/2020,Good (Drop out of 9 at CSF1PO),X,,18,,,15,16,,10,11,14,15,,11,,,10,13,,10,13,18,21,,19,,,9 (DO),13,,9,,,7,8,15,16,,28,31,,10,,12,,8,9,,-,15,16,,17,22,,13,14,,24,25,,16,17,,,Maris
NB-SD,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will grow and make a honeycomb like pattern and then grow into the honeycomb space as the plate becomes more confluent. 
",Relapse,Progressing,Unknown,Bone Marrow,Loss p21.3-pterm,Loss p13-pterm,cnLOH q23.2-23.3,Gan q12-qter,F1174L,Amplified,C176F,NA,3,NA,5,NA,NA,NA,NA,6,8,,7,3,3,7,8,12/04/2019,KU,"From KLC, P7, 04/06/2018 (STR from thaw is good)",11/26/2019,3/3/2020,Good (Drop out of 9 at CSF1PO),X,,18,,,15,16,,10,11,14,15,,11,,,10,13,,10,13,18,21,,19,,,9 (DO),13,,9,,,7,8,15,16,,28,31,,10,,12,,8,9,,-,15,16,,17,22,,13,14,,24,25,,16,17,,,Maris
NB-SD,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will grow and make a honeycomb like pattern and then grow into the honeycomb space as the plate becomes more confluent. 
",Relapse,Progressing,Unknown,Bone Marrow,Loss p21.3-pterm,Loss p13-pterm,cnLOH q23.2-23.3,Gan q12-qter,F1174L,Amplified,C176F,NA,3,NA,5,NA,NA,NA,NA,6,8,,7,3,3,8,8,12/04/2019,KU,"From KLC, P7, 04/06/2018 (STR from thaw is good)",11/26/2019,3/3/2020,Good (Drop out of 9 at CSF1PO),X,,18,,,15,16,,10,11,14,15,,11,,,10,13,,10,13,18,21,,19,,,9 (DO),13,,9,,,7,8,15,16,,28,31,,10,,12,,8,9,,-,15,16,,17,22,,13,14,,24,25,,16,17,,,Maris
NB-SD,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will grow and make a honeycomb like pattern and then grow into the honeycomb space as the plate becomes more confluent. 
",Relapse,Progressing,Unknown,Bone Marrow,Loss p21.3-pterm,Loss p13-pterm,cnLOH q23.2-23.3,Gan q12-qter,F1174L,Amplified,C176F,NA,3,NA,5,NA,NA,NA,NA,6,8,,7,3,3,9,9,12/27/2019,KU,"From KU, P8, 12/04/2019",12/20/2019,3/3/2020,Good (Drop out of 9 at CSF1PO),X,,18,,,15,16,,10,11,14,15,,11,,,10,13,,10,13,18,21,,19,,,9 (DO),13,,9,,,7,8,15,16,,28,31,,10,,12,,8,9,,-,15,16,,17,22,,13,14,,24,25,,16,17,,,Maris
NB-SD,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will grow and make a honeycomb like pattern and then grow into the honeycomb space as the plate becomes more confluent. 
",Relapse,Progressing,Unknown,Bone Marrow,Loss p21.3-pterm,Loss p13-pterm,cnLOH q23.2-23.3,Gan q12-qter,F1174L,Amplified,C176F,NA,3,NA,5,NA,NA,NA,NA,6,8,,7,3,3,10,9,12/27/2019,KU,"From KU, P8, 12/04/2019",12/20/2019,3/3/2020,Good (Drop out of 9 at CSF1PO),X,,18,,,15,16,,10,11,14,15,,11,,,10,13,,10,13,18,21,,19,,,9 (DO),13,,9,,,7,8,15,16,,28,31,,10,,12,,8,9,,-,15,16,,17,22,,13,14,,24,25,,16,17,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,4,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,4,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,4,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,4,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,4,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,4,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,4,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,4,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",NA,NA,NA,2,NA,NA,NA,NA,4,8,,7,3,5,1,6,04/25/2017,LS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",NA,NA,NA,2,NA,NA,NA,NA,4,8,,7,3,5,2,,07/13/2016,RTS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",NA,NA,NA,2,NA,NA,NA,NA,4,8,,7,3,5,3,,07/13/2016,RTS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",NA,NA,NA,2,NA,NA,NA,NA,4,8,,7,3,5,4,12,04/08/2016,RTS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",NA,NA,NA,2,NA,NA,NA,NA,4,8,,7,3,5,5,3,06/27/2017,KLC,"from RTS, 7/13/16",06/27/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",NA,NA,NA,2,NA,NA,NA,NA,4,8,,7,3,5,6,4,07/19/2019,KU,from P3 KLC 06/27/2019 (STR from thaw is good),07/12/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",NA,NA,NA,2,NA,NA,NA,NA,4,8,,7,3,5,7,4,07/19/2019,KU,from P3 KLC 06/27/2019 (STR from thaw is good),07/12/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",NA,NA,NA,2,NA,NA,NA,NA,4,8,,7,3,5,8,4,07/19/2019,KU,from P3 KLC 06/27/2019 (STR from thaw is good),07/12/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,5,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",NA,NA,NA,2,NA,NA,NA,NA,4,8,,7,3,5,10,5,12/27/2019,KU,,12/20/2019,3/3/2020,Good,X,Y,17,,,14,16.3,,12,,14,,,8,12,,11,15,,8,11,15,,,24,25,,11,12,,8,10,,9,,16,21,,32,33.1,,11,,11,12,6,9,,9,11,12,,18,,,13,13.2,,19,23,,14,17,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,6,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,6,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,6,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,6,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,6,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,6,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",NA,NA,NA,2,NA,NA,NA,NA,4,8,,7,3,6,8,5,12/27/2019,KU,"From P4, KU, 07/19/2019",12/20/2019,3/3/2020,Good,X,Y,17,,,14,16.3,,12,,14,,,8,12,,11,15,,8,11,15,,,24,25,,11,12,,8,10,,9,,16,21,,32,33.1,,11,,11,12,6,9,,9,11,12,,18,,,13,13.2,,19,23,,14,17,,,Maris
NGP,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",NA,NA,NA,2,NA,NA,NA,NA,4,8,,7,3,6,9,5,12/27/2019,KU,"From P4, KU, 07/19/2019",12/20/2019,3/3/2020,Good,X,Y,17,,,14,16.3,,12,,14,,,8,12,,11,15,,8,11,15,,,24,25,,11,12,,8,10,,9,,16,21,,32,33.1,,11,,11,12,6,9,,9,11,12,,18,,,13,13.2,,19,23,,14,17,,,Maris
NGP,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",NA,NA,NA,2,NA,NA,NA,NA,4,8,,7,3,6,10,5,12/27/2019,KU,"From P4, KU, 07/19/2019",12/20/2019,3/3/2020,Good,X,Y,17,,,14,16.3,,12,,14,,,8,12,,11,15,,8,11,15,,,24,25,,11,12,,8,10,,9,,16,21,,32,33.1,,11,,11,12,6,9,,9,11,12,,18,,,13,13.2,,19,23,,14,17,,,Maris
NLF,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Solid Tumor,Loss p32.3-pterm,Loss/Al p26.1; Al p26.2; Gain 26.3,,Loss/Al q23.3-qterm,WT,Amplified,V203M,NA,2,NA,NA,NA,NA,NA,NA,3,NA,,7,3,7,1,3,09/28/2017,klc,"from P2, LSH, 12/10/15",09/29/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NLF,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Solid Tumor,Loss p32.3-pterm,Loss/Al p26.1; Al p26.2; Gain 26.3,,Loss/Al q23.3-qterm,WT,Amplified,V203M,NA,2,NA,NA,NA,NA,NA,NA,3,NA,,7,3,7,2,3,09/28/2017,klc,"from P2, LSH, 12/10/15",09/29/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,7,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,7,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,7,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NLF,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Solid Tumor,Loss p32.3-pterm,Loss/Al p26.1; Al p26.2; Gain 26.3,,Loss/Al q23.3-qterm,WT,Amplified,V203M,NA,2,NA,NA,NA,NA,NA,NA,3,NA,,7,3,7,6,10,6/13/2017,KLC,,06/09/2017,10/15/2018,Good (Drop out of Y at Amelogenin),X,Y (DO),16,17,,15,,,10,11,13,15,,9,14,,15,18,,10,,14,17,,23,,,11,,,13,,,6,8,17,18,19,28,32.2,,10,11,11,12,8,,,-,13,14,,17,18,,14,,,19,21,,16,,,,Maris
NLF,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Solid Tumor,Loss p32.3-pterm,Loss/Al p26.1; Al p26.2; Gain 26.3,,Loss/Al q23.3-qterm,WT,Amplified,V203M,NA,2,NA,NA,NA,NA,NA,NA,3,NA,,7,3,7,7,10,6/13/2017,KLC,,06/09/2017,10/15/2018,Good (Drop out of Y at Amelogenin),X,Y (DO),16,17,,15,,,10,11,13,15,,9,14,,15,18,,10,,14,17,,23,,,11,,,13,,,6,8,17,18,19,28,32.2,,10,11,11,12,8,,,-,13,14,,17,18,,14,,,19,21,,16,,,,Maris
NLF,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Solid Tumor,Loss p32.3-pterm,Loss/Al p26.1; Al p26.2; Gain 26.3,,Loss/Al q23.3-qterm,WT,Amplified,V203M,NA,2,NA,NA,NA,NA,NA,NA,3,NA,,7,3,7,8,11,10/04/2018,KU,"from KLC, P10, 06/13/2017 (STR from thaw is good)",09/28/2018,10/15/2018,Good (Drop out of Y at Amelogenin),X,Y (DO),16,17,,15,,,10,11,13,15,,9,14,,15,18,,10,,14,17,,23,,,11,,,13,,,6,8,17,18,19,28,32.2,,10,11,11,12,8,,,-,13,14,,17,18,,14,,,19,21,,16,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,7,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,7,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NLF,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Solid Tumor,Loss p32.3-pterm,Loss/Al p26.1; Al p26.2; Gain 26.3,,Loss/Al q23.3-qterm,WT,Amplified,V203M,NA,2,NA,NA,NA,NA,NA,NA,3,NA,,7,3,8,1,13,01/11/2019,KU,"from KU, P11, 10/04/2018",01/08/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NLF,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Solid Tumor,Loss p32.3-pterm,Loss/Al p26.1; Al p26.2; Gain 26.3,,Loss/Al q23.3-qterm,WT,Amplified,V203M,NA,2,NA,NA,NA,NA,NA,NA,3,NA,,7,3,8,2,12,07/15/2019,KU,"from KU, P11, 10/04/2018",06/07/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NLF,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Solid Tumor,Loss p32.3-pterm,Loss/Al p26.1; Al p26.2; Gain 26.3,,Loss/Al q23.3-qterm,WT,Amplified,V203M,NA,2,NA,NA,NA,NA,NA,NA,3,NA,,7,3,8,3,12,07/15/2019,KU,"from KU, P11, 10/04/2018",06/07/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NLF,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Solid Tumor,Loss p32.3-pterm,Loss/Al p26.1; Al p26.2; Gain 26.3,,Loss/Al q23.3-qterm,WT,Amplified,V203M,NA,2,NA,NA,NA,NA,NA,NA,3,NA,,7,3,8,4,13,12/23/2019,KU,"From KU, P12, 07/15/2019",12/20/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NLF,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Solid Tumor,Loss p32.3-pterm,Loss/Al p26.1; Al p26.2; Gain 26.3,,Loss/Al q23.3-qterm,WT,Amplified,V203M,NA,2,NA,NA,NA,NA,NA,NA,3,NA,,7,3,8,5,13,12/23/2019,KU,"From KU, P12, 07/15/2019",12/20/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NLF,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Solid Tumor,Loss p32.3-pterm,Loss/Al p26.1; Al p26.2; Gain 26.3,,Loss/Al q23.3-qterm,WT,Amplified,V203M,NA,2,NA,NA,NA,NA,NA,NA,3,NA,,7,3,8,6,13,12/23/2019,KU,"From KU, P12, 07/15/2019",12/20/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NLF,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Solid Tumor,Loss p32.3-pterm,Loss/Al p26.1; Al p26.2; Gain 26.3,,Loss/Al q23.3-qterm,WT,Amplified,V203M,NA,2,NA,NA,NA,NA,NA,NA,3,NA,,7,3,8,7,13,12/23/2019,KU,"From KU, P12, 07/15/2019",12/20/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NLF,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No prior treatments,Solid Tumor,Loss p32.3-pterm,Loss/Al p26.1; Al p26.2; Gain 26.3,,Loss/Al q23.3-qterm,WT,Amplified,V203M,NA,2,NA,NA,NA,NA,NA,NA,3,NA,,7,3,8,8,13,12/23/2019,KU,"From KU, P12, 07/15/2019",12/20/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,8,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,8,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
RPE-1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,3,9,1,4,02/27/2017,klc,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
RPE-1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,3,9,2,4,06/21/2017,klc,,06/30/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
RPE-1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,3,9,3,3,01/16/2016,LSH,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,9,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,9,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
RPE-1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,3,9,6,4,02/27/2017,klc,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
RPE-1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,3,9,7,4,02/27/2017,klc,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
RPE-1,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,3,9,8,4,02/27/2017,klc,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,9,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,9,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,10,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
RPE-1,MYCN-ER,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,3,10,2,4,08/23/2013,LSH,"Cole PNAS 2011, generated by Hogarty Lab",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
RPE-1,MYCN-ER,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,3,10,3,4,08/23/2013,LSH,"Cole PNAS 2011, generated by Hogarty Lab",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
RPE-1,MYCN-ER,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,3,10,4,4,08/23/2013,LSH,"Cole PNAS 2011, generated by Hogarty Lab",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
RPE-1,MYCN-ER,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,3,10,5,4,08/23/2013,LSH,"Cole PNAS 2011, generated by Hogarty Lab",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
RPE-1,MYCN-ER,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,3,10,6,4,08/23/2013,LSH,"Cole PNAS 2011, generated by Hogarty Lab",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
RPE-1,MYCN-ER,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,3,10,7,4,08/23/2013,LSH,"Cole PNAS 2011, generated by Hogarty Lab",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,10,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,10,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,3,10,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SH-SY5Y,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Has a small fraction of non-adherent cells, but for experimental purposes we largely foucs on the adherent cells",Replase,Progressing,"Patient has prior chemotherapy treatment (Vincristine, cyclophosphamide, daunomycin, trifluoromethyl-2'-deoxyuridine, adriamycin).","Bone Marrow [SH-SY5Y is a thrice-cloned sub-line of bone marrow biopsy-derived line SK-N-SH. (SK-N-SH -> SH-SY -> SH-SY5Y)]
",None,None,Loss q22.1-q24.2,Fain q21.32-qterm,F1174L,Non-amplified,WT,NA,NA,NA,5,NA,NA,NA,NA,7,NA,,7,4,1,2,5,08/17/2018,KLC/LSH,"From LSH, P4, 03/01/2016 (STR from thaw is good)",08/10/2018,08/22/2018,Good (STR of thaw is good) ,X,,15,16,,12,,,11,11.3,14,,,11,,,7,11,,8,13,13,16,,17,19,,11,,,10,12,,7,10,14,18,,31,31.2,,7,10,12,,8,11,,,15,,,18,22,,13,14,,23.2,24,,16,17,,,Maris
SH-SY5Y,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Has a small fraction of non-adherent cells, but for experimental purposes we largely foucs on the adherent cells",Replase,Progressing,"Patient has prior chemotherapy treatment (Vincristine, cyclophosphamide, daunomycin, trifluoromethyl-2'-deoxyuridine, adriamycin).","Bone Marrow [SH-SY5Y is a thrice-cloned sub-line of bone marrow biopsy-derived line SK-N-SH. (SK-N-SH -> SH-SY -> SH-SY5Y)]
",None,None,Loss q22.1-q24.2,Fain q21.32-qterm,F1174L,Non-amplified,WT,NA,NA,NA,5,NA,NA,NA,NA,7,NA,,7,4,1,3,5,08/17/2018,KLC/LSH,"From LSH, P4, 03/01/2016 (STR from thaw is good)",08/10/2018,08/22/2018,Good (STR of thaw is good) ,X,,15,16,,12,,,11,11.3,14,,,11,,,7,11,,8,13,13,16,,17,19,,11,,,10,12,,7,10,14,18,,31,31.2,,7,10,12,,8,11,,,15,,,18,22,,13,14,,23.2,24,,16,17,,,Maris
SH-SY5Y,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Has a small fraction of non-adherent cells, but for experimental purposes we largely foucs on the adherent cells",Replase,Progressing,"Patient has prior chemotherapy treatment (Vincristine, cyclophosphamide, daunomycin, trifluoromethyl-2'-deoxyuridine, adriamycin).","Bone Marrow [SH-SY5Y is a thrice-cloned sub-line of bone marrow biopsy-derived line SK-N-SH. (SK-N-SH -> SH-SY -> SH-SY5Y)]
",None,None,Loss q22.1-q24.2,Fain q21.32-qterm,F1174L,Non-amplified,WT,NA,NA,NA,5,NA,NA,NA,NA,7,NA,,7,4,1,4,5,08/17/2018,KLC/LSH,"From LSH, P4, 03/01/2016 (STR from thaw is good)",08/10/2018,08/22/2018,Good (STR of thaw is good) ,X,,15,16,,12,,,11,11.3,14,,,11,,,7,11,,8,13,13,16,,17,19,,11,,,10,12,,7,10,14,18,,31,31.2,,7,10,12,,8,11,,,15,,,18,22,,13,14,,23.2,24,,16,17,,,Maris
SH-SY5Y,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Has a small fraction of non-adherent cells, but for experimental purposes we largely foucs on the adherent cells",Replase,Progressing,"Patient has prior chemotherapy treatment (Vincristine, cyclophosphamide, daunomycin, trifluoromethyl-2'-deoxyuridine, adriamycin).","Bone Marrow [SH-SY5Y is a thrice-cloned sub-line of bone marrow biopsy-derived line SK-N-SH. (SK-N-SH -> SH-SY -> SH-SY5Y)]
",None,None,Loss q22.1-q24.2,Fain q21.32-qterm,F1174L,Non-amplified,WT,NA,NA,NA,5,NA,NA,NA,NA,7,NA,,7,4,1,5,6,08/22/2018,KLC/LSH,"From LSH, P4, 03/01/2016 (STR from thaw is good)",08/10/2018,08/22/2018,Good (STR of thaw is good) ,X,,15,16,,12,,,11,11.3,14,,,11,,,7,11,,8,13,13,16,,17,19,,11,,,10,12,,7,10,14,18,,31,31.2,,7,10,12,,8,11,,,15,,,18,22,,13,14,,23.2,24,,16,17,,,Maris
SH-SY5Y,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Has a small fraction of non-adherent cells, but for experimental purposes we largely foucs on the adherent cells",Replase,Progressing,"Patient has prior chemotherapy treatment (Vincristine, cyclophosphamide, daunomycin, trifluoromethyl-2'-deoxyuridine, adriamycin).","Bone Marrow [SH-SY5Y is a thrice-cloned sub-line of bone marrow biopsy-derived line SK-N-SH. (SK-N-SH -> SH-SY -> SH-SY5Y)]
",None,None,Loss q22.1-q24.2,Fain q21.32-qterm,F1174L,Non-amplified,WT,NA,NA,NA,5,NA,NA,NA,NA,7,NA,,7,4,1,6,6,08/22/2018,KLC/LSH,"From LSH, P4, 03/01/2016 (STR from thaw is good)",08/10/2018,08/22/2018,Good (STR of thaw is good) ,X,,15,16,,12,,,11,11.3,14,,,11,,,7,11,,8,13,13,16,,17,19,,11,,,10,12,,7,10,14,18,,31,31.2,,7,10,12,,8,11,,,15,,,18,22,,13,14,,23.2,24,,16,17,,,Maris
SH-SY5Y,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Has a small fraction of non-adherent cells, but for experimental purposes we largely foucs on the adherent cells",Replase,Progressing,"Patient has prior chemotherapy treatment (Vincristine, cyclophosphamide, daunomycin, trifluoromethyl-2'-deoxyuridine, adriamycin).","Bone Marrow [SH-SY5Y is a thrice-cloned sub-line of bone marrow biopsy-derived line SK-N-SH. (SK-N-SH -> SH-SY -> SH-SY5Y)]
",None,None,Loss q22.1-q24.2,Fain q21.32-qterm,F1174L,Non-amplified,WT,NA,NA,NA,5,NA,NA,NA,NA,7,NA,,7,4,1,7,6,08/22/2018,KLC/LSH,"From LSH, P4, 03/01/2016 (STR from thaw is good)",08/10/2018,08/22/2018,Good (STR of thaw is good) ,X,,15,16,,12,,,11,11.3,14,,,11,,,7,11,,8,13,13,16,,17,19,,11,,,10,12,,7,10,14,18,,31,31.2,,7,10,12,,8,11,,,15,,,18,22,,13,14,,23.2,24,,16,17,,,Maris
SH-SY5Y,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Has a small fraction of non-adherent cells, but for experimental purposes we largely foucs on the adherent cells",Replase,Progressing,"Patient has prior chemotherapy treatment (Vincristine, cyclophosphamide, daunomycin, trifluoromethyl-2'-deoxyuridine, adriamycin).","Bone Marrow [SH-SY5Y is a thrice-cloned sub-line of bone marrow biopsy-derived line SK-N-SH. (SK-N-SH -> SH-SY -> SH-SY5Y)]
",None,None,Loss q22.1-q24.2,Fain q21.32-qterm,F1174L,Non-amplified,WT,NA,NA,NA,5,NA,NA,NA,NA,7,NA,,7,4,1,8,5,08/17/2018,KLC/KB,"From KB, P4, 06/18/2015 (STR from thaw is good)",08/10/2018,08/22/2018,Good (STR of thaw is good) ,X,,15,16,,12,,,11,11.3,14,,,11,,,7,11,,8,13,13,16,,17,19,,11,,,10,12,,7,10,14,18,,31,31.2,,7,10,12,,8,11,,,15,,,18,22,,13,14,,23.2,24,,16,17,,,Maris
SH-SY5Y,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Has a small fraction of non-adherent cells, but for experimental purposes we largely foucs on the adherent cells",Replase,Progressing,"Patient has prior chemotherapy treatment (Vincristine, cyclophosphamide, daunomycin, trifluoromethyl-2'-deoxyuridine, adriamycin).","Bone Marrow [SH-SY5Y is a thrice-cloned sub-line of bone marrow biopsy-derived line SK-N-SH. (SK-N-SH -> SH-SY -> SH-SY5Y)]
",None,None,Loss q22.1-q24.2,Fain q21.32-qterm,F1174L,Non-amplified,WT,NA,NA,NA,5,NA,NA,NA,NA,7,NA,,7,4,1,9,5,08/17/2018,KLC/KB,"From KB, P4, 06/18/2015 (STR from thaw is good)",08/10/2018,08/22/2018,Good (STR of thaw is good) ,X,,15,16,,12,,,11,11.3,14,,,11,,,7,11,,8,13,13,16,,17,19,,11,,,10,12,,7,10,14,18,,31,31.2,,7,10,12,,8,11,,,15,,,18,22,,13,14,,23.2,24,,16,17,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,2,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,2,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,2,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,2,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,2,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,2,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,3,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-AS,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Bone Marrow,Loss p36.22-36.32,Loss p14.2-pterm,q13.4-qterm,Gain q21.31-qterm,WT,Non-amplified,H168R,NA,NA,NA,4-5,NA,NA,NA,NA,5,6,,7,4,3,2,2,09/28/2017,klc,"Fresh from ATCC, lot 700037800, 09/13/2017",10/17/2017,03/03/2020,Good,X,,14,,,12,16.3,,11,,14,,,9,,,7,14,,14,,14,15,,17,24,,10,12,,9,,,9.3,,16,17,,32.2,33.2,,11,13,11,12,11,12,,-,13,14,,20,24,,12,14,,20,22,,11,,,,Maris
SK-N-AS,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Bone Marrow,Loss p36.22-36.32,Loss p14.2-pterm,q13.4-qterm,Gain q21.31-qterm,WT,Non-amplified,H168R,NA,NA,NA,4-5,NA,NA,NA,NA,5,6,,7,4,3,3,2,09/28/2017,klc,"Fresh from ATCC, lot 700037800, 09/13/2017",10/17/2017,03/03/2020,Good,X,,14,,,12,16.3,,11,,14,,,9,,,7,14,,14,,14,15,,17,24,,10,12,,9,,,9.3,,16,17,,32.2,33.2,,11,13,11,12,11,12,,-,13,14,,20,24,,12,14,,20,22,,11,,,,Maris
SK-N-AS,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Bone Marrow,Loss p36.22-36.32,Loss p14.2-pterm,q13.4-qterm,Gain q21.31-qterm,WT,Non-amplified,H168R,NA,NA,NA,4-5,NA,NA,NA,NA,5,6,,7,4,3,4,2,09/28/2017,klc,"Fresh from ATCC, lot 700037800, 09/13/2017",10/17/2017,03/03/2020,Good,X,,14,,,12,16.3,,11,,14,,,9,,,7,14,,14,,14,15,,17,24,,10,12,,9,,,9.3,,16,17,,32.2,33.2,,11,13,11,12,11,12,,-,13,14,,20,24,,12,14,,20,22,,11,,,,Maris
SK-N-AS,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Bone Marrow,Loss p36.22-36.32,Loss p14.2-pterm,q13.4-qterm,Gain q21.31-qterm,WT,Non-amplified,H168R,NA,NA,NA,4-5,NA,NA,NA,NA,5,6,,7,4,3,5,2,09/28/2017,klc,"Fresh from ATCC, lot 700037800, 09/13/2017",10/17/2017,03/03/2020,Good,X,,14,,,12,16.3,,11,,14,,,9,,,7,14,,14,,14,15,,17,24,,10,12,,9,,,9.3,,16,17,,32.2,33.2,,11,13,11,12,11,12,,-,13,14,,20,24,,12,14,,20,22,,11,,,,Maris
SK-N-AS,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Bone Marrow,Loss p36.22-36.32,Loss p14.2-pterm,q13.4-qterm,Gain q21.31-qterm,WT,Non-amplified,H168R,NA,NA,NA,4-5,NA,NA,NA,NA,5,6,,7,4,3,6,2,09/28/2017,klc,"Fresh from ATCC, lot 700037800, 09/13/2017",10/17/2017,03/03/2020,Good,X,,14,,,12,16.3,,11,,14,,,9,,,7,14,,14,,14,15,,17,24,,10,12,,9,,,9.3,,16,17,,32.2,33.2,,11,13,11,12,11,12,,-,13,14,,20,24,,12,14,,20,22,,11,,,,Maris
SK-N-AS,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Bone Marrow,Loss p36.22-36.32,Loss p14.2-pterm,q13.4-qterm,Gain q21.31-qterm,WT,Non-amplified,H168R,NA,NA,NA,4-5,NA,NA,NA,NA,5,6,,7,4,3,7,2,09/28/2017,klc,"Fresh from ATCC, lot 700037800, 09/13/2017",10/17/2017,03/03/2020,Good,X,,14,,,12,16.3,,11,,14,,,9,,,7,14,,14,,14,15,,17,24,,10,12,,9,,,9.3,,16,17,,32.2,33.2,,11,13,11,12,11,12,,-,13,14,,20,24,,12,14,,20,22,,11,,,,Maris
SK-N-AS,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Bone Marrow,Loss p36.22-36.32,Loss p14.2-pterm,q13.4-qterm,Gain q21.31-qterm,WT,Non-amplified,H168R,NA,NA,NA,4-5,NA,NA,NA,NA,5,6,,7,4,3,8,3,02/14/2020,KU,"From KLC, P2, 09/28/2017",02/07/2020,03/03/2020,Good,X,,14,,,12,16.3,,11,,14,,,9,,,7,14,,14,,14,15,,17,24,,10,12,,9,,,9.3,,16,17,,32.2,33.2,,11,13,11,12,11,12,,-,13,14,,20,24,,12,14,,20,22,,11,,,,Maris
SK-N-AS,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Bone Marrow,Loss p36.22-36.32,Loss p14.2-pterm,q13.4-qterm,Gain q21.31-qterm,WT,Non-amplified,H168R,NA,NA,NA,4-5,NA,NA,NA,NA,5,6,,7,4,3,9,3,02/14/2020,KU,"From KLC, P2, 09/28/2017",02/07/2020,03/03/2020,Good,X,,14,,,12,16.3,,11,,14,,,9,,,7,14,,14,,14,15,,17,24,,10,12,,9,,,9.3,,16,17,,32.2,33.2,,11,13,11,12,11,12,,-,13,14,,20,24,,12,14,,20,22,,11,,,,Maris
SK-N-AS,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Bone Marrow,Loss p36.22-36.32,Loss p14.2-pterm,q13.4-qterm,Gain q21.31-qterm,WT,Non-amplified,H168R,NA,NA,NA,4-5,NA,NA,NA,NA,5,6,,7,4,3,10,3,02/14/2020,KU,"From KLC, P2, 09/28/2017",02/07/2020,03/03/2020,Good,X,,14,,,12,16.3,,11,,14,,,9,,,7,14,,14,,14,15,,17,24,,10,12,,9,,,9.3,,16,17,,32.2,33.2,,11,13,11,12,11,12,,-,13,14,,20,24,,12,14,,20,22,,11,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,4,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,4,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,4,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,4,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,4,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,4,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-AS,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Bone Marrow,Loss p36.22-36.32,Loss p14.2-pterm,q13.4-qterm,Gain q21.31-qterm,WT,Non-amplified,H168R,NA,NA,NA,4-5,NA,NA,NA,NA,5,6,,7,4,4,9,3,02/14/2020,KU,"From KLC, P2, 09/28/2017",02/07/2020,03/03/2020,Good,X,,14,,,12,16.3,,11,,14,,,9,,,7,14,,14,,14,15,,17,24,,10,12,,9,,,9.3,,16,17,,32.2,33.2,,11,13,11,12,11,12,,-,13,14,,20,24,,12,14,,20,22,,11,,,,Maris
SK-N-AS,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Bone Marrow,Loss p36.22-36.32,Loss p14.2-pterm,q13.4-qterm,Gain q21.31-qterm,WT,Non-amplified,H168R,NA,NA,NA,4-5,NA,NA,NA,NA,5,6,,7,4,4,10,3,02/14/2020,KU,"From KLC, P2, 09/28/2017",02/07/2020,03/03/2020,Good,X,,14,,,12,16.3,,11,,14,,,9,,,7,14,,14,,14,15,,17,24,,10,12,,9,,,9.3,,16,17,,32.2,33.2,,11,13,11,12,11,12,,-,13,14,,20,24,,12,14,,20,22,,11,,,,Maris
SK-N-BE(2),Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow,cnLOH p21.4-pterm,Loss 14.2-pterm,GaiNAl q13.1-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,NA,NA,NA,NA,NA,4-5,NA,,7,4,5,1,4,10/31/2012,LSH,,11/02/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2),Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow,cnLOH p21.4-pterm,Loss 14.2-pterm,GaiNAl q13.1-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,NA,NA,NA,NA,NA,4-5,NA,,7,4,5,2,9,09/04/2018,KU,"From KLC, P8, 07/06/2018",08/31/2018,12/10/2019,"Good (Drop out of 14,18 at PENTA E; 14 at PENTA D, 11 and 16 at D22S1045",X,Y,19,,,11,17.3,,11,14,15,16,,11,,,14 (DO),18 (DO),,9,11,16,,,17,23,,10,,,13,14 (DO),,6,7,18,,,30,32.2,,9,10,12,,8,11,,11,13,14,,18,24,,12,13,,22,25,,22 (DO),25 (DO),,,Maris
SK-N-BE(2),Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow,cnLOH p21.4-pterm,Loss 14.2-pterm,GaiNAl q13.1-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,NA,NA,NA,NA,NA,4-5,NA,,7,4,5,3,3,01/21/2016,LSH,,11/02/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2),Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow,cnLOH p21.4-pterm,Loss 14.2-pterm,GaiNAl q13.1-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,NA,NA,NA,NA,NA,4-5,NA,,7,4,5,4,7,02/20/2017,klc,,11/02/2012,12/10/2019,Good,X,Y,19,,,11,17.3,,11,14,15,16,,11,,,14,18,,9,11,16,,,17,23,,10,,,13,14,,6,7,18,,,30,32.2,,9,10,12,,8,11,,11,13,14,,18,24,,12,13,,22,25,,11,16,,,Maris
SK-N-BE(2),Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow,cnLOH p21.4-pterm,Loss 14.2-pterm,GaiNAl q13.1-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,NA,NA,NA,NA,NA,4-5,NA,,7,4,5,5,7,02/20/2017,klc,,11/02/2012,12/10/2019,Good,X,Y,19,,,11,17.3,,11,14,15,16,,11,,,14,18,,9,11,16,,,17,23,,10,,,13,14,,6,7,18,,,30,32.2,,9,10,12,,8,11,,11,13,14,,18,24,,12,13,,22,25,,11,16,,,Maris
SK-N-BE(2),Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow,cnLOH p21.4-pterm,Loss 14.2-pterm,GaiNAl q13.1-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,NA,NA,NA,NA,NA,4-5,NA,,7,4,5,6,7,02/20/2017,klc,,11/02/2012,12/10/2019,Good,X,Y,19,,,11,17.3,,11,14,15,16,,11,,,14,18,,9,11,16,,,17,23,,10,,,13,14,,6,7,18,,,30,32.2,,9,10,12,,8,11,,11,13,14,,18,24,,12,13,,22,25,,11,16,,,Maris
SK-N-BE(2),Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow,cnLOH p21.4-pterm,Loss 14.2-pterm,GaiNAl q13.1-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,NA,NA,NA,NA,NA,4-5,NA,,7,4,5,7,9,09/04/2018,KU,"From KLC, P8, 07/06/2018",08/31/2018,12/10/2019,"Good (Drop out of 14,18 at PENTA E; 14 at PENTA D, 11 and 16 at D22S1045",X,Y,19,,,11,17.3,,11,14,15,16,,11,,,14 (DO),18 (DO),,9,11,16,,,17,23,,10,,,13,14 (DO),,6,7,18,,,30,32.2,,9,10,12,,8,11,,11,13,14,,18,24,,12,13,,22,25,,22 (DO),25 (DO),,,Maris
SK-N-BE(2),Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow,cnLOH p21.4-pterm,Loss 14.2-pterm,GaiNAl q13.1-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,NA,NA,NA,NA,NA,4-5,NA,,7,4,5,8,5,04/27/2017,LS,,04/28/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2),Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow,cnLOH p21.4-pterm,Loss 14.2-pterm,GaiNAl q13.1-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,NA,NA,NA,NA,NA,4-5,NA,,7,4,5,9,5,04/27/2017,LS,,04/28/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2),Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow,cnLOH p21.4-pterm,Loss 14.2-pterm,GaiNAl q13.1-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,NA,NA,NA,NA,NA,4-5,NA,,7,4,5,10,5,04/27/2017,LS,,04/28/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2),Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow,cnLOH p21.4-pterm,Loss 14.2-pterm,GaiNAl q13.1-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,NA,NA,NA,NA,NA,4-5,NA,,7,4,6,1,9,07/09/2018,KLC,"From KLC, P7, 02/20/2017 (STR from thaw is good)",07/06/2018,12/10/2019,Good (STR of thaw is good),X,Y,19,,,11,17.3,,11,14,15,16,,11,,,14,18,,9,11,16,,,17,23,,10,,,13,14,,6,7,18,,,30,32.2,,9,10,12,,8,11,,11,13,14,,18,24,,12,13,,22,25,,11,16,,,Maris
SK-N-BE(2),Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow,cnLOH p21.4-pterm,Loss 14.2-pterm,GaiNAl q13.1-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,NA,NA,NA,NA,NA,4-5,NA,,7,4,6,2,9,07/09/2018,KLC,"From KLC, P7, 02/20/2017 (STR from thaw is good)",07/06/2018,12/10/2019,Good (STR of thaw is good),X,Y,19,,,11,17.3,,11,14,15,16,,11,,,14,18,,9,11,16,,,17,23,,10,,,13,14,,6,7,18,,,30,32.2,,9,10,12,,8,11,,11,13,14,,18,24,,12,13,,22,25,,11,16,,,Maris
SK-N-BE(2),Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow,cnLOH p21.4-pterm,Loss 14.2-pterm,GaiNAl q13.1-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,NA,NA,NA,NA,NA,4-5,NA,,7,4,6,3,9,07/09/2018,KLC,"From KLC, P7, 02/20/2017 (STR from thaw is good)",07/06/2018,12/10/2019,Good (STR of thaw is good),X,Y,19,,,11,17.3,,11,14,15,16,,11,,,14,18,,9,11,16,,,17,23,,10,,,13,14,,6,7,18,,,30,32.2,,9,10,12,,8,11,,11,13,14,,18,24,,12,13,,22,25,,11,16,,,Maris
SK-N-BE(2),Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow,cnLOH p21.4-pterm,Loss 14.2-pterm,GaiNAl q13.1-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,NA,NA,NA,NA,NA,4-5,NA,,7,4,6,4,9,07/09/2018,KLC,"From KLC, P7, 02/20/2017 (STR from thaw is good)",07/06/2018,12/10/2019,Good (STR of thaw is good),X,Y,19,,,11,17.3,,11,14,15,16,,11,,,14,18,,9,11,16,,,17,23,,10,,,13,14,,6,7,18,,,30,32.2,,9,10,12,,8,11,,11,13,14,,18,24,,12,13,,22,25,,11,16,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,6,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,6,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,6,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,6,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,6,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,6,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,3,NA,NA,NA,NA,6,NA,,7,4,7,1,2,10/17/2014,LSH,,10/10/2014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,3,NA,NA,NA,NA,6,NA,,7,4,7,2,2,10/27/2015,LSH,,10/10/2014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,3,NA,NA,NA,NA,6,NA,,7,4,7,3,2,11/4/16,JLH,,06/27/2017,12/10/2019,Good (Drop out of Y at Amelogenin),X,Y (DO),19,,,11,17.3,,14,,15,16,,11,,,14,18,,9,11,16,,,23,,,10,,,13,14,,6,7(DO),18,,,30,32.2,,9,10,12,,11,,,-,13,14,,18,24,,12,13,,22,25,,11,16,,,Maris
SK-N-BE(2)-C,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,3,NA,NA,NA,NA,6,NA,,7,4,7,4,2,11/4/16,JLH,,06/27/2017,12/10/2019,Good (Drop out of Y at Amelogenin),X,Y (DO),19,,,11,17.3,,14,,15,16,,11,,,14,18,,9,11,16,,,23,,,10,,,13,14,,6,7(DO),18,,,30,32.2,,9,10,12,,11,,,-,13,14,,18,24,,12,13,,22,25,,11,16,,,Maris
SK-N-BE(2)-C,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,3,NA,NA,NA,NA,6,NA,,7,4,7,5,2,11/4/16,JLH,,06/27/2017,12/10/2019,Good (Drop out of Y at Amelogenin),X,Y (DO),19,,,11,17.3,,14,,15,16,,11,,,14,18,,9,11,16,,,23,,,10,,,13,14,,6,7(DO),18,,,30,32.2,,9,10,12,,11,,,-,13,14,,18,24,,12,13,,22,25,,11,16,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,7,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,7,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,3,NA,NA,NA,NA,6,NA,,7,4,7,8,4,07/20/2018,KLC,"From KLC, P3, 06/30/2017",07/26/2018,03/03/2020,Good (Drop out of Y at Amelogenin),X,Y (DO),19,,,11,17.3,,14,,15,16,,11,,,14,18,,9,11,16,,,23,,,10,,,13,14,,6,7(DO),18,,,30,32.2,,9,10,12,,11,,,-,13,14,,18,24,,12,13,,22,25,,11,16,,,Maris
SK-N-BE(2)-C,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,3,NA,NA,NA,NA,6,NA,,7,4,7,9,4,07/20/2018,KLC,"From KLC, P3, 06/30/2017",07/26/2018,03/03/2020,Good (Drop out of Y at Amelogenin),X,Y (DO),19,,,11,17.3,,14,,15,16,,11,,,14,18,,9,11,16,,,23,,,10,,,13,14,,6,7(DO),18,,,30,32.2,,9,10,12,,11,,,-,13,14,,18,24,,12,13,,22,25,,11,16,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,7,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,3,NA,NA,NA,NA,6,NA,,7,4,8,1,3,06/30/2017,klc,"from JLH, P2, 11/04/16 (STR from thaw is good)",06/27/2017,12/10/2019,Good (Drop out of Y at Amelogenin),X,Y (DO),19,,,11,17.3,,14,,15,16,,11,,,14,18,,9,11,16,,,23,,,10,,,13,14,,6,7(DO),18,,,30,32.2,,9,10,12,,11,,,-,13,14,,18,24,,12,13,,22,25,,11,16,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,8,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,8,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,3,NA,NA,NA,NA,6,NA,,7,4,8,4,3,10/01/2018,KU,"from JLH, P2, 11/04/16 (STR from thaw is good)",09/28/2018,12/10/2019,Good (Drop out of Y at Amelogenin),X,Y (DO),19,,,11,17.3,,14,,15,16,,11,,,14,18,,9,11,16,,,23,,,10,,,13,14,,6,7(DO),18,,,30,32.2,,9,10,12,,11,,,-,13,14,,18,24,,12,13,,22,25,,11,16,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,8,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,8,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,3,NA,NA,NA,NA,6,NA,,7,4,8,7,6,08/30/2019,KU,From P4 KLC 07/20/2018,08/20/2019,03/03/2020,Good (Drop out of Y at Amelogenin),X,Y (DO),19,,,11,17.3,,14,,15,16,,11,,,14,18,,9,11,16,,,23,,,10,,,13,14,,6,7(DO),18,,,30,32.2,,9,10,12,,11,,,-,13,14,,18,24,,12,13,,22,25,,11,16,,,Maris
SK-N-BE(2)-C,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,NA,NA,NA,3,NA,NA,NA,NA,6,NA,,7,4,8,8,6,08/30/2019,KU,From P4 KLC 07/20/2018,08/20/2019,03/03/2020,Good (Drop out of Y at Amelogenin),X,Y (DO),19,,,11,17.3,,14,,15,16,,11,,,14,18,,9,11,16,,,23,,,10,,,13,14,,6,7(DO),18,,,30,32.2,,9,10,12,,11,,,-,13,14,,18,24,,12,13,,22,25,,11,16,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,8,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,8,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-DZ,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,GaiNAl p26.1-pterm,Loss q21-qterm,Gain q21.2-qterm,WT,Amplified,R110L,NA,NA,NA,2-3,NA,NA,NA,NA,5-6,NA,,7,4,9,1,11,02/18/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-DZ,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,GaiNAl p26.1-pterm,Loss q21-qterm,Gain q21.2-qterm,WT,Amplified,R110L,NA,NA,NA,2-3,NA,NA,NA,NA,5-6,NA,,7,4,9,2,8,09/20/2017,JLH,"thawed from LS, p6, 5/3/17",09/19/2017,08/22/2018,"Good (Drop out of 17.3 at D1S1656
 ""slight bump at D1S1656:17.3; way under AT"")",X,,17,,,16,17.3 (DO),,10,11,14,16,,8,11,,7,10,,9,11,15,17,,21,22,23,12,,,9,14,,6,9,16,18,,29,31,,12,13,12,,8,,,,12,13,,18,21,,14.2,16,,18,22,,15,19,,,Maris
SK-N-DZ,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,GaiNAl p26.1-pterm,Loss q21-qterm,Gain q21.2-qterm,WT,Amplified,R110L,NA,NA,NA,2-3,NA,NA,NA,NA,5-6,NA,,7,4,9,3,5,11/8/16,JC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-DZ,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,GaiNAl p26.1-pterm,Loss q21-qterm,Gain q21.2-qterm,WT,Amplified,R110L,NA,NA,NA,2-3,NA,NA,NA,NA,5-6,NA,,7,4,9,4,5,11/8/16,JC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-DZ,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,GaiNAl p26.1-pterm,Loss q21-qterm,Gain q21.2-qterm,WT,Amplified,R110L,NA,NA,NA,2-3,NA,NA,NA,NA,5-6,NA,,7,4,9,5,6,05/03/2017,LS,,04/28/2017,03/03/2020,Good,X,,17,,,16,17.3,,10,11,14,16,,8,11,,7,10,,9,11,15,17,,21,22,23,12,,,9,14,,6,9,16,18,,29,31,,12,13,12,,8,,,-,12,13,,18,21,,14.2,16,,18,22,,15,19,,,Maris
SK-N-DZ,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,GaiNAl p26.1-pterm,Loss q21-qterm,Gain q21.2-qterm,WT,Amplified,R110L,NA,NA,NA,2-3,NA,NA,NA,NA,5-6,NA,,7,4,9,6,8,09/20/2017,JLH,"thawed from LS, p6, 5/3/17",09/19/2017,08/22/2018,"Good (Drop out of 17.3 at D1S1656
 ""slight bump at D1S1656:17.3; way under AT"")",X,,17,,,16,17.3 (DO),,10,11,14,16,,8,11,,7,10,,9,11,15,17,,21,22,23,12,,,9,14,,6,9,16,18,,29,31,,12,13,12,,8,,,,12,13,,18,21,,14.2,16,,18,22,,15,19,,,Maris
SK-N-DZ,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,GaiNAl p26.1-pterm,Loss q21-qterm,Gain q21.2-qterm,WT,Amplified,R110L,NA,NA,NA,2-3,NA,NA,NA,NA,5-6,NA,,7,4,9,7,7,02/18/20,KU,"From LS, p6, 5/3/17",02/14/20,03/03/2020,Good,X,,17,,,16,17.3,,10,11,14,16,,8,11,,7,10,,9,11,15,17,,21,22,23,12,,,9,14,,6,9,16,18,,29,31,,12,13,12,,8,,,-,12,13,,18,21,,14.2,16,,18,22,,15,19,,,Maris
SK-N-DZ,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,GaiNAl p26.1-pterm,Loss q21-qterm,Gain q21.2-qterm,WT,Amplified,R110L,NA,NA,NA,2-3,NA,NA,NA,NA,5-6,NA,,7,4,9,8,7,02/18/20,KU,"From LS, p6, 5/3/17",02/14/20,03/03/2020,Good,X,,17,,,16,17.3,,10,11,14,16,,8,11,,7,10,,9,11,15,17,,21,22,23,12,,,9,14,,6,9,16,18,,29,31,,12,13,12,,8,,,-,12,13,,18,21,,14.2,16,,18,22,,15,19,,,Maris
SK-N-DZ,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,GaiNAl p26.1-pterm,Loss q21-qterm,Gain q21.2-qterm,WT,Amplified,R110L,NA,NA,NA,2-3,NA,NA,NA,NA,5-6,NA,,7,4,9,9,7,02/18/20,KU,"From LS, p6, 5/3/17",02/14/20,03/03/2020,Good,X,,17,,,16,17.3,,10,11,14,16,,8,11,,7,10,,9,11,15,17,,21,22,23,12,,,9,14,,6,9,16,18,,29,31,,12,13,12,,8,,,-,12,13,,18,21,,14.2,16,,18,22,,15,19,,,Maris
SK-N-DZ,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,GaiNAl p26.1-pterm,Loss q21-qterm,Gain q21.2-qterm,WT,Amplified,R110L,NA,NA,NA,2-3,NA,NA,NA,NA,5-6,NA,,7,4,9,10,7,02/18/20,KU,"From LS, p6, 5/3/17",02/14/20,03/03/2020,Good,X,,17,,,16,17.3,,10,11,14,16,,8,11,,7,10,,9,11,15,17,,21,22,23,12,,,9,14,,6,9,16,18,,29,31,,12,13,12,,8,,,-,12,13,,18,21,,14.2,16,,18,22,,15,19,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,10,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,10,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,10,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,10,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,10,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,10,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,10,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,10,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,4,10,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-DZ,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,GaiNAl p26.1-pterm,Loss q21-qterm,Gain q21.2-qterm,WT,Amplified,R110L,NA,NA,NA,2-3,NA,NA,NA,NA,5-6,NA,,7,4,10,10,7,02/18/20,KU,"From LS, p6, 5/3/17",02/14/20,03/03/2020,Good,X,,17,,,16,17.3,,10,11,14,16,,8,11,,7,10,,9,11,15,17,,21,22,23,12,,,9,14,,6,9,16,18,,29,31,,12,13,12,,8,,,-,12,13,,18,21,,14.2,16,,18,22,,15,19,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-FI,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Has multiple morphologies,Unknown,Progressing,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,None,None,None,Gain q21.31-qterm,WT,Non-amplified,M246R,NA,NA,NA,NA,5,NA,6,NA,7,NA,,7,5,1,4,8,06/22/2017,LS,,06/27/2017,12/10/2019,Good,X,Y,16,18,,11,13,,11,14,15,,,11,14,,11,20,,11,12,12,14,,17,18,,10,12,,2.2,13,,6,9.3,16,17,,28,30,,8,9,12,13,8,9,,10,11,12,,15,22,,12,,,22,,,15,17,,,Maris
SK-N-FI,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Has multiple morphologies,Unknown,Progressing,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,None,None,None,Gain q21.31-qterm,WT,Non-amplified,M246R,NA,NA,NA,NA,5,NA,6,NA,7,NA,,7,5,1,5,8,06/22/2017,LS,,06/27/2017,12/10/2019,Good,X,Y,16,18,,11,13,,11,14,15,,,11,14,,11,20,,11,12,12,14,,17,18,,10,12,,2.2,13,,6,9.3,16,17,,28,30,,8,9,12,13,8,9,,10,11,12,,15,22,,12,,,22,,,15,17,,,Maris
SK-N-FI,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Has multiple morphologies,Unknown,Progressing,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,None,None,None,Gain q21.31-qterm,WT,Non-amplified,M246R,NA,NA,NA,NA,5,NA,6,NA,7,NA,,7,5,1,6,8,06/22/2017,LS,,06/27/2017,12/10/2019,Good,X,Y,16,18,,11,13,,11,14,15,,,11,14,,11,20,,11,12,12,14,,17,18,,10,12,,2.2,13,,6,9.3,16,17,,28,30,,8,9,12,13,8,9,,10,11,12,,15,22,,12,,,22,,,15,17,,,Maris
SK-N-FI,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Has multiple morphologies,Unknown,Progressing,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,None,None,None,Gain q21.31-qterm,WT,Non-amplified,M246R,NA,NA,NA,NA,5,NA,6,NA,7,NA,,7,5,1,7,8,06/22/2017,LS,,06/27/2017,12/10/2019,Good,X,Y,16,18,,11,13,,11,14,15,,,11,14,,11,20,,11,12,12,14,,17,18,,10,12,,2.2,13,,6,9.3,16,17,,28,30,,8,9,12,13,8,9,,10,11,12,,15,22,,12,,,22,,,15,17,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-FI,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Has multiple morphologies,Unknown,Progressing,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,None,None,None,Gain q21.31-qterm,WT,Non-amplified,M246R,NA,NA,NA,NA,5,NA,6,NA,7,NA,,7,5,1,9,6,09/10/2018,KU,"From KLC, P4, 6/27/2017",08/31/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-FI,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Has multiple morphologies,Unknown,Progressing,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,None,None,None,Gain q21.31-qterm,WT,Non-amplified,M246R,NA,NA,NA,NA,5,NA,6,NA,7,NA,,7,5,1,10,6,12/19/2019,KU,"From LSH, P5, 02/09/2016",12/17/2019,03/03/2020,Good,X,Y,16,18,,11,13,,11,14,15,,,11,14,,11,20,,11,12,12,14,,17,18,,10,12,,2.2,13,,6,9.3,16,17,,28,30,,8,9,12,13,8,9,,10,11,12,,15,22,,12,,,22,,,15,17,,,Maris
SK-N-FI,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Has multiple morphologies,Unknown,Progressing,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,None,None,None,Gain q21.31-qterm,WT,Non-amplified,M246R,NA,NA,NA,NA,5,NA,6,NA,7,NA,,7,5,2,1,6,12/19/2019,KU,"From LSH, P5, 02/09/2016",12/17/2019,03/03/2020,Good,X,Y,16,18,,11,13,,11,14,15,,,11,14,,11,20,,11,12,12,14,,17,18,,10,12,,2.2,13,,6,9.3,16,17,,28,30,,8,9,12,13,8,9,,10,11,12,,15,22,,12,,,22,,,15,17,,,Maris
SK-N-FI,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Has multiple morphologies,Unknown,Progressing,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,None,None,None,Gain q21.31-qterm,WT,Non-amplified,M246R,NA,NA,NA,NA,5,NA,6,NA,7,NA,,7,5,2,2,6,12/19/2019,KU,"From LSH, P5, 02/09/2016",12/17/2019,03/03/2020,Good,X,Y,16,18,,11,13,,11,14,15,,,11,14,,11,20,,11,12,12,14,,17,18,,10,12,,2.2,13,,6,9.3,16,17,,28,30,,8,9,12,13,8,9,,10,11,12,,15,22,,12,,,22,,,15,17,,,Maris
SK-N-FI,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Has multiple morphologies,Unknown,Progressing,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,None,None,None,Gain q21.31-qterm,WT,Non-amplified,M246R,NA,NA,NA,NA,5,NA,6,NA,7,NA,,7,5,2,3,6,12/19/2019,KU,"From LSH, P5, 02/09/2016",12/17/2019,03/03/2020,Good,X,Y,16,18,,11,13,,11,14,15,,,11,14,,11,20,,11,12,12,14,,17,18,,10,12,,2.2,13,,6,9.3,16,17,,28,30,,8,9,12,13,8,9,,10,11,12,,15,22,,12,,,22,,,15,17,,,Maris
SK-N-FI,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Has multiple morphologies,Unknown,Progressing,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,None,None,None,Gain q21.31-qterm,WT,Non-amplified,M246R,NA,NA,NA,NA,5,NA,6,NA,7,NA,,7,5,2,4,7,02/13/2019,KU,"From KLC, P5, 09/04/2018 (STR of thaw is good)",,03/03/2020,Remove,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-FI,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Has multiple morphologies,Unknown,Progressing,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,None,None,None,Gain q21.31-qterm,WT,Non-amplified,M246R,NA,NA,NA,NA,5,NA,6,NA,7,NA,,7,5,2,5,7,02/13/2019,KU,"From KLC, P5, 09/04/2018 (STR of thaw is good)",,03/03/2020,Remove,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-FI,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Has multiple morphologies,Unknown,Progressing,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,None,None,None,Gain q21.31-qterm,WT,Non-amplified,M246R,NA,NA,NA,NA,5,NA,6,NA,7,NA,,7,5,2,6,6,12/19/2019,KU,"From LSH, P5, 02/09/2016",12/17/2019,03/03/2020,Good,X,Y,16,18,,11,13,,11,14,15,,,11,14,,11,20,,11,12,12,14,,17,18,,10,12,,2.2,13,,6,9.3,16,17,,28,30,,8,9,12,13,8,9,,10,11,12,,15,22,,12,,,22,,,15,17,,,Maris
SK-N-FI,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Has multiple morphologies,Unknown,Progressing,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,None,None,None,Gain q21.31-qterm,WT,Non-amplified,M246R,NA,NA,NA,NA,5,NA,6,NA,7,NA,,7,5,2,7,6,12/19/2019,KU,"From LSH, P5, 02/09/2016",12/17/2019,03/03/2020,Good,X,Y,16,18,,11,13,,11,14,15,,,11,14,,11,20,,11,12,12,14,,17,18,,10,12,,2.2,13,,6,9.3,16,17,,28,30,,8,9,12,13,8,9,,10,11,12,,15,22,,12,,,22,,,15,17,,,Maris
SK-N-FI,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Has multiple morphologies,Unknown,Progressing,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,None,None,None,Gain q21.31-qterm,WT,Non-amplified,M246R,NA,NA,NA,NA,5,NA,6,NA,7,NA,,7,5,2,8,6,12/19/2019,KU,"From LSH, P5, 02/09/2016",12/17/2019,03/03/2020,Good,X,Y,16,18,,11,13,,11,14,15,,,11,14,,11,20,,11,12,12,14,,17,18,,10,12,,2.2,13,,6,9.3,16,17,,28,30,,8,9,12,13,8,9,,10,11,12,,15,22,,12,,,22,,,15,17,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,2,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,2,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SMS-KAN,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Mixed Adherence,Slow growing cell line,Diagnosis ,Diagnosis,No prior treatments,Primary Tumor,Loss p13.3-pterm,None,Loss q14.2-q23.3,Gain q11.1-qterm,WT,Amplified,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,5,3,1,10,01/24/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SMS-KAN,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Mixed Adherence,Slow growing cell line,Diagnosis ,Diagnosis,No prior treatments,Primary Tumor,Loss p13.3-pterm,None,Loss q14.2-q23.3,Gain q11.1-qterm,WT,Amplified,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,5,3,2,10,01/24/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SMS-KAN,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Mixed Adherence,Slow growing cell line,Diagnosis ,Diagnosis,No prior treatments,Primary Tumor,Loss p13.3-pterm,None,Loss q14.2-q23.3,Gain q11.1-qterm,WT,Amplified,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,5,3,4,3,02/24/2016,LSH,,06/30/2017,3/3/2020,Good,X,,15,17,,13,15,,11.3,14,16,17,,9,11,,12,15,,11,13,17,21,,18,19,,10,12,,9,11,,7,8,15,16,,28,30,,8,9,9,13,8,11,,-,14,16,,18,23,,12,,,19,21,,14,17,,,Maris
SMS-KAN,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Mixed Adherence,Slow growing cell line,Diagnosis ,Diagnosis,No prior treatments,Primary Tumor,Loss p13.3-pterm,None,Loss q14.2-q23.3,Gain q11.1-qterm,WT,Amplified,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,5,3,5,3,02/24/2016,LSH,,06/30/2017,3/3/2020,Good,X,,15,17,,13,15,,11.3,14,16,17,,9,11,,12,15,,11,13,17,21,,18,19,,10,12,,9,11,,7,8,15,16,,28,30,,8,9,9,13,8,11,,-,14,16,,18,23,,12,,,19,21,,14,17,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,3,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SMS-KAN,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Mixed Adherence,Slow growing cell line,Diagnosis ,Diagnosis,No prior treatments,Primary Tumor,Loss p13.3-pterm,None,Loss q14.2-q23.3,Gain q11.1-qterm,WT,Amplified,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,5,3,7,6,07/24/2017,KLC,"From LSH, P3, 02/24/2016 (STR of thaw is good)",,3/3/2020,Good (STR of thaw is good),X,,15,17,,13,15,,11.3,14,16,17,,9,11,,12,15,,11,13,17,21,,18,19,,10,12,,9,11,,7,8,15,16,,28,30,,8,9,9,13,8,11,,-,14,16,,18,23,,12,,,19,21,,14,17,,,Maris
SMS-KAN,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Mixed Adherence,Slow growing cell line,Diagnosis ,Diagnosis,No prior treatments,Primary Tumor,Loss p13.3-pterm,None,Loss q14.2-q23.3,Gain q11.1-qterm,WT,Amplified,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,5,3,8,6,07/24/2017,KLC,"From LSH, P3, 02/24/2016 (STR of thaw is good)",,3/3/2020,Good (STR of thaw is good),X,,15,17,,13,15,,11.3,14,16,17,,9,11,,12,15,,11,13,17,21,,18,19,,10,12,,9,11,,7,8,15,16,,28,30,,8,9,9,13,8,11,,-,14,16,,18,23,,12,,,19,21,,14,17,,,Maris
SMS-KAN,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Mixed Adherence,Slow growing cell line,Diagnosis ,Diagnosis,No prior treatments,Primary Tumor,Loss p13.3-pterm,None,Loss q14.2-q23.3,Gain q11.1-qterm,WT,Amplified,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,5,3,9,4,01/02/2020,KU,"From LSH, P3, 02/24/2016 (STR of thaw is good)",12/17/2019,3/3/2020,Good (STR of thaw is good),X,,15,17,,13,15,,11.3,14,16,17,,9,11,,12,15,,11,13,17,21,,18,19,,10,12,,9,11,,7,8,15,16,,28,30,,8,9,9,13,8,11,,-,14,16,,18,23,,12,,,19,21,,14,17,,,Maris
SMS-KAN,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Mixed Adherence,Slow growing cell line,Diagnosis ,Diagnosis,No prior treatments,Primary Tumor,Loss p13.3-pterm,None,Loss q14.2-q23.3,Gain q11.1-qterm,WT,Amplified,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,5,3,10,4,01/02/2020,KU,"From LSH, P3, 02/24/2016 (STR of thaw is good)",12/17/2019,3/3/2020,Good (STR of thaw is good),X,,15,17,,13,15,,11.3,14,16,17,,9,11,,12,15,,11,13,17,21,,18,19,,10,12,,9,11,,7,8,15,16,,28,30,,8,9,9,13,8,11,,-,14,16,,18,23,,12,,,19,21,,14,17,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,4,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,4,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,4,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,4,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,4,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,4,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SMS-KAN,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Mixed Adherence,Slow growing cell line,Diagnosis ,Diagnosis,No prior treatments,Primary Tumor,Loss p13.3-pterm,None,Loss q14.2-q23.3,Gain q11.1-qterm,WT,Amplified,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,5,4,9,4,01/02/2020,KU,"From LSH, P3, 02/24/2016 (STR of thaw is good)",12/17/2019,3/3/2020,Good (STR of thaw is good),X,,15,17,,13,15,,11.3,14,16,17,,9,11,,12,15,,11,13,17,21,,18,19,,10,12,,9,11,,7,8,15,16,,28,30,,8,9,9,13,8,11,,-,14,16,,18,23,,12,,,19,21,,14,17,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,4,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-SH,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Two distinct morphologies ,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,None,None,LOH 23.1,Gain q21.31-qterm,F1174L,Non-amplified,WT,NA,NA,NA,NA,5,NA,6,NA,NA,NA,,7,5,5,1,2,09/26/2017,JLH,"new from ATCC lot #63226337, 09/08/2017",09/15/2017,08/22/2018,Good,X,,15,16,,12,,,11,11.3,14,,,11,,,7,11,,8,13,13,16,,17,19,,11,,,10,12,,7,10,14,18,,31,31.2,,7,10,12,,8,11,,,15,,,18,22,,13,14,,23.2,24,,16,17,,,Maris
SK-N-SH,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Two distinct morphologies ,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,None,None,LOH 23.1,Gain q21.31-qterm,F1174L,Non-amplified,WT,NA,NA,NA,NA,5,NA,6,NA,NA,NA,,7,5,5,2,2,09/26/2017,JLH,"new from ATCC lot #63226337, 09/08/2017",09/15/2017,08/22/2018,Good,X,,15,16,,12,,,11,11.3,14,,,11,,,7,11,,8,13,13,16,,17,19,,11,,,10,12,,7,10,14,18,,31,31.2,,7,10,12,,8,11,,,15,,,18,22,,13,14,,23.2,24,,16,17,,,Maris
SK-N-SH,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Two distinct morphologies ,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,None,None,LOH 23.1,Gain q21.31-qterm,F1174L,Non-amplified,WT,NA,NA,NA,NA,5,NA,6,NA,NA,NA,,7,5,5,3,2,09/26/2017,JLH,"new from ATCC lot #63226337, 09/08/2017",09/15/2017,08/22/2018,Good,X,,15,16,,12,,,11,11.3,14,,,11,,,7,11,,8,13,13,16,,17,19,,11,,,10,12,,7,10,14,18,,31,31.2,,7,10,12,,8,11,,,15,,,18,22,,13,14,,23.2,24,,16,17,,,Maris
SK-N-SH,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Two distinct morphologies ,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,None,None,LOH 23.1,Gain q21.31-qterm,F1174L,Non-amplified,WT,NA,NA,NA,NA,5,NA,6,NA,NA,NA,,7,5,5,4,2,09/26/2017,JLH,"new from ATCC lot #63226337, 09/08/2017",09/15/2017,08/22/2018,Good,X,,15,16,,12,,,11,11.3,14,,,11,,,7,11,,8,13,13,16,,17,19,,11,,,10,12,,7,10,14,18,,31,31.2,,7,10,12,,8,11,,,15,,,18,22,,13,14,,23.2,24,,16,17,,,Maris
SK-N-SH,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Two distinct morphologies ,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,None,None,LOH 23.1,Gain q21.31-qterm,F1174L,Non-amplified,WT,NA,NA,NA,NA,5,NA,6,NA,NA,NA,,7,5,5,5,2,09/26/2017,JLH,"new from ATCC lot #63226337, 09/08/2017",09/15/2017,08/22/2018,Good,X,,15,16,,12,,,11,11.3,14,,,11,,,7,11,,8,13,13,16,,17,19,,11,,,10,12,,7,10,14,18,,31,31.2,,7,10,12,,8,11,,,15,,,18,22,,13,14,,23.2,24,,16,17,,,Maris
SK-N-SH,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Two distinct morphologies ,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,None,None,LOH 23.1,Gain q21.31-qterm,F1174L,Non-amplified,WT,NA,NA,NA,NA,5,NA,6,NA,NA,NA,,7,5,5,6,7,02/04/2020,KU,"From P5, KLC, 10/11/2017",02/04/2020,03/03/2020,Good,X,,15,16,,12,,,11,11.3,14,,,11,,,7,11,,8,13,13,16,,17,19,,11,,,10,12,,7,10,14,18,,31,31.2,,7,10,12,,8,11,,,15,,,18,22,,13,14,,23.2,24,,16,17,,,Maris
SK-N-SH,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Two distinct morphologies ,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,None,None,LOH 23.1,Gain q21.31-qterm,F1174L,Non-amplified,WT,NA,NA,NA,NA,5,NA,6,NA,NA,NA,,7,5,5,7,7,02/04/2020,KU,"From P5, KLC, 10/11/2017",02/04/2020,03/03/2020,Good,X,,15,16,,12,,,11,11.3,14,,,11,,,7,11,,8,13,13,16,,17,19,,11,,,10,12,,7,10,14,18,,31,31.2,,7,10,12,,8,11,,,15,,,18,22,,13,14,,23.2,24,,16,17,,,Maris
SK-N-SH,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Two distinct morphologies ,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,None,None,LOH 23.1,Gain q21.31-qterm,F1174L,Non-amplified,WT,NA,NA,NA,NA,5,NA,6,NA,NA,NA,,7,5,5,8,5,10/11/2017,klc,"new from ATCC lot #63226337, 09/08/2017",09/15/2017,08/22/2018,Good,X,,15,16,,12,,,11,11.3,14,,,11,,,7,11,,8,13,13,16,,17,19,,11,,,10,12,,7,10,14,18,,31,31.2,,7,10,12,,8,11,,,15,,,18,22,,13,14,,23.2,24,,16,17,,,Maris
SK-N-SH,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Two distinct morphologies ,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,None,None,LOH 23.1,Gain q21.31-qterm,F1174L,Non-amplified,WT,NA,NA,NA,NA,5,NA,6,NA,NA,NA,,7,5,5,9,7,02/04/2020,KU,"From P5, KLC, 10/11/2017",02/04/2020,03/03/2020,Good,X,,15,16,,12,,,11,11.3,14,,,11,,,7,11,,8,13,13,16,,17,19,,11,,,10,12,,7,10,14,18,,31,31.2,,7,10,12,,8,11,,,15,,,18,22,,13,14,,23.2,24,,16,17,,,Maris
SK-N-SH,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Two distinct morphologies ,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,None,None,LOH 23.1,Gain q21.31-qterm,F1174L,Non-amplified,WT,NA,NA,NA,NA,5,NA,6,NA,NA,NA,,7,5,5,10,7,02/04/2020,KU,"From P5, KLC, 10/11/2017",02/04/2020,03/03/2020,Good,X,,15,16,,12,,,11,11.3,14,,,11,,,7,11,,8,13,13,16,,17,19,,11,,,10,12,,7,10,14,18,,31,31.2,,7,10,12,,8,11,,,15,,,18,22,,13,14,,23.2,24,,16,17,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,6,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,6,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,6,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,6,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,6,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,6,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,6,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,6,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,6,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,7,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SMS-SAN,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent ,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p32.3-pterm,None,Loss q25,Gain q21.2-qterm,F1174L,Amplified,WT,NA,5,NA,5-6,NA,NA,NA,NA,7,NA,,7,5,7,2,3,01/06/2016,LSH,,12/7/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SMS-SAN,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent ,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p32.3-pterm,None,Loss q25,Gain q21.2-qterm,F1174L,Amplified,WT,NA,5,NA,5-6,NA,NA,NA,NA,7,NA,,7,5,7,3,4,02/12/2016,LSH,,12/7/2012,10/19/2018,Good (STR of subsequent freeze is good),X,,15,17,,12,15,,11,14,15,,,11,12,,12,14,,12,,16,19,,19,,,12,,,13,,,6,9.3,17,18,,29,31.2,,8,11,11,,8,12,,-,10,11,,20,22,,13,14,,19,,,16,17,,,Maris
SMS-SAN,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent ,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p32.3-pterm,None,Loss q25,Gain q21.2-qterm,F1174L,Amplified,WT,NA,5,NA,5-6,NA,NA,NA,NA,7,NA,,7,5,7,4,5,06/26/2017,klc,"from LSH, p4, 2/12/16",06/30/2017,10/19/2018,Good,X,,15,17,,12,15,,11,14,15,,,11,12,,12,14,,12,,16,19,,19,,,12,,,13,,,6,9.3,17,18,,29,31.2,,8,11,11,,8,12,,-,10,11,,20,22,,13,14,,19,,,16,17,,,Maris
SMS-SAN,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent ,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p32.3-pterm,None,Loss q25,Gain q21.2-qterm,F1174L,Amplified,WT,NA,5,NA,5-6,NA,NA,NA,NA,7,NA,,7,5,7,5,4,07/20/2016,LSH,,12/7/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SMS-SAN,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent ,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p32.3-pterm,None,Loss q25,Gain q21.2-qterm,F1174L,Amplified,WT,NA,5,NA,5-6,NA,NA,NA,NA,7,NA,,7,5,7,6,6,11/20/2017,klc,"From P5, klc, 06/27/2017",11/17/2017,10/19/2018,Good,X,,15,17,,12,15,,11,14,15,,,11,12,,12,14,,12,,16,19,,19,,,12,,,13,,,6,9.3,17,18,,29,31.2,,8,11,11,,8,12,,-,10,11,,20,22,,13,14,,19,,,16,17,,,Maris
SMS-SAN,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent ,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p32.3-pterm,None,Loss q25,Gain q21.2-qterm,F1174L,Amplified,WT,NA,5,NA,5-6,NA,NA,NA,NA,7,NA,,7,5,7,7,6,02/11/2020,KU,"From KLC, P5, 06/26/2017",02/04/2020,3/3/2020,Good,X,,15,17,,12,15,,11,14,15,,,11,12,,12,14,,12,,16,19,,19,,,12,,,13,,,6,9.3,17,18,,29,31.2,,8,11,11,,8,12,,-,10,11,,20,22,,13,14,,19,,,16,17,,,Maris
SMS-SAN,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent ,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p32.3-pterm,None,Loss q25,Gain q21.2-qterm,F1174L,Amplified,WT,NA,5,NA,5-6,NA,NA,NA,NA,7,NA,,7,5,7,8,6,02/11/2020,KU,"From KLC, P5, 06/26/2017",02/04/2020,3/3/2020,Good,X,,15,17,,12,15,,11,14,15,,,11,12,,12,14,,12,,16,19,,19,,,12,,,13,,,6,9.3,17,18,,29,31.2,,8,11,11,,8,12,,-,10,11,,20,22,,13,14,,19,,,16,17,,,Maris
SMS-SAN,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent ,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p32.3-pterm,None,Loss q25,Gain q21.2-qterm,F1174L,Amplified,WT,NA,5,NA,5-6,NA,NA,NA,NA,7,NA,,7,5,7,9,6,02/11/2020,KU,"From KLC, P5, 06/26/2017",02/04/2020,3/3/2020,Good,X,,15,17,,12,15,,11,14,15,,,11,12,,12,14,,12,,16,19,,19,,,12,,,13,,,6,9.3,17,18,,29,31.2,,8,11,11,,8,12,,-,10,11,,20,22,,13,14,,19,,,16,17,,,Maris
SMS-SAN,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent ,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p32.3-pterm,None,Loss q25,Gain q21.2-qterm,F1174L,Amplified,WT,NA,5,NA,5-6,NA,NA,NA,NA,7,NA,,7,5,7,10,6,02/11/2020,KU,"From KLC, P5, 06/26/2017",02/04/2020,3/3/2020,Good,X,,15,17,,12,15,,11,14,15,,,11,12,,12,14,,12,,16,19,,19,,,12,,,13,,,6,9.3,17,18,,29,31.2,,8,11,11,,8,12,,-,10,11,,20,22,,13,14,,19,,,16,17,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,8,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,8,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,8,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,8,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,8,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,8,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,8,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,8,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SMS-SAN,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent ,,Diagnosis,Diagnosis,No prior treatments,Bone Marrow,Loss p32.3-pterm,None,Loss q25,Gain q21.2-qterm,F1174L,Amplified,WT,NA,5,NA,5-6,NA,NA,NA,NA,7,NA,,7,5,8,10,6,02/11/2020,KU,"From KLC, P5, 06/26/2018",02/04/2020,3/3/2020,Good,X,,15,17,,12,15,,11,14,15,,,11,12,,12,14,,12,,16,19,,19,,,12,,,13,,,6,9.3,17,18,,29,31.2,,8,11,11,,8,12,,-,10,11,,20,22,,13,14,,19,,,16,17,,,Maris
IMR-32,Cell Bank,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given prior to sample collection,Solid Tumor ,Loss p32.3-pter,Loss p12.3,cnLOH q23.1,Gain q21.2-qter,WT,Amplified,WT,NA,NA,NA,4-5,NA,NA,NA,NA,6-7,9,,7,5,9,1,8,09/12/2018,KU,From P7 LSH 11/07/2014 (STR from thaw is good),09/14/2018,10/19/2018,Good (Drop out of 7 at PENTA E; STR of subsequent freeze is good (KLC P7 10/31/17)),X,Y,16,,,17,17.3,,10,11,13,14,,9,,,7,15,,8,,12,15 (DO),,23,24,,11,12,,11,12,,7,9.3,15,,,30,31,,9,10,11,12,11,,,11,13,,,19.3,23,,14,15,,21,24,,16,18,,,Maris
IMR-32,Cell Bank,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given prior to sample collection,Solid Tumor ,Loss p32.3-pter,Loss p12.3,cnLOH q23.1,Gain q21.2-qter,WT,Amplified,WT,NA,NA,NA,4-5,NA,NA,NA,NA,6-7,9,,7,5,9,2,5,02/06/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
IMR-32,Cell Bank,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given prior to sample collection,Solid Tumor ,Loss p32.3-pter,Loss p12.3,cnLOH q23.1,Gain q21.2-qter,WT,Amplified,WT,NA,NA,NA,4-5,NA,NA,NA,NA,6-7,9,,7,5,9,3,4,02/25/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
IMR-32,Cell Bank,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given prior to sample collection,Solid Tumor ,Loss p32.3-pter,Loss p12.3,cnLOH q23.1,Gain q21.2-qter,WT,Amplified,WT,NA,NA,NA,4-5,NA,NA,NA,NA,6-7,9,,7,5,9,4,7,11/07/2014,LSH,,10/22/2014,10/19/2018,Good (Drop out of 15 at D18S51),X,Y,16,,,17,17.3,,10,11,13,14,,9,,,7,15,,8,,12,15 (DO),,23,24,,11,12,,11,12,,7,9.3,15,,,30,31,,9,10,11,12,11,,,11,13,,,19.3,23,,14,15,,21,24,,16,18,,,Maris
IMR-32,Cell Bank,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given prior to sample collection,Solid Tumor ,Loss p32.3-pter,Loss p12.3,cnLOH q23.1,Gain q21.2-qter,WT,Amplified,WT,NA,NA,NA,4-5,NA,NA,NA,NA,6-7,9,,7,5,9,5,7,11/07/2014,LSH,,10/22/2014,10/19/2018,Good (Drop out of 15 at D18S51),X,Y,16,,,17,17.3,,10,11,13,14,,9,,,7,15,,8,,12,15 (DO),,23,24,,11,12,,11,12,,7,9.3,15,,,30,31,,9,10,11,12,11,,,11,13,,,19.3,23,,14,15,,21,24,,16,18,,,Maris
IMR-32,Cell Bank,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given prior to sample collection,Solid Tumor ,Loss p32.3-pter,Loss p12.3,cnLOH q23.1,Gain q21.2-qter,WT,Amplified,WT,NA,NA,NA,4-5,NA,NA,NA,NA,6-7,9,,7,5,9,6,7,11/07/2014,LSH,,10/22/2014,10/19/2018,Good (Drop out of 15 at D18S51),X,Y,16,,,17,17.3,,10,11,13,14,,9,,,7,15,,8,,12,15 (DO),,23,24,,11,12,,11,12,,7,9.3,15,,,30,31,,9,10,11,12,11,,,11,13,,,19.3,23,,14,15,,21,24,,16,18,,,Maris
IMR-32,Cell Bank,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given prior to sample collection,Solid Tumor ,Loss p32.3-pter,Loss p12.3,cnLOH q23.1,Gain q21.2-qter,WT,Amplified,WT,NA,NA,NA,4-5,NA,NA,NA,NA,6-7,9,,7,5,9,7,8,09/12/2018,KU,From P7 LSH 11/07/2014 (STR from thaw is good),09/14/2018,10/19/2018,Good (Drop out of 15 at D18S51; STR from thaw is good),X,Y,16,,,17,17.3,,10,11,13,14,,9,,,7,15,,8,,12,15 (DO),,23,24,,11,12,,11,12,,7,9.3,15,,,30,31,,9,10,11,12,11,,,11,13,,,19.3,23,,14,15,,21,24,,16,18,,,Maris
IMR-32,Cell Bank,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given prior to sample collection,Solid Tumor ,Loss p32.3-pter,Loss p12.3,cnLOH q23.1,Gain q21.2-qter,WT,Amplified,WT,NA,NA,NA,4-5,NA,NA,NA,NA,6-7,9,,7,5,9,8,8,09/12/2018,KU,From P7 LSH 11/07/2014 (STR from thaw is good),09/14/2018,10/19/2018,Good (Drop out of 15 at D18S51; STR from thaw is good),X,Y,16,,,17,17.3,,10,11,13,14,,9,,,7,15,,8,,12,15 (DO),,23,24,,11,12,,11,12,,7,9.3,15,,,30,31,,9,10,11,12,11,,,11,13,,,19.3,23,,14,15,,21,24,,16,18,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,9,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,9,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,10,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,10,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,10,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,5,10,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
IMR-32,Cell Bank,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given prior to sample collection,Solid Tumor ,Loss p32.3-pter,Loss p12.3,cnLOH q23.1,Gain q21.2-qter,WT,Amplified,WT,NA,NA,NA,4-5,NA,NA,NA,NA,6-7,9,,7,5,10,5,9,11/02/2017,klc,"from LS, P6, 04/10/2017",11/03/2017,3/3/2020,Good ,X,Y,16,,,17,17.3,,10,11,13,14,,9,,,7,15,,8,,12,15,,23,24,,11,12,,11,12,,7,9.3,15,,,30,31,,9,10,11,12,11,,,11,13,,,19.3,23,,14,15,,21,24,,16,18,,,Maris
IMR-32,Cell Bank,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given prior to sample collection,Solid Tumor ,Loss p32.3-pter,Loss p12.3,cnLOH q23.1,Gain q21.2-qter,WT,Amplified,WT,NA,NA,NA,4-5,NA,NA,NA,NA,6-7,9,,7,5,10,6,9,11/02/2017,klc,"from LS, P6, 04/10/2017",11/03/2017,10/19/2018,Good ,X,Y,16,,,17,17.3,,10,11,13,14,,9,,,7,15,,8,,12,15,,23,24,,11,12,,11,12,,7,9.3,15,,,30,31,,9,10,11,12,11,,,11,13,,,19.3,23,,14,15,,21,24,,16,18,,,Maris
IMR-32,Cell Bank,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given prior to sample collection,Solid Tumor ,Loss p32.3-pter,Loss p12.3,cnLOH q23.1,Gain q21.2-qter,WT,Amplified,WT,NA,NA,NA,4-5,NA,NA,NA,NA,6-7,9,,7,5,10,7,9,11/02/2017,klc,"from LS, P6, 04/10/2017",11/03/2017,10/19/2018,Good ,X,Y,16,,,17,17.3,,10,11,13,14,,9,,,7,15,,8,,12,15,,23,24,,11,12,,11,12,,7,9.3,15,,,30,31,,9,10,11,12,11,,,11,13,,,19.3,23,,14,15,,21,24,,16,18,,,Maris
IMR-32,Cell Bank,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given prior to sample collection,Solid Tumor ,Loss p32.3-pter,Loss p12.3,cnLOH q23.1,Gain q21.2-qter,WT,Amplified,WT,NA,NA,NA,4-5,NA,NA,NA,NA,6-7,9,,7,5,10,8,10,01/16/2018,klc,"from KLC, P9, 11/02/2017",,10/19/2018,Good,X,Y,16,,,17,17.3,,10,11,13,14,,9,,,7,15,,8,,12,15,,23,24,,11,12,,11,12,,7,9.3,15,,,30,31,,9,10,11,12,11,,,11,13,,,19.3,23,,14,15,,21,24,,16,18,,,Maris
IMR-32,Cell Bank,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given prior to sample collection,Solid Tumor ,Loss p32.3-pter,Loss p12.3,cnLOH q23.1,Gain q21.2-qter,WT,Amplified,WT,NA,NA,NA,4-5,NA,NA,NA,NA,6-7,9,,7,5,10,9,10,01/16/2018,klc,"from KLC, P9, 11/02/2017",,10/19/2018,Good,X,Y,16,,,17,17.3,,10,11,13,14,,9,,,7,15,,8,,12,15,,23,24,,11,12,,11,12,,7,9.3,15,,,30,31,,9,10,11,12,11,,,11,13,,,19.3,23,,14,15,,21,24,,16,18,,,Maris
IMR-32,Cell Bank,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given prior to sample collection,Solid Tumor ,Loss p32.3-pter,Loss p12.3,cnLOH q23.1,Gain q21.2-qter,WT,Amplified,WT,NA,NA,NA,4-5,NA,NA,NA,NA,6-7,9,,7,5,10,10,10,01/16/2018,klc,"from KLC, P9, 11/02/2017",,10/19/2018,Good,X,Y,16,,,17,17.3,,10,11,13,14,,9,,,7,15,,8,,12,15,,23,24,,11,12,,11,12,,7,9.3,15,,,30,31,,9,10,11,12,11,,,11,13,,,19.3,23,,14,15,,21,24,,16,18,,,Maris
CHP-212,Cell Bank,"EMEM and Ham’s F12 (1:1) Base, 1% Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,NA,NA,NA,6,NA,NA,NA,NA,8-9,10,,7,6,1,1,4,11/25/2012,LSH,,11/30/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHP-212,Cell Bank,"EMEM and Ham’s F12 (1:1) Base, 1% Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,NA,NA,NA,6,NA,NA,NA,NA,8-9,10,,7,6,1,2,4,11/25/2012,LSH,,11/30/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHP-212,Cell Bank,"EMEM and Ham’s F12 (1:1) Base, 1% Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,NA,NA,NA,6,NA,NA,NA,NA,8-9,10,,7,6,1,4,7,01/19/2016,LSH,,,3/3/20,Good,X,Y,15,17,,15,,,11.3,14,13,16,,8,13,,5,15,,13,,14,16,,22,25,,12,,,9,10,,6,,15,18,,27,29,,11,,10,12,8,11,,11,11,13,,17.3,22,,12,15,,20,,,16,,,,Maris
CHP-212,Cell Bank,"EMEM and Ham’s F12 (1:1) Base, 1% Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,NA,NA,NA,6,NA,NA,NA,NA,8-9,10,,7,6,1,5,7,01/19/2016,LSH,,,3/3/20,Good,X,Y,15,17,,15,,,11.3,14,13,16,,8,13,,5,15,,13,,14,16,,22,25,,12,,,9,10,,6,,15,18,,27,29,,11,,10,12,8,11,,11,11,13,,17.3,22,,12,15,,20,,,16,,,,Maris
CHP-212,Cell Bank,"EMEM and Ham’s F12 (1:1) Base, 1% Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,NA,NA,NA,6,NA,NA,NA,NA,8-9,10,,7,6,1,6,7,01/19/2016,LSH,,,3/3/20,Good,X,Y,15,17,,15,,,11.3,14,13,16,,8,13,,5,15,,13,,14,16,,22,25,,12,,,9,10,,6,,15,18,,27,29,,11,,10,12,8,11,,11,11,13,,17.3,22,,12,15,,20,,,16,,,,Maris
CHP-212,Cell Bank,"EMEM and Ham’s F12 (1:1) Base, 1% Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,NA,NA,NA,6,NA,NA,NA,NA,8-9,10,,7,6,1,7,7,01/19/2016,LSH,,,3/3/20,Good,X,Y,15,17,,15,,,11.3,14,13,16,,8,13,,5,15,,13,,14,16,,22,25,,12,,,9,10,,6,,15,18,,27,29,,11,,10,12,8,11,,11,11,13,,17.3,22,,12,15,,20,,,16,,,,Maris
CHP-212,Cell Bank,"EMEM and Ham’s F12 (1:1) Base, 1% Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,NA,NA,NA,6,NA,NA,NA,NA,8-9,10,,7,6,1,8,9,05/11/2017,LS,,5/12/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHP-212,Cell Bank,"EMEM and Ham’s F12 (1:1) Base, 1% Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,NA,NA,NA,6,NA,NA,NA,NA,8-9,10,,7,6,1,9,9,05/11/2017,LS,,5/12/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHP-212,Cell Bank,"EMEM and Ham’s F12 (1:1) Base, 1% Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,NA,NA,NA,6,NA,NA,NA,NA,8-9,10,,7,6,1,10,6,09/20/2017,klc,"From LSH, P4, 12/12/14",09/19/2017,12/10/2019,Good,X,Y,15,17,,15,,,11.3,14,13,16,,8,13,,5,15,,13,,14,16,,22,25,,12,,,9,10,,6,,15,18,,27,29,,11,,10,12,8,11,,11,11,13,,17.3,22,,12,15,,20,,,16,,,,Maris
CHP-212,Cell Bank,"EMEM and Ham’s F12 (1:1) Base, 1% Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,NA,NA,NA,6,NA,NA,NA,NA,8-9,10,,7,6,2,1,8,02/11/2020,KU,"From LSH, P7, 01/19/2016",02/07/2020,3/3/20,Good,X,Y,15,17,,15,,,11.3,14,13,16,,8,13,,5,15,,13,,14,16,,22,25,,12,,,9,10,,6,,15,18,,27,29,,11,,10,12,8,11,,11,11,13,,17.3,22,,12,15,,20,,,16,,,,Maris
CHP-212,Cell Bank,"EMEM and Ham’s F12 (1:1) Base, 1% Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,NA,NA,NA,6,NA,NA,NA,NA,8-9,10,,7,6,2,2,8,02/11/2020,KU,"From LSH, P7, 01/19/2016",02/07/2020,3/3/20,Good,X,Y,15,17,,15,,,11.3,14,13,16,,8,13,,5,15,,13,,14,16,,22,25,,12,,,9,10,,6,,15,18,,27,29,,11,,10,12,8,11,,11,11,13,,17.3,22,,12,15,,20,,,16,,,,Maris
CHP-212,Cell Bank,"EMEM and Ham’s F12 (1:1) Base, 1% Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,NA,NA,NA,6,NA,NA,NA,NA,8-9,10,,7,6,2,3,8,02/11/2020,KU,"From LSH, P7, 01/19/2016",02/07/2020,3/3/20,Good,X,Y,15,17,,15,,,11.3,14,13,16,,8,13,,5,15,,13,,14,16,,22,25,,12,,,9,10,,6,,15,18,,27,29,,11,,10,12,8,11,,11,11,13,,17.3,22,,12,15,,20,,,16,,,,Maris
CHP-212,Cell Bank,"EMEM and Ham’s F12 (1:1) Base, 1% Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,NA,NA,NA,6,NA,NA,NA,NA,8-9,10,,7,6,2,4,8,02/11/2020,KU,"From LSH, P7, 01/19/2016",02/07/2020,3/3/20,Good,X,Y,15,17,,15,,,11.3,14,13,16,,8,13,,5,15,,13,,14,16,,22,25,,12,,,9,10,,6,,15,18,,27,29,,11,,10,12,8,11,,11,11,13,,17.3,22,,12,15,,20,,,16,,,,Maris
CHP-212,Cell Bank,"EMEM and Ham’s F12 (1:1) Base, 1% Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,NA,NA,NA,6,NA,NA,NA,NA,8-9,10,,7,6,2,5,8,02/11/2020,KU,"From LSH, P7, 01/19/2016",02/07/2020,3/3/20,Good,X,Y,15,17,,15,,,11.3,14,13,16,,8,13,,5,15,,13,,14,16,,22,25,,12,,,9,10,,6,,15,18,,27,29,,11,,10,12,8,11,,11,11,13,,17.3,22,,12,15,,20,,,16,,,,Maris
CHP-212,Cell Bank,"EMEM and Ham’s F12 (1:1) Base, 1% Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,NA,NA,NA,6,NA,NA,NA,NA,8-9,10,,7,6,2,6,8,02/11/2020,KU,"From LSH, P7, 01/19/2016",02/07/2020,3/3/20,Good,X,Y,15,17,,15,,,11.3,14,13,16,,8,13,,5,15,,13,,14,16,,22,25,,12,,,9,10,,6,,15,18,,27,29,,11,,10,12,8,11,,11,11,13,,17.3,22,,12,15,,20,,,16,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,2,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,2,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,2,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,2,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,3,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
HEK293T,Cell Bank,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,6,3,2,4,01/03/2016,KB,,09/08/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
HEK293T,Cell Bank,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,6,3,3,4,01/03/2016,KB,,09/08/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
HEK293T,Cell Bank,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,6,3,4,4,01/03/2016,KB,,09/08/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,3,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
HEK293T,Cell Bank,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,6,3,6,9,05/24/2016,JC,,09/08/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
HEK293T,Cell Bank,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,6,3,7,9,05/24/2016,JC,,09/08/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
HEK293T,Cell Bank,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,6,3,8,4,04/04/2018,klc,,04/06/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
HEK293T,Cell Bank,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,6,3,9,4,04/04/2018,klc,,04/06/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,3,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
HEK293T,Cell Bank,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,6,4,1,3,08/31/2017,JLH,,09/08/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
HEK293T,Cell Bank,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,6,4,2,3,08/31/2017,JLH,,09/08/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
HEK293T,Cell Bank,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,6,4,3,3,08/31/2017,JLH,,09/08/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,4,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,4,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,4,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,4,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,4,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,4,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,5,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NMB,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,cnLOH p34.2-pterm,None,Loss q21-qterm,LOH/Gain q11.2-qterm,WT,Amplified,G245S,NA,2,NA,3,NA,NA,NA,NA,4,5,,7,6,5,2,13,11/26/2012,LSH,,11/30/2012,03/03/2020,Good (STR of subsequent freeze is good),X,,15,17,,11,17.3,,11,11.3,11,15,,11,12,,13,16,,9,13,17,,,20,23,,11,12,,5,11,,7,8,17,18,19,28,,,10,,11,,7,9,,-,14,,,20,,,11,13,,22,25,,14,17,,,Maris
NMB,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,cnLOH p34.2-pterm,None,Loss q21-qterm,LOH/Gain q11.2-qterm,WT,Amplified,G245S,NA,2,NA,3,NA,NA,NA,NA,4,5,,7,6,5,3,13,11/26/2012,LSH,,11/30/2012,03/03/2020,Good (STR of subsequent freeze is good),X,,15,17,,11,17.3,,11,11.3,11,15,,11,12,,13,16,,9,13,17,,,20,23,,11,12,,5,11,,7,8,17,18,19,28,,,10,,11,,7,9,,-,14,,,20,,,11,13,,22,25,,14,17,,,Maris
NMB,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,cnLOH p34.2-pterm,None,Loss q21-qterm,LOH/Gain q11.2-qterm,WT,Amplified,G245S,NA,2,NA,3,NA,NA,NA,NA,4,5,,7,6,5,4,5,11/04/2014,LSH,,10/30/2014,12/10/2019,Good,X,,15,17,,11,17.3,,11,11.3,11,15,,11,12,,13,16,,9,13,17,,,20,23,,11,12,,5,11,,7,8,17,18,19,28,,,10,,11,,7,9,,-,14,,,20,,,11,13,,22,25,,14,17,,,Maris
NMB,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,cnLOH p34.2-pterm,None,Loss q21-qterm,LOH/Gain q11.2-qterm,WT,Amplified,G245S,NA,2,NA,3,NA,NA,NA,NA,4,5,,7,6,5,5,14,12/18/2019,KU,"From LSH, P13, 11/26/2012",12/17/2019,03/03/2020,Good,X,,15,17,,11,17.3,,11,11.3,11,15,,11,12,,13,16,,9,13,17,,,20,23,,11,12,,5,11,,7,8,17,18,19,28,,,10,,11,,7,9,,-,14,,,20,,,11,13,,22,25,,14,17,,,Maris
NMB,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,cnLOH p34.2-pterm,None,Loss q21-qterm,LOH/Gain q11.2-qterm,WT,Amplified,G245S,NA,2,NA,3,NA,NA,NA,NA,4,5,,7,6,5,6,14,12/18/2019,KU,"From LSH, P13, 11/26/2012",12/17/2019,03/03/2020,Good,X,,15,17,,11,17.3,,11,11.3,11,15,,11,12,,13,16,,9,13,17,,,20,23,,11,12,,5,11,,7,8,17,18,19,28,,,10,,11,,7,9,,-,14,,,20,,,11,13,,22,25,,14,17,,,Maris
NMB,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,cnLOH p34.2-pterm,None,Loss q21-qterm,LOH/Gain q11.2-qterm,WT,Amplified,G245S,NA,2,NA,3,NA,NA,NA,NA,4,5,,7,6,5,7,14,12/18/2019,KU,"From LSH, P13, 11/26/2012",12/17/2019,03/03/2020,Good,X,,15,17,,11,17.3,,11,11.3,11,15,,11,12,,13,16,,9,13,17,,,20,23,,11,12,,5,11,,7,8,17,18,19,28,,,10,,11,,7,9,,-,14,,,20,,,11,13,,22,25,,14,17,,,Maris
NMB,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,cnLOH p34.2-pterm,None,Loss q21-qterm,LOH/Gain q11.2-qterm,WT,Amplified,G245S,NA,2,NA,3,NA,NA,NA,NA,4,5,,7,6,5,8,14,12/18/2019,KU,"From LSH, P13, 11/26/2012",12/17/2019,03/03/2020,Good,X,,15,17,,11,17.3,,11,11.3,11,15,,11,12,,13,16,,9,13,17,,,20,23,,11,12,,5,11,,7,8,17,18,19,28,,,10,,11,,7,9,,-,14,,,20,,,11,13,,22,25,,14,17,,,Maris
NMB,Cell Bank,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,cnLOH p34.2-pterm,None,Loss q21-qterm,LOH/Gain q11.2-qterm,WT,Amplified,G245S,NA,2,NA,3,NA,NA,NA,NA,4,5,,7,6,5,9,14,12/18/2019,KU,"From LSH, P13, 11/26/2012",12/17/2019,03/03/2020,Good,X,,15,17,,11,17.3,,11,11.3,11,15,,11,12,,13,16,,9,13,17,,,20,23,,11,12,,5,11,,7,8,17,18,19,28,,,10,,11,,7,9,,-,14,,,20,,,11,13,,22,25,,14,17,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,5,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHLA-079,Cell Bank,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Loosely adherent,"Cells will start with mixed adherence, and will become more adherent after a few passages.",Unknown,Progressing,"Cisplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Patients received bone marrow transplantation prior to sample collection.",Solid Tumor,Unknown,Unknown,Unknown,Unknown,WT,Non-amplified,WT,NA,3-4,NA,5,NA,NA,NA,NA,9,NA,,7,6,6,1,21,09/10/2007,AF (PReynolds),"Fresh from P Reynolds, rcv'd 11/09/2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHLA-079,Cell Bank,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Loosely adherent,"Cells will start with mixed adherence, and will become more adherent after a few passages.",Unknown,Progressing,"Cisplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Patients received bone marrow transplantation prior to sample collection.",Solid Tumor,Unknown,Unknown,Unknown,Unknown,WT,Non-amplified,WT,NA,3-4,NA,5,NA,NA,NA,NA,9,NA,,7,6,6,2,2,11/28/2017,klc,"Fresh from PReynolds lab, P22, 11/9/2017",11/17/2017,10/19/2018,"Good (Slight disrepancies at D1S1656, D2S411, D10S1248)",X,,17,18,,12,14,,11,11.3,14,15,,12,,,10,11,,12,,14,,,17,23,,9,10,,12,15,,8,9.3,17,18,,30,30.2,,8,9,11,13,9,11,,-,12,,,17,,,14,15,,20,21,,11,15,,,Maris
CHLA-079,Cell Bank,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Loosely adherent,"Cells will start with mixed adherence, and will become more adherent after a few passages.",Unknown,Progressing,"Cisplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Patients received bone marrow transplantation prior to sample collection.",Solid Tumor,Unknown,Unknown,Unknown,Unknown,WT,Non-amplified,WT,NA,3-4,NA,5,NA,NA,NA,NA,9,NA,,7,6,6,3,2,11/28/2017,klc,"Fresh from PReynolds lab, P22, 11/9/2017",11/17/2017,10/19/2018,"Good (Slight disrepancies at D1S1656, D2S411, D10S1248)",X,,17,18,,12,14,,11,11.3,14,15,,12,,,10,11,,12,,14,,,17,23,,9,10,,12,15,,8,9.3,17,18,,30,30.2,,8,9,11,13,9,11,,-,12,,,17,,,14,15,,20,21,,11,15,,,Maris
CHLA-079,Cell Bank,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Loosely adherent,"Cells will start with mixed adherence, and will become more adherent after a few passages.",Unknown,Progressing,"Cisplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Patients received bone marrow transplantation prior to sample collection.",Solid Tumor,Unknown,Unknown,Unknown,Unknown,WT,Non-amplified,WT,NA,3-4,NA,5,NA,NA,NA,NA,9,NA,,7,6,6,4,2,11/28/2017,klc,"Fresh from PReynolds lab, P22, 11/9/2017",11/17/2017,10/19/2018,"Good (Slight disrepancies at D1S1656, D2S411, D10S1248)",X,,17,18,,12,14,,11,11.3,14,15,,12,,,10,11,,12,,14,,,17,23,,9,10,,12,15,,8,9.3,17,18,,30,30.2,,8,9,11,13,9,11,,-,12,,,17,,,14,15,,20,21,,11,15,,,Maris
CHLA-079,Cell Bank,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Loosely adherent,"Cells will start with mixed adherence, and will become more adherent after a few passages.",Unknown,Progressing,"Cisplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Patients received bone marrow transplantation prior to sample collection.",Solid Tumor,Unknown,Unknown,Unknown,Unknown,WT,Non-amplified,WT,NA,3-4,NA,5,NA,NA,NA,NA,9,NA,,7,6,6,5,2,11/28/2017,klc,"Fresh from PReynolds lab, P22, 11/9/2017",11/17/2017,10/19/2018,"Good (Slight disrepancies at D1S1656, D2S411, D10S1248)",X,,17,18,,12,14,,11,11.3,14,15,,12,,,10,11,,12,,14,,,17,23,,9,10,,12,15,,8,9.3,17,18,,30,30.2,,8,9,11,13,9,11,,-,12,,,17,,,14,15,,20,21,,11,15,,,Maris
CHLA-079,Cell Bank,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Loosely adherent,"Cells will start with mixed adherence, and will become more adherent after a few passages.",Unknown,Progressing,"Cisplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Patients received bone marrow transplantation prior to sample collection.",Solid Tumor,Unknown,Unknown,Unknown,Unknown,WT,Non-amplified,WT,NA,3-4,NA,5,NA,NA,NA,NA,9,NA,,7,6,6,6,2,11/28/2017,klc,"Fresh from PReynolds lab, P22, 11/9/2017",11/17/2017,10/19/2018,"Good (Slight disrepancies at D1S1656, D2S411, D10S1248)",X,,17,18,,12,14,,11,11.3,14,15,,12,,,10,11,,12,,14,,,17,23,,9,10,,12,15,,8,9.3,17,18,,30,30.2,,8,9,11,13,9,11,,-,12,,,17,,,14,15,,20,21,,11,15,,,Maris
CHLA-079,Cell Bank,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Loosely adherent,"Cells will start with mixed adherence, and will become more adherent after a few passages.",Unknown,Progressing,"Cisplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Patients received bone marrow transplantation prior to sample collection.",Solid Tumor,Unknown,Unknown,Unknown,Unknown,WT,Non-amplified,WT,NA,3-4,NA,5,NA,NA,NA,NA,9,NA,,7,6,6,7,2,11/28/2017,klc,"Fresh from PReynolds lab, P22, 11/9/2017",11/17/2017,10/19/2018,"Good (Slight disrepancies at D1S1656, D2S411, D10S1248)",X,,17,18,,12,14,,11,11.3,14,15,,12,,,10,11,,12,,14,,,17,23,,9,10,,12,15,,8,9.3,17,18,,30,30.2,,8,9,11,13,9,11,,-,12,,,17,,,14,15,,20,21,,11,15,,,Maris
CHLA-079,Cell Bank,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Loosely adherent,"Cells will start with mixed adherence, and will become more adherent after a few passages.",Unknown,Progressing,"Cisplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Patients received bone marrow transplantation prior to sample collection.",Solid Tumor,Unknown,Unknown,Unknown,Unknown,WT,Non-amplified,WT,NA,3-4,NA,5,NA,NA,NA,NA,9,NA,,7,6,6,8,2,11/28/2017,klc,"Fresh from PReynolds lab, P22, 11/9/2017",11/17/2017,10/19/2018,"Good (Slight disrepancies at D1S1656, D2S411, D10S1248)",X,,17,18,,12,14,,11,11.3,14,15,,12,,,10,11,,12,,14,,,17,23,,9,10,,12,15,,8,9.3,17,18,,30,30.2,,8,9,11,13,9,11,,-,12,,,17,,,14,15,,20,21,,11,15,,,Maris
CHLA-079,Cell Bank,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Loosely adherent,"Cells will start with mixed adherence, and will become more adherent after a few passages.",Unknown,Progressing,"Cisplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Patients received bone marrow transplantation prior to sample collection.",Solid Tumor,Unknown,Unknown,Unknown,Unknown,WT,Non-amplified,WT,NA,3-4,NA,5,NA,NA,NA,NA,9,NA,,7,6,6,9,2,11/28/2017,klc,"Fresh from PReynolds lab, P22, 11/9/2017",11/17/2017,10/19/2018,"Good (Slight disrepancies at D1S1656, D2S411, D10S1248)",X,,17,18,,12,14,,11,11.3,14,15,,12,,,10,11,,12,,14,,,17,23,,9,10,,12,15,,8,9.3,17,18,,30,30.2,,8,9,11,13,9,11,,-,12,,,17,,,14,15,,20,21,,11,15,,,Maris
CHLA-079,Cell Bank,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Loosely adherent,"Cells will start with mixed adherence, and will become more adherent after a few passages.",Unknown,Progressing,"Cisplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Patients received bone marrow transplantation prior to sample collection.",Solid Tumor,Unknown,Unknown,Unknown,Unknown,WT,Non-amplified,WT,NA,3-4,NA,5,NA,NA,NA,NA,9,NA,,7,6,6,10,2,11/28/2017,klc,"Fresh from PReynolds lab, P22, 11/9/2017",11/17/2017,10/19/2018,"Good (Slight disrepancies at D1S1656, D2S411, D10S1248)",X,,17,18,,12,14,,11,11.3,14,15,,12,,,10,11,,12,,14,,,17,23,,9,10,,12,15,,8,9.3,17,18,,30,30.2,,8,9,11,13,9,11,,-,12,,,17,,,14,15,,20,21,,11,15,,,Maris
NB-1643,Cell Bank,"IMDM Media, 20% FBS, 2mM L-Glutamine, 1% Pen/Strep",0.02% Versene,Adherent,"Slow to grow out of thaw, and growth rate will increase once it has been passaged a few times. 
",Diagnosis,Diagnosis,No prior treatments,Solid Tumor,Loss p34.2-pterm,None,Loss q23.1-qterm,Gain q21.31-qterm,R1275Q,Amplified,WT,NA,4,NA,5,NA,NA,NA,NA,NA,NA,,7,6,7,1,7,12/17/2012,LSH,"fresh from P. Reynolds, sequenced 11/26/12",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-1643,Cell Bank,"IMDM Media, 20% FBS, 2mM L-Glutamine, 1% Pen/Strep",0.02% Versene,Adherent,"Slow to grow out of thaw, and growth rate will increase once it has been passaged a few times. 
",Diagnosis,Diagnosis,No prior treatments,Solid Tumor,Loss p34.2-pterm,None,Loss q23.1-qterm,Gain q21.31-qterm,R1275Q,Amplified,WT,NA,4,NA,5,NA,NA,NA,NA,NA,NA,,7,6,7,2,45+4,10/02/2017,JLH,"fresh from P. Reynolds, p45, 08/30/2017",09/08/2017,10/19/2018,Good,X,Y,16,18,,17.3,,,13,14,13,,,12,,,7,11,,9,12,12,15,,23,24,,11,13,,10,,,8,9.3,16,17,,28,,,10,11,11,12,8,11,,11,14,16,,19,23,,13,14,,22,23,,15,16,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,7,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-1643,Cell Bank,"IMDM Media, 20% FBS, 2mM L-Glutamine, 1% Pen/Strep",0.02% Versene,Adherent,"Slow to grow out of thaw, and growth rate will increase once it has been passaged a few times. 
",Diagnosis,Diagnosis,No prior treatments,Solid Tumor,Loss p34.2-pterm,None,Loss q23.1-qterm,Gain q21.31-qterm,R1275Q,Amplified,WT,NA,4,NA,5,NA,NA,NA,NA,NA,NA,,7,6,7,4,45+4,10/02/2017,JLH,fresh from P. Reynolds 08/30/17,09/08/2017,10/19/2018,Good,X,Y,16,18,,17.3,,,13,14,13,,,12,,,7,11,,9,12,12,15,,23,24,,11,13,,10,,,8,9.3,16,17,,28,,,10,11,11,12,8,11,,11,14,16,,19,23,,13,14,,22,23,,15,16,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,7,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-1643,Cell Bank,"IMDM Media, 20% FBS, 2mM L-Glutamine, 1% Pen/Strep",0.02% Versene,Adherent,"Slow to grow out of thaw, and growth rate will increase once it has been passaged a few times. 
",Diagnosis,Diagnosis,No prior treatments,Solid Tumor,Loss p34.2-pterm,None,Loss q23.1-qterm,Gain q21.31-qterm,R1275Q,Amplified,WT,NA,4,NA,5,NA,NA,NA,NA,NA,NA,,7,6,7,6,45+4,10/02/2017,JLH,fresh from P. Reynolds 08/30/17,09/08/2017,10/19/2018,Good,X,Y,16,18,,17.3,,,13,14,13,,,12,,,7,11,,9,12,12,15,,23,24,,11,13,,10,,,8,9.3,16,17,,28,,,10,11,11,12,8,11,,11,14,16,,19,23,,13,14,,22,23,,15,16,,,Maris
NB-1643,Cell Bank,"IMDM Media, 20% FBS, 2mM L-Glutamine, 1% Pen/Strep",0.02% Versene,Adherent,"Slow to grow out of thaw, and growth rate will increase once it has been passaged a few times. 
",Diagnosis,Diagnosis,No prior treatments,Solid Tumor,Loss p34.2-pterm,None,Loss q23.1-qterm,Gain q21.31-qterm,R1275Q,Amplified,WT,NA,4,NA,5,NA,NA,NA,NA,NA,NA,,7,6,7,7,45+4,10/02/2017,JLH,fresh from P. Reynolds 08/30/17,09/08/2017,10/19/2018,Good,X,Y,16,18,,17.3,,,13,14,13,,,12,,,7,11,,9,12,12,15,,23,24,,11,13,,10,,,8,9.3,16,17,,28,,,10,11,11,12,8,11,,11,14,16,,19,23,,13,14,,22,23,,15,16,,,Maris
NB-1643,Cell Bank,"IMDM Media, 20% FBS, 2mM L-Glutamine, 1% Pen/Strep",0.02% Versene,Adherent,"Slow to grow out of thaw, and growth rate will increase once it has been passaged a few times. 
",Diagnosis,Diagnosis,No prior treatments,Solid Tumor,Loss p34.2-pterm,None,Loss q23.1-qterm,Gain q21.31-qterm,R1275Q,Amplified,WT,NA,4,NA,5,NA,NA,NA,NA,NA,NA,,7,6,7,8,45+2,09/19/2017,JLH/klc,fresh from P. Reynolds 08/30/17,09/08/2017,3/3/2020,Good,X,Y,16,18,,17.3,,,13,14,13,,,12,,,7,11,,9,12,12,15,,23,24,,11,13,,10,,,8,9.3,16,17,,28,,,10,11,11,12,8,11,,11,14,16,,19,23,,13,14,,22,23,,15,16,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,7,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHLA-079,Cell Bank,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Loosely adherent,"Cells will start with mixed adherence, and will become more adherent after a few passages.",Unknown,Progressing,"Cisplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Patients received bone marrow transplantation prior to sample collection.",Solid Tumor,Unknown,Unknown,Unknown,Unknown,WT,Non-amplified,WT,NA,3-4,NA,5,NA,NA,NA,NA,9,NA,,7,6,7,10,2,11/28/2017,klc,"Fresh from PReynolds lab, P22, 11/9/2017",11/17/2017,10/19/2018,"Good (Slight disrepancies at D1S1656, D2S411, D10S1248)",X,,17,18,,12,14,,11,11.3,14,15,,12,,,10,11,,12,,14,,,17,23,,9,10,,12,15,,8,9.3,17,18,,30,30.2,,8,9,11,13,9,11,,-,12,,,17,,,14,15,,20,21,,11,15,,,Maris
NB-1643,Cell Bank,"IMDM Media, 20% FBS, 2mM L-Glutamine, 1% Pen/Strep",0.02% Versene,Adherent,"Slow to grow out of thaw, and growth rate will increase once it has been passaged a few times. 
",Diagnosis,Diagnosis,No prior treatments,Solid Tumor,Loss p34.2-pterm,None,Loss q23.1-qterm,Gain q21.31-qterm,R1275Q,Amplified,WT,NA,4,NA,5,NA,NA,NA,NA,NA,NA,,7,6,8,1,45,01/31/2017,KM (PR Lab),fresh from P. Reynolds 08/30/17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-1643,Cell Bank,"IMDM Media, 20% FBS, 2mM L-Glutamine, 1% Pen/Strep",0.02% Versene,Adherent,"Slow to grow out of thaw, and growth rate will increase once it has been passaged a few times. 
",Diagnosis,Diagnosis,No prior treatments,Solid Tumor,Loss p34.2-pterm,None,Loss q23.1-qterm,Gain q21.31-qterm,R1275Q,Amplified,WT,NA,4,NA,5,NA,NA,NA,NA,NA,NA,,7,6,8,2,45+2,09/19/2017,JLH/klc,fresh from P. Reynolds 08/30/17,09/08/2017,3/3/2020,Good,X,Y,16,18,,17.3,,,13,14,13,,,12,,,7,11,,9,12,12,15,,23,24,,11,13,,10,,,8,9.3,16,17,,28,,,10,11,11,12,8,11,,11,14,16,,19,23,,13,14,,22,23,,15,16,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,8,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,8,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,8,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,8,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,8,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,8,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,8,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,8,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,9,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,9,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,9,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,9,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,9,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,9,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,9,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,9,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,9,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,9,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,10,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHLA-079,Cell Bank,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Loosely adherent,"Cells will start with mixed adherence, and will become more adherent after a few passages.",Unknown,Progressing,"Cisplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Patients received bone marrow transplantation prior to sample collection.",Solid Tumor,Unknown,Unknown,Unknown,Unknown,WT,Non-amplified,WT,NA,3-4,NA,5,NA,NA,NA,NA,9,NA,,7,6,10,2,2,11/20/2017,klc,"Fresh from PReynolds lab, P22, 11/9/2017",11/17/2017,10/19/2018,"Good (Slight disrepancies at D1S1656, D2S411, D10S1248)",X,,17,18,,12,14,,11,11.3,14,15,,12,,,10,11,,12,,14,,,17,23,,9,10,,12,15,,8,9.3,17,18,,30,30.2,,8,9,11,13,9,11,,-,12,,,17,,,14,15,,20,21,,11,15,,,Maris
CHLA-079,Cell Bank,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Loosely adherent,"Cells will start with mixed adherence, and will become more adherent after a few passages.",Unknown,Progressing,"Cisplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Patients received bone marrow transplantation prior to sample collection.",Solid Tumor,Unknown,Unknown,Unknown,Unknown,WT,Non-amplified,WT,NA,3-4,NA,5,NA,NA,NA,NA,9,NA,,7,6,10,3,2,11/20/2017,klc,"Fresh from PReynolds lab, P22, 11/9/2017",11/17/2017,10/19/2018,"Good (Slight disrepancies at D1S1656, D2S411, D10S1248)",X,,17,18,,12,14,,11,11.3,14,15,,12,,,10,11,,12,,14,,,17,23,,9,10,,12,15,,8,9.3,17,18,,30,30.2,,8,9,11,13,9,11,,-,12,,,17,,,14,15,,20,21,,11,15,,,Maris
CHLA-079,Cell Bank,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",0.02% Versene,Loosely adherent,"Cells will start with mixed adherence, and will become more adherent after a few passages.",Unknown,Progressing,"Cisplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Patients received bone marrow transplantation prior to sample collection.",Solid Tumor,Unknown,Unknown,Unknown,Unknown,WT,Non-amplified,WT,NA,3-4,NA,5,NA,NA,NA,NA,9,NA,,7,6,10,4,2,11/20/2017,klc,"Fresh from PReynolds lab, P22, 11/9/2017",11/17/2017,10/19/2018,"Good (Slight disrepancies at D1S1656, D2S411, D10S1248)",X,,17,18,,12,14,,11,11.3,14,15,,12,,,10,11,,12,,14,,,17,23,,9,10,,12,15,,8,9.3,17,18,,30,30.2,,8,9,11,13,9,11,,-,12,,,17,,,14,15,,20,21,,11,15,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,10,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,10,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,10,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,10,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,10,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,6,10,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-561,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS
",0.02% Versene,Mixed Adherence- predominately adherent , ,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245I,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,1,6,6,7/14/2017,klc,,6/27/2017,12/10/19,Good,X,,17,18,,12,15.3,,10,11.3,14,,,12,,,7,12,,10,14,13,14,,18,19,,10,12,,9,11,12,6,9.3,16,19,,29,32.2,,9,11,11,12,8,,,,12,13,,19,20,,14,16,,22,24,,14,15,,,Maris
COG-N-561,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS
",0.02% Versene,Mixed Adherence- predominately adherent , ,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245I,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,1,7,6,7/14/2017,klc,,6/27/2017,12/10/19,Good,X,,17,18,,12,15.3,,10,11.3,14,,,12,,,7,12,,10,14,13,14,,18,19,,10,12,,9,11,12,6,9.3,16,19,,29,32.2,,9,11,11,12,8,,,,12,13,,19,20,,14,16,,22,24,,14,15,,,Maris
COG-N-561,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS
",0.02% Versene,Mixed Adherence- predominately adherent , ,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245I,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,1,8,6,7/14/2017,klc,,6/27/2017,12/10/19,Good,X,,17,18,,12,15.3,,10,11.3,14,,,12,,,7,12,,10,14,13,14,,18,19,,10,12,,9,11,12,6,9.3,16,19,,29,32.2,,9,11,11,12,8,,,,12,13,,19,20,,14,16,,22,24,,14,15,,,Maris
COG-N-561,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS
",0.02% Versene,Mixed Adherence- predominately adherent , ,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245I,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,1,9,7,7/12/2017,LS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-561,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS
",0.02% Versene,Mixed Adherence- predominately adherent , ,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245I,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,1,10,7,7/12/2017,LS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-561,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS
",0.02% Versene,Mixed Adherence- predominately adherent , ,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245I,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,2,1,4,3/14/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-561,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS
",0.02% Versene,Mixed Adherence- predominately adherent , ,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245I,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,2,2,4,3/14/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-561,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS
",0.02% Versene,Mixed Adherence- predominately adherent , ,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245I,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,2,3,4,3/14/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-561,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS
",0.02% Versene,Mixed Adherence- predominately adherent , ,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245I,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,2,4,5,12/16/2015,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,2,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,2,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,2,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,2,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-561,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS
",0.02% Versene,Mixed Adherence- predominately adherent , ,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245I,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,2,9,7,7/12/2017,LS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,2,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,3,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-453,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,Grows primarily in clumps,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1147L,Amplified,WT,NA,8,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,3,2,28+16,12/16/2015,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-453,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,Grows primarily in clumps,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1147L,Amplified,WT,NA,8,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,3,3,6,06/12/2017,LS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-453,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,Grows primarily in clumps,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1147L,Amplified,WT,NA,8,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,3,4,6,06/12/2017,LS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-453,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,Grows primarily in clumps,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1147L,Amplified,WT,NA,8,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,3,5,6,08/22/2017,LS,,,10/19/2018,Good,X,Y,16,18,,12,16,,11,14,15,,,8,12,,7,11,,12,,15,17,,18,23,,10,,,11,16,,9,,14,19,,29,,,10,,11,13,8,,,10,15,,,19,21,,12,16,,18,22,,13,16,,,Maris
COG-N-453,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,Grows primarily in clumps,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1147L,Amplified,WT,NA,8,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,3,6,6,08/22/2017,LS,,,10/19/2018,Good,X,Y,16,18,,12,16,,11,14,15,,,8,12,,7,11,,12,,15,17,,18,23,,10,,,11,16,,9,,14,19,,29,,,10,,11,13,8,,,10,15,,,19,21,,12,16,,18,22,,13,16,,,Maris
COG-N-453,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,Grows primarily in clumps,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1147L,Amplified,WT,NA,8,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,3,7,6,08/22/2017,LS,,,10/19/2018,Good,X,Y,16,18,,12,16,,11,14,15,,,8,12,,7,11,,12,,15,17,,18,23,,10,,,11,16,,9,,14,19,,29,,,10,,11,13,8,,,10,15,,,19,21,,12,16,,18,22,,13,16,,,Maris
COG-N-453,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,Grows primarily in clumps,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1147L,Amplified,WT,NA,8,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,3,8,7,11/04/2019,KU,"From KU/LSH, P5, 09/19/2018 (STR from thaw is good)",10/11/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-453,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,Grows primarily in clumps,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1147L,Amplified,WT,NA,8,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,3,9,7,11/04/2019,KU,"From KU/LSH, P5, 09/19/2018 (STR from thaw is good)",10/11/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-453,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,Grows primarily in clumps,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1147L,Amplified,WT,NA,8,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,3,10,7,11/04/2019,KU,"From KU/LSH, P5, 09/19/2018 (STR from thaw is good)",10/11/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-453,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,Grows primarily in clumps,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1147L,Amplified,WT,NA,8,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,4,1,5,09/19/2018,KU/LSH,"From LSH, P4, 07/03/2016",09/14/2018,10/19/2018,Good (STR of thaw is good),X,Y,16,18,,12,16,,11,14,15,,,8,12,,7,11,,12,,15,17,,18,23,,10,,,11,16,,9,,14,19,,29,,,10,,11,13,8,,,10,15,,,19,21,,12,16,,18,22,,13,16,,,Maris
COG-N-453,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,Grows primarily in clumps,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1147L,Amplified,WT,NA,8,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,4,2,5,09/19/2018,KU/LSH,"From LSH, P4, 07/03/2016",09/14/2018,10/19/2018,Good (STR of thaw is good),X,Y,16,18,,12,16,,11,14,15,,,8,12,,7,11,,12,,15,17,,18,23,,10,,,11,16,,9,,14,19,,29,,,10,,11,13,8,,,10,15,,,19,21,,12,16,,18,22,,13,16,,,Maris
COG-N-453,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,Grows primarily in clumps,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1147L,Amplified,WT,NA,8,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,4,3,5,09/19/2018,KU/LSH,"From LSH, P4, 07/03/2016",09/14/2018,10/19/2018,Good (STR of thaw is good),X,Y,16,18,,12,16,,11,14,15,,,8,12,,7,11,,12,,15,17,,18,23,,10,,,11,16,,9,,14,19,,29,,,10,,11,13,8,,,10,15,,,19,21,,12,16,,18,22,,13,16,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,4,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,4,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,4,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,4,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,4,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,4,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-496,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Amplified,WT,NA,3,NA,4,NA,NA,5-6,NA,6-7,9,,7,7,5,1,4,10/20/2015,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-496,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Amplified,WT,NA,3,NA,4,NA,NA,5-6,NA,6-7,9,,7,7,5,2,4,10/20/2015,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-496,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Amplified,WT,NA,3,NA,4,NA,NA,5-6,NA,6-7,9,,7,7,5,4,4,03/03/2016,LSH,,,3/3/2020,Good (Slight disrepancy at D3S1358),X,,16,17,,11,12,,11,,16,,,8,9,,10,11,12,10,11,12,,,18,23,,10,11,,10,14,,7,9.3,17,19,,28,29,,9,10,11,12,9,11,,-,10,12,,18,32,,14,,,22,24,,15,16,,,Maris
COG-N-496,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Amplified,WT,NA,3,NA,4,NA,NA,5-6,NA,6-7,9,,7,7,5,5,4,03/03/2016,LSH,,,3/3/2020,Good (Slight disrepancy at D3S1358),X,,16,17,,11,12,,11,,16,,,8,9,,10,11,12,10,11,12,,,18,23,,10,11,,10,14,,7,9.3,17,19,,28,29,,9,10,11,12,9,11,,-,10,12,,18,32,,14,,,22,24,,15,16,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,5,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-496,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Amplified,WT,NA,3,NA,4,NA,NA,5-6,NA,6-7,9,,7,7,5,7,3(+6),07/03/2017,KLC,"From LS freeze, 06/12/2017, 4 more passages out",06/27/2017,12/10/2019,Good,X,,15,17,,11,12,,11,,16,,,8,9,,10,11,12,10,11,12,,,18,23,,10,11,,10,14,,7,9.3,17,19,,28,29,,9,10,11,12,9,11,,,10,12,,18,22,,14,,,22,24,,15,16,,,Maris
COG-N-496,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Amplified,WT,NA,3,NA,4,NA,NA,5-6,NA,6-7,9,,7,7,5,8,3(+6),07/03/2017,KLC,"From LS freeze, 06/12/2017, 4 more passages out",06/27/2017,12/10/2019,Good,X,,15,17,,11,12,,11,,16,,,8,9,,10,11,12,10,11,12,,,18,23,,10,11,,10,14,,7,9.3,17,19,,28,29,,9,10,11,12,9,11,,,10,12,,18,22,,14,,,22,24,,15,16,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,5,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,5,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-496,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Amplified,WT,NA,3,NA,4,NA,NA,5-6,NA,6-7,9,,7,7,6,1,7,11/27/2017,KLC,"From LS freeze, 06/12/2017, 7",11/17/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-496,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Amplified,WT,NA,3,NA,4,NA,NA,5-6,NA,6-7,9,,7,7,6,2,7,11/27/2017,KLC,"From LS freeze, 06/12/2017, 7",11/17/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-496,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Amplified,WT,NA,3,NA,4,NA,NA,5-6,NA,6-7,9,,7,7,6,3,7,11/27/2017,KLC,"From LS freeze, 06/12/2017, 7",11/17/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,6,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,6,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,6,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,6,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-534,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Non-amplified,Unknown,NA,5,NA,6,NA,NA,NA,NA,7,NA,,7,7,6,9,10,02/12/2020,KU,"From KU, P8, 01/02/2020",02/04/2020,3/3/20,Good,X,Y,15,,,16,16.3,,11,15,13,16,,12,14,,18,,,11,,12,17,,23,24,,10,11,,12,14,,9,9.3,17,,,29,32.2,,7,12,11,12,8,,,10,14,,,22,25,,13,,,21,23,,17,,,,Maris
COG-N-534,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Non-amplified,Unknown,NA,5,NA,6,NA,NA,NA,NA,7,NA,,7,7,6,10,10,02/12/2020,KU,"From KU, P8, 01/02/2020",02/04/2020,3/3/20,Good,X,Y,15,,,16,16.3,,11,15,13,16,,12,14,,18,,,11,,12,17,,23,24,,10,11,,12,14,,9,9.3,17,,,29,32.2,,7,12,11,12,8,,,10,14,,,22,25,,13,,,21,23,,17,,,,Maris
COG-N-534,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Non-amplified,Unknown,NA,5,NA,6,NA,NA,NA,NA,7,NA,,7,7,7,1,6,02/16/2015,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-534,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Non-amplified,Unknown,NA,5,NA,6,NA,NA,NA,NA,7,NA,,7,7,7,2,4,03/08/2016,LSH,,,12/10/2019,Good (Drop out of 11 at CSF1P0),X,Y,15,,,16,16.3,,11,15,13,16,,12,14,,18,,,11,,12,17,,23,24,,10,11 (DO),,12,14,,9,9.3,17,,,29,32.2,,7,12,11,12,8,,,INC,14,,,22,25,,13,,,21,23,,17,,,,Maris
COG-N-534,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Non-amplified,Unknown,NA,5,NA,6,NA,NA,NA,NA,7,NA,,7,7,7,3,4,03/08/2016,LSH,,,12/10/2019,Good (Drop out of 11 at CSF1P0),X,Y,15,,,16,16.3,,11,15,13,16,,12,14,,18,,,11,,12,17,,23,24,,10,11 (DO),,12,14,,9,9.3,17,,,29,32.2,,7,12,11,12,8,,,INC,14,,,22,25,,13,,,21,23,,17,,,,Maris
COG-N-534,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Non-amplified,Unknown,NA,5,NA,6,NA,NA,NA,NA,7,NA,,7,7,7,4,10,02/12/2020,KU,"From KU, P8, 01/02/2020",02/04/2020,3/3/20,Good,X,Y,15,,,16,16.3,,11,15,13,16,,12,14,,18,,,11,,12,17,,23,24,,10,11,,12,14,,9,9.3,17,,,29,32.2,,7,12,11,12,8,,,10,14,,,22,25,,13,,,21,23,,17,,,,Maris
COG-N-534,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Non-amplified,Unknown,NA,5,NA,6,NA,NA,NA,NA,7,NA,,7,7,7,5,10,02/12/2020,KU,"From KU, P8, 01/02/2020",02/04/2020,3/3/20,Good,X,Y,15,,,16,16.3,,11,15,13,16,,12,14,,18,,,11,,12,17,,23,24,,10,11,,12,14,,9,9.3,17,,,29,32.2,,7,12,11,12,8,,,10,14,,,22,25,,13,,,21,23,,17,,,,Maris
COG-N-534,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Non-amplified,Unknown,NA,5,NA,6,NA,NA,NA,NA,7,NA,,7,7,7,6,6,01/28/2019,KU,"From LSH, P4, 03/08/2016 (STR of thaw is good)",12/10/2019,12/10/2019,"Good (Drop out of 11 at CSF1P0, STR of thaw is good)",X,Y,15,,,16,16.3,,11,15,13,16,,12,14,,18,,,11,,12,17,,23,24,,10,11 (DO),,12,14,,9,9.3,17,,,29,32.2,,7,12,11,12,8,,,INC,14,,,22,25,,13,,,21,23,,17,,,,Maris
COG-N-534,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Non-amplified,Unknown,NA,5,NA,6,NA,NA,NA,NA,7,NA,,7,7,7,7,8,01/02/2020,KU,"From KU, P6, 1/28/2019",12/10/2019,3/3/20,Good,X,Y,15,,,16,16.3,,11,15,13,16,,12,14,,18,,,11,,12,17,,23,24,,10,11,,12,14,,9,9.3,17,,,29,32.2,,7,12,11,12,8,,,10,14,,,22,25,,13,,,21,23,,17,,,,Maris
COG-N-534,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Non-amplified,Unknown,NA,5,NA,6,NA,NA,NA,NA,7,NA,,7,7,7,8,8,01/02/2020,KU,"From KU, P6, 1/28/2019",12/10/2019,3/3/20,Good,X,Y,15,,,16,16.3,,11,15,13,16,,12,14,,18,,,11,,12,17,,23,24,,10,11,,12,14,,9,9.3,17,,,29,32.2,,7,12,11,12,8,,,10,14,,,22,25,,13,,,21,23,,17,,,,Maris
COG-N-534,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Non-amplified,Unknown,NA,5,NA,6,NA,NA,NA,NA,7,NA,,7,7,7,9,8,01/02/2020,KU,"From KU, P6, 1/28/2019",12/10/2019,3/3/20,Good,X,Y,15,,,16,16.3,,11,15,13,16,,12,14,,18,,,11,,12,17,,23,24,,10,11,,12,14,,9,9.3,17,,,29,32.2,,7,12,11,12,8,,,10,14,,,22,25,,13,,,21,23,,17,,,,Maris
COG-N-534,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Non-amplified,Unknown,NA,5,NA,6,NA,NA,NA,NA,7,NA,,7,7,7,10,10,02/12/2020,KU,"From KU, P8, 01/02/2020",02/04/2020,3/3/20,Good,X,Y,15,,,16,16.3,,11,15,13,16,,12,14,,18,,,11,,12,17,,23,24,,10,11,,12,14,,9,9.3,17,,,29,32.2,,7,12,11,12,8,,,10,14,,,22,25,,13,,,21,23,,17,,,,Maris
COG-N-590,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,7,8,1,8,09/19/2018,KU,"Fresh from COG: NR, P4, 05/29/2018",08/10/2018,10/15/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-590,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,7,8,2,8,09/19/2018,KU,"Fresh from COG: NR, P4, 05/29/2018",08/10/2018,10/15/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-590,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,7,8,3,8,09/19/2018,KU,"Fresh from COG: NR, P4, 05/29/2018",08/10/2018,10/15/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-590,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,7,8,4,8,09/19/2018,KU,"Fresh from COG: NR, P4, 05/29/2018",08/10/2018,10/15/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-590,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,7,8,5,5,08/22/2018,KU,"Fresh from COG: NR, P4, 05/29/2018",08/10/2018,10/15/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-590,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,7,8,6,5,08/22/2018,KU,"Fresh from COG: NR, P4, 05/29/2018",08/10/2018,10/15/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-590,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,7,8,7,5,08/22/2018,KU,"Fresh from COG: NR, P4, 05/29/2018",08/10/2018,10/15/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-590,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,7,8,8,5,08/22/2018,KU,"Fresh from COG: NR, P4, 05/29/2018",08/10/2018,10/15/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,8,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,8,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-426 (FELIX),Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Loosely Adherent,"Felix grows very slowly, and can be easily detached with force so be gentle when washing cells. Cells like to remain spread apart, so for measuring confluency look at the neurite interactions. If it appears that every cells has multiple contacts, via neurites, with its surrounding cells it may be confluent.",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245C,Non-amplified,WT,NA,14,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,9,1,46+18,02/24/2016,LSH,,,12/10/2019,Good (STR of subsequent freeze is good),X,Y,19,,,17,17.3,,11,,15,,,9,10,,7,,,10,12,10,13,,24,25,,10,,,9,10,,6,9.3,16,,,28,,,7,12,12,,10,12,,10,14,,,22,,,14,15.2,,23,,,15,,,,Maris
COG-N-426 (FELIX),Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Loosely Adherent,"Felix grows very slowly, and can be easily detached with force so be gentle when washing cells. Cells like to remain spread apart, so for measuring confluency look at the neurite interactions. If it appears that every cells has multiple contacts, via neurites, with its surrounding cells it may be confluent.",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245C,Non-amplified,WT,NA,14,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,9,2,46+18,02/24/2016,LSH,,,12/10/2019,Good (STR of subsequent freeze is good),X,Y,19,,,17,17.3,,11,,15,,,9,10,,7,,,10,12,10,13,,24,25,,10,,,9,10,,6,9.3,16,,,28,,,7,12,12,,10,12,,10,14,,,22,,,14,15.2,,23,,,15,,,,Maris
COG-N-426 (FELIX),Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Loosely Adherent,"Felix grows very slowly, and can be easily detached with force so be gentle when washing cells. Cells like to remain spread apart, so for measuring confluency look at the neurite interactions. If it appears that every cells has multiple contacts, via neurites, with its surrounding cells it may be confluent.",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245C,Non-amplified,WT,NA,14,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,9,3,46+18,02/24/2016,LSH,,,12/10/2019,Good (STR of subsequent freeze is good),X,Y,19,,,17,17.3,,11,,15,,,9,10,,7,,,10,12,10,13,,24,25,,10,,,9,10,,6,9.3,16,,,28,,,7,12,12,,10,12,,10,14,,,22,,,14,15.2,,23,,,15,,,,Maris
COG-N-426 (FELIX),Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Loosely Adherent,"Felix grows very slowly, and can be easily detached with force so be gentle when washing cells. Cells like to remain spread apart, so for measuring confluency look at the neurite interactions. If it appears that every cells has multiple contacts, via neurites, with its surrounding cells it may be confluent.",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245C,Non-amplified,WT,NA,14,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,9,4,3,08/31/2017,JLH,"From LSH freeze, 2/24/16, p46+18 = p67",08/15/2017,12/10/2019,Good (STR of subsequent freeze is good),X,Y,19,,,17,17.3,,11,,15,,,9,10,,7,,,10,12,10,13,,24,25,,10,,,9,10,,6,9.3,16,,,28,,,7,12,12,,10,12,,10,14,,,22,,,14,15.2,,23,,,15,,,,Maris
COG-N-426 (FELIX),Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Loosely Adherent,"Felix grows very slowly, and can be easily detached with force so be gentle when washing cells. Cells like to remain spread apart, so for measuring confluency look at the neurite interactions. If it appears that every cells has multiple contacts, via neurites, with its surrounding cells it may be confluent.",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245C,Non-amplified,WT,NA,14,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,9,5,3,08/31/2017,JLH,"From LSH freeze, 2/24/16, p46+18 = p67",08/15/2017,12/10/2019,Good (STR of subsequent freeze is good),X,Y,19,,,17,17.3,,11,,15,,,9,10,,7,,,10,12,10,13,,24,25,,10,,,9,10,,6,9.3,16,,,28,,,7,12,12,,10,12,,10,14,,,22,,,14,15.2,,23,,,15,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,9,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-426 (FELIX),Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Loosely Adherent,"Felix grows very slowly, and can be easily detached with force so be gentle when washing cells. Cells like to remain spread apart, so for measuring confluency look at the neurite interactions. If it appears that every cells has multiple contacts, via neurites, with its surrounding cells it may be confluent.",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245C,Non-amplified,WT,NA,14,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,9,7,6,11/10/2017,klc,"from JLH freeze, 8/31/2017, p46+18+6=p70",10/10/2017,12/10/2019,Good (STR of subsequent freeze is good),X,Y,19,,,17,17.3,,11,,15,,,9,10,,7,,,10,12,10,13,,24,25,,10,,,9,10,,6,9.3,16,,,28,,,7,12,12,,10,12,,10,14,,,22,,,14,15.2,,23,,,15,,,,Maris
COG-N-426 (FELIX),Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Loosely Adherent,"Felix grows very slowly, and can be easily detached with force so be gentle when washing cells. Cells like to remain spread apart, so for measuring confluency look at the neurite interactions. If it appears that every cells has multiple contacts, via neurites, with its surrounding cells it may be confluent.",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245C,Non-amplified,WT,NA,14,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,9,8,46+8,07/29/2019,KU,From P46+6 KLC 11/10/2017 (STR of thaw is good),07/12/2019,12/10/2019,Good (STR of thaw is good),X,Y,19,,,17,17.3,,11,,15,,,9,10,,7,,,10,12,10,13,,24,25,,10,,,9,10,,6,9.3,16,,,28,,,7,12,12,,10,12,,10,14,,,22,,,14,15.2,,23,,,15,,,,Maris
COG-N-426 (FELIX),Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Loosely Adherent,"Felix grows very slowly, and can be easily detached with force so be gentle when washing cells. Cells like to remain spread apart, so for measuring confluency look at the neurite interactions. If it appears that every cells has multiple contacts, via neurites, with its surrounding cells it may be confluent.",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245C,Non-amplified,WT,NA,14,NA,NA,NA,NA,NA,NA,NA,NA,,7,7,9,9,46+8,07/29/2019,KU,From P46+6 KLC 11/10/2017 (STR of thaw is good),07/12/2019,12/10/2019,Good (STR of thaw is good),X,Y,19,,,17,17.3,,11,,15,,,9,10,,7,,,10,12,10,13,,24,25,,10,,,9,10,,6,9.3,16,,,28,,,7,12,12,,10,12,,10,14,,,22,,,14,15.2,,23,,,15,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,9,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,10,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-603,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,7,10,2,13,10/08/2018,KU,"Fresh from COG: JN, P7, 08/31/2018",08/10/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-603,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,7,10,3,13,10/08/2018,KU,"Fresh from COG: JN, P7, 08/31/2018",08/10/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-603,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,7,10,4,13,10/08/2018,KU,"Fresh from COG: JN, P7, 08/31/2018",08/10/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-603,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,7,10,5,9,08/24/2018,KU,"Fresh from COG: JN, P7, 08/31/2018",08/10/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-603,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,7,10,6,9,08/24/2018,KU,"Fresh from COG: JN, P7, 08/31/2018",08/10/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-603,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,7,10,7,9,08/24/2018,KU,"Fresh from COG: JN, P7, 08/31/2018",08/10/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-603,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,7,10,8,9,08/24/2018,KU,"Fresh from COG: JN, P7, 08/31/2018",08/10/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-603,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,7,10,9,9,08/24/2018,KU,"Fresh from COG: JN, P7, 08/31/2019",08/10/2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,7,10,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
9464D,mouse,"DMEM/M3 
 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,1,1,2,09/18/2017,JLH,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
9464D,mouse,"DMEM/M3 
 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,1,2,2,09/18/2017,JLH,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
9464D,mouse,"DMEM/M3 
 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,1,3,2,09/18/2017,JLH,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
9464D,mouse,"DMEM/M3 
 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,1,4,2,09/18/2017,JLH,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
9464D,mouse,"DMEM/M3 
 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,1,5,2,09/18/2017,JLH,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
9464D,mouse,"DMEM/M3 
 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,1,6,2,09/18/2017,JLH,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
9464D,mouse,"DMEM/M3 
 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,1,7,2,09/18/2017,JLH,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
9464D,mouse,"DMEM/M3 
 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,1,8,2,09/18/2017,JLH,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
9464D,mouse,"DMEM/M3 
 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,1,9,2,09/18/2017,JLH,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
9464D,mouse,"DMEM/M3 
 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,1,10,2,09/18/2017,JLH,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,2,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,2,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,2,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,2,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
9464D-GD2+,mouse,"DMEM/M3 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,2,9,6,09/21/2017,klc,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
9464D-GD2+,mouse,"DMEM/M3 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,2,10,6,09/21/2017,klc,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
9464D-GD2+,mouse,"DMEM/M3 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,3,1,6,09/21/2017,klc,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
9464D-GD2+,mouse,"DMEM/M3 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,3,2,6,09/21/2017,klc,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
9464D-GD2+,mouse,"DMEM/M3 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,3,3,6,09/21/2017,klc,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
9464D-GD2+,mouse,"DMEM/M3 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,3,4,6,09/21/2017,klc,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
9464D-GD2+,mouse,"DMEM/M3 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,3,5,6,09/21/2017,klc,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
9464D-GD2+,mouse,"DMEM/M3 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,3,6,6,09/21/2017,klc,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
9464D-GD2+,mouse,"DMEM/M3 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,3,7,6,09/21/2017,klc,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
9464D-GD2+,mouse,"DMEM/M3 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,3,8,6,09/21/2017,klc,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
9464D-GD2+,mouse,"DMEM/M3 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,3,9,6,09/21/2017,klc,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
9464D-GD2+,mouse,"DMEM/M3 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,3,10,6,09/21/2017,klc,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NXS2,mouse,"DMEM/M3 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,4,1,2+3,09/26/2017,klc,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NXS2,mouse,"DMEM/M3 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,4,2,2+3,09/26/2017,klc,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NXS2,mouse,"DMEM/M3 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,4,3,2+3,09/26/2017,klc,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NXS2,mouse,"DMEM/M3 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,4,4,2+3,09/26/2017,klc,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NXS2,mouse,"DMEM/M3 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,4,5,2+3,09/26/2017,klc,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NXS2,mouse,"DMEM/M3 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,4,6,2+3,09/26/2017,klc,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NXS2,mouse,"DMEM/M3 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,4,7,2+3,09/26/2017,klc,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NXS2,mouse,"DMEM/M3 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,4,8,2+3,09/26/2017,klc,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NXS2,mouse,"DMEM/M3 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,4,9,2+3,09/26/2017,klc,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NXS2,mouse,"DMEM/M3 (DMEM hiGlucose, no HEPES, w Na Pyruvate, L-glutamine) 1% GlutaMax, 3%M3, 10%FBS, 1%PS",,,,,,,,,,,,,,,,,,,,,,,,,,7,8,4,10,2+3,09/26/2017,klc,,09/19/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,8,5,1,,03/21/2013,LSH,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,8,5,2,,03/21/2013,LSH,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,8,5,3,,03/21/2013,LSH,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,5,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,8,5,5,,03/21/2013,LSH,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,5,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,8,5,7,16,04/04/2013,LSH,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,8,5,8,19,04/17/2013,LSH,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,8,5,9,19,04/17/2013,LSH,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,8,5,10,18,04/17/2013,LSH,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,8,6,1,18,04/17/2013,LSH,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,8,6,2,17,05/09/2013,LSH,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,8,6,3,18,06/13/2013,LSH,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,6,4,,12/07/2012,SC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,6,5,,12/07/2012,SC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,6,6,,12/07/2012,SC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly-GFP-Luc,GFP-Luc,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,8,6,7,,12/07/2012,SC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,6,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,6,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,8,6,10,14,04/17/2013,LSH,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,8,7,1,10,03/21/2013,LSH,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,8,7,2,14,04/17/2013,LSH,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,7,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,8,7,4,13,04/04/2013,LSH,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,8,7,5,16,10/03/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,8,7,6,12,04/04/2013,LSH,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,8,7,7,16,04/17/2013,LSH,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,8,7,8,16,04/17/2013,LSH,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,8,7,9,14,04/17/2013,LSH,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,8,7,10,14,04/17/2013,LSH,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,8,8,1,16,05/09/2013,LSH,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,8,8,2,17,06/13/2013,LSH,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,8,8,3,23,08/02/2013,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,8,8,4,23,08/02/2013,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,8,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,8,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,8,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,8,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,8,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly,?,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,8,8,10,,12/07/2012,SC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHP-212,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,,,,,,,,,,,,7,8,9,1,8,03/21/2013,LSH,,11/30/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHP-212,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,,,,,,,,,,,,7,8,9,2,14,03/21/2013,LSH,,11/30/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHP-212,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,,,,,,,,,,,,7,8,9,3,11,03/21/2013,LSH,,11/30/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHP-212,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,,,,,,,,,,,,7,8,9,4,16,04/04/2013,LSH,,11/30/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHP-212,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,,,,,,,,,,,,7,8,9,5,13,04/04/2013,LSH,,11/30/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHP-212,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,,,,,,,,,,,,7,8,9,6,19,04/17/2013,LSH,,11/30/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHP-212,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,,,,,,,,,,,,7,8,9,7,19,04/17/2013,LSH,,11/30/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHP-212,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,,,,,,,,,,,,7,8,9,8,15,04/17/2013,LSH,,11/30/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHP-212,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,,,,,,,,,,,,7,8,9,9,15,04/17/2013,LSH,,11/30/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHP-212,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,,,,,,,,,,,,7,8,9,10,11,05/09/2013,LSH,,11/30/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,10,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHP-212,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,,,,,,,,,,,,7,8,10,2,11,05/09/2013,LSH,,11/30/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHP-212,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,,,,,,,,,,,,7,8,10,3,12,06/13/2013,LSH,,11/30/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHP-212,BETiR,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,,,,,,,,,,,,7,8,10,4,13,08/02/2013,LSH,,11/30/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,10,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,10,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,10,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,10,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,10,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,8,10,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,9,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
DAOY,,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,1,2,6,06/08/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
DAOY,,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,1,3,6,06/08/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
DAOY,,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,1,4,6,06/08/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
DAOY,,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,1,5,6,06/08/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,9,1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-PN-DW,,"DMEM, 10 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,1,7,13,12/08/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-PN-DW,,"DMEM, 10 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,1,8,13,12/08/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-PN-DW,,"DMEM, 10 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,1,9,13,12/08/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-PN-DW,,"DMEM, 10 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,1,10,13,12/08/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
DAOY-shLIN28B-2,,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 1 ug/mL",7,9,2,1,3,08/09/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
DAOY-shLIN28B-2,,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 1 ug/mL",7,9,2,2,3,08/09/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
DAOY-shLIN28B-1,,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 1 ug/mL",7,9,2,3,3,08/09/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
DAOY-shLIN28B-1,,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 1 ug/mL",7,9,2,4,3,08/09/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
DAOY-shNTC,,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 1 ug/mL",7,9,2,5,3,08/09/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
DAOY-shNTC,,"DMEM, 20 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 1 ug/mL",7,9,2,6,3,08/09/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-PN-DW,,"DMEM, 10 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,2,7,13,12/08/2017,klc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-PN-DW,,"DMEM, 10 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,2,8,13,12/11/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-PN-DW,,"DMEM, 10 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,2,9,13,12/11/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-PN-DW,,"DMEM, 10 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,2,10,13,12/11/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-PN-DW,,"DMEM, 10 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,3,1,12,05/28/2013,KLC,,06/07/2013,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-PN-DW,,"DMEM, 10 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,3,2,13,12/11/2017,KLC,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-PN-DW,,"DMEM, 10 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,3,3,13,12/11/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-PN-DW,,"DMEM, 10 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,3,4,13,12/11/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-PN-DW-shNTC,,"DMEM, 10 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 1 ug/mL",7,9,3,5,5,08/19/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-PN-DW-shNTC,,"DMEM, 10 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 1 ug/mL",7,9,3,6,5,08/19/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-PN-DW-shLIN28B-2,,"DMEM, 10 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 1 ug/mL",7,9,3,7,5,08/27/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-PN-DW-shLIN28B-2,,"DMEM, 10 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 1 ug/mL",7,9,3,8,5,08/27/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-PN-DW-shLIN28B-1,,"DMEM, 10 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 1 ug/mL",7,9,3,9,5,09/13/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-PN-DW-shLIN28B-1,,"DMEM, 10 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 1 ug/mL",7,9,3,10,5,09/13/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
ONS76,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,4,1,6,11/29/2017,KLC,,12/04/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
ONS76,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,4,2,6,11/29/2017,KLC,,12/04/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
ONS76,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,4,3,6,11/29/2017,KLC,,12/04/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
ONS76,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,4,4,6,11/29/2017,KLC,,12/04/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
ONS76,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,4,5,6,11/29/2017,KLC,,12/04/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
ONS76,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,4,6,6,11/29/2017,KLC,,12/04/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
ONS76,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,4,7,6,11/29/2017,KLC,,12/04/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
ONS76,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,4,8,6,11/29/2017,KLC,,12/04/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
ONS76,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,4,9,7,12/01/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
ONS76,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,4,10,7,12/01/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
ONS76,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,5,1,6,06/08/2013,KLC,,MR records,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
ONS76,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,5,2,7,12/01/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
ONS76,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,5,3,7,12/01/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
ONS76,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,5,4,7,12/01/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
ONS76-shLIN28B-2,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 1 ug/mL",7,9,5,5,3,08/07/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
ONS76-shLIN28B-2,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 1 ug/mL",7,9,5,6,3,08/07/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
ONS76-shNTC,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 1 ug/mL",7,9,5,7,3,08/07/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
ONS76-shNTC,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 1 ug/mL",7,9,5,8,3,08/07/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
ONS76-shLIN28B-1,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 1 ug/mL",7,9,5,9,3,08/07/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
ONS76-shLIN28B-1,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 1 ug/mL",7,9,5,10,3,08/07/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
D283,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,6,1,15,12/14/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
D283,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,6,2,15,12/14/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
D283,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,6,3,15,12/14/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
D283,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,6,4,15,12/14/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
D283,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,6,5,15,12/14/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
D283,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,6,6,15,12/14/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
D283,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,6,7,15,12/14/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
D283,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,6,8,15,12/14/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
D283,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,6,9,15,12/14/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
D283,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,6,10,15,12/14/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
D283,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,7,1,15,05/31/2013,KLC,,06/07/2013,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
D283,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,7,2,15,12/14/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
D283,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,7,3,15,12/14/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
D283-shNTC,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 1 ug/mL",7,9,7,4,3,08/12/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
D283-shNTC,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 1 ug/mL",7,9,7,5,3,08/12/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
D283-shLIN28B-1,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",,,,,,,,,,,,,,,,,,,,,,,,,"PPuromycin resistant, 1 ug/mL",7,9,7,6,6,10/8/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
D283-shLIN28B-1,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 1 ug/mL",7,9,7,7,6,10/8/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
D283-shLIN28B-2,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,7,8,,11/25/13,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
D283-shLIN28B-2,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,7,9,,11/25/13,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
D283-shLIN28B-2,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,7,10,,11/25/13,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,9,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-PN-DW,,"DMEM, 10 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,8,2,13,12/11/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,9,8,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,9,8,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly,shLIN2 - Bob40,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,9,8,5,5,11/20/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly,shLIN2 - Bob40,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,9,8,6,5,11/20/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly,shCON - Bob39,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,9,8,7,5,11/20/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly,shCON - Bob39,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,9,8,8,5,11/20/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,9,8,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,9,8,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Be2C-shNTC,shNTC,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 2ug/mL",7,9,9,1,4,08/16/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Be2C-shNTC,shNTC,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 2ug/mL",7,9,9,2,4,08/16/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Be2C-shLIN28B-1,shLIN28B-1,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 2ug/mL",7,9,9,3,5,08/23/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Be2C-shLIN28B-1,shLIN28B-1,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 2ug/mL",7,9,9,4,5,08/23/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Be2C-shLIN28B-2,shLIN28B-2,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 2ug/mL",7,9,9,5,5,08/23/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Be2C-shLIN28B-2,shLIN28B-2,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,"Puromycin resistant, 2ug/mL",7,9,9,6,5,08/23/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly-shCON,Bob39,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,9,9,7,4,11/18/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly-shCON,Bob39,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,9,9,8,4,11/18/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly-shLin28B-2,Bob40,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,9,9,9,5,11/18/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly-shLin28B-2,Bob40,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,9,9,10,5,11/18/2013,KLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,9,10,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
ONS76,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,10,2,7,12/01/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
ONS76,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,10,3,7,12/01/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
D283,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,10,4,15,12/14/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
D283,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,10,5,15,12/14/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
D283,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,10,6,15,12/14/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
D283,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep
",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,10,7,15,12/14/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-PN-DW,,"DMEM, 10 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,10,8,13,12/11/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-PN-DW,,"DMEM, 10 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,10,9,13,12/11/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-PN-DW,,"DMEM, 10 % Fetal Bovine Serum, 1 % of Pen/Strep, 2 mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,9,10,10,13,12/11/2017,klc,,12/05/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
IMR-05 Net-Luc,Net+Luc xenograft,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection ,Solid Tumor Same patient as IMR-32 Subclone of IMR-3,Gain + LOH p32.3-pter,GaiNAl p24.3-26.3,Loss q22.1-qter,Gain q21.2-qter,WT,Amplified,WT,,,,,,,,,,,,7,10,1,1,2,02/28/2013,MG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
IMR-05 Net-Luc,Net+Luc xenograft,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection ,Solid Tumor Same patient as IMR-32 Subclone of IMR-3,Gain + LOH p32.3-pter,GaiNAl p24.3-26.3,Loss q22.1-qter,Gain q21.2-qter,WT,Amplified,WT,,,,,,,,,,,,7,10,1,2,2,02/28/2013,MG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
IMR-05 Net-Luc,Net+Luc xenograft,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection ,Solid Tumor Same patient as IMR-32 Subclone of IMR-3,Gain + LOH p32.3-pter,GaiNAl p24.3-26.3,Loss q22.1-qter,Gain q21.2-qter,WT,Amplified,WT,,,,,,,,,,,,7,10,1,3,2,02/28/2013,MG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
IMR-05 Net-Luc,Net+Luc xenograft,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection ,Solid Tumor Same patient as IMR-32 Subclone of IMR-3,Gain + LOH p32.3-pter,GaiNAl p24.3-26.3,Loss q22.1-qter,Gain q21.2-qter,WT,Amplified,WT,,,,,,,,,,,,7,10,1,4,2,02/28/2013,MG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,1,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,1,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
B78,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,10,2,1,2,07/27/2019,KU,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
B78,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,10,2,2,2,07/27/2019,KU,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
B78,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,10,2,3,2,07/27/2019,KU,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,2,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,2,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
B16,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,10,2,7,2,07/27/2019,KU,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
B16,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,10,2,8,2,07/27/2019,KU,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
B16,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,10,2,9,2,07/27/2019,KU,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
B16,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",,,,,,,,,,,,,,,,,,,,,,,,,,7,10,2,10,2,07/27/2019,KU,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
MCF7,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep, 
+NEAA",,,,,,,,,,,,,,,,,,,,,,,,,,7,10,3,1,8,10/26/2017,klc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
MCF7,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep, 
+NEAA",,,,,,,,,,,,,,,,,,,,,,,,,,7,10,3,2,8,10/26/2017,klc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
MCF7,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep, 
+NEAA",,,,,,,,,,,,,,,,,,,,,,,,,,7,10,3,3,8,10/26/2017,klc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
MCF7,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep, 
+NEAA",,,,,,,,,,,,,,,,,,,,,,,,,,7,10,3,4,8,10/26/2017,klc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
MCF7,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep, 
+NEAA",,,,,,,,,,,,,,,,,,,,,,,,,,7,10,3,5,8,10/26/2017,klc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
MCF7,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep, 
+NEAA",,,,,,,,,,,,,,,,,,,,,,,,,,7,10,3,6,8,10/26/2017,klc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
MCF7,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep, 
+NEAA",,,,,,,,,,,,,,,,,,,,,,,,,,7,10,3,7,8,10/26/2017,klc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
MCF7,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep, 
+NEAA",,,,,,,,,,,,,,,,,,,,,,,,,,7,10,3,8,8,10/26/2017,klc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
MCF7,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep, 
+NEAA",,,,,,,,,,,,,,,,,,,,,,,,,,7,10,3,9,12,11/10/2017,klc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
MCF7,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep, 
+NEAA",,,,,,,,,,,,,,,,,,,,,,,,,,7,10,3,10,12,11/10/2017,klc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,4,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,4,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,4,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,4,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,4,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
MCF7,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep, 
+NEAA",,,,,,,,,,,,,,,,,,,,,,,,,,7,10,4,8,12,11/10/2017,klc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
MCF7,,"EMEM Media, 10%FBS, 2mM L-Glutamine, 1% Pen/Strep, 
+NEAA",,,,,,,,,,,,,,,,,,,,,,,,,,7,10,4,9,12,11/10/2017,klc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,4,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C Net+,Net+ xenograft,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,10,5,1,3,02/28/2013,MG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C Net+,Net+ xenograft,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,10,5,2,3,02/28/2013,MG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C Net+,Net+ xenograft,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,10,5,3,3,02/28/2013,MG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C Net+,Net+ xenograft,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,10,5,4,3,02/28/2013,MG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,5,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2) Net+,Net+ xenograft,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow,cnLOH p21.4-pterm,Loss 14.2-pterm,GaiNAl q13.1-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,10,5,6,1,02/28/2013,MG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2) Net+,Net+ xenograft,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow,cnLOH p21.4-pterm,Loss 14.2-pterm,GaiNAl q13.1-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,10,5,7,1,02/28/2013,MG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2) Net+,Net+ xenograft,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow,cnLOH p21.4-pterm,Loss 14.2-pterm,GaiNAl q13.1-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,10,5,8,1,02/28/2013,MG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2) Net+,Net+ xenograft,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow,cnLOH p21.4-pterm,Loss 14.2-pterm,GaiNAl q13.1-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,10,5,9,1,02/28/2013,MG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,5,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,6,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,6,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,6,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,6,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,6,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,6,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,6,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,6,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,6,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-1691 Net-Luc,Net+Luc xenograft,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,Loss p26.1,LOH q11-qter; Loss q22.1-q24.3,None,WT,Amplified,WT,,,,,,,,,,,,7,10,7,1,21,02/28/2013,MG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-1691 Net-Luc,Net+Luc xenograft,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,Loss p26.1,LOH q11-qter; Loss q22.1-q24.3,None,WT,Amplified,WT,,,,,,,,,,,,7,10,7,2,21,02/28/2013,MG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-1691 Net-Luc,Net+Luc xenograft,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,Loss p26.1,LOH q11-qter; Loss q22.1-q24.3,None,WT,Amplified,WT,,,,,,,,,,,,7,10,7,3,21,02/28/2013,MG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-1691 Net-Luc,Net+Luc xenograft,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,Loss p26.1,LOH q11-qter; Loss q22.1-q24.3,None,WT,Amplified,WT,,,,,,,,,,,,7,10,7,4,21,02/28/2013,MG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-1691 Net-Luc,Net+Luc cells,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,Loss p26.1,LOH q11-qter; Loss q22.1-q24.3,None,WT,Amplified,WT,,,,,,,,,,,,7,10,7,5,40,06/05/2013,MG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-1691 Net-Luc,Net+Luc cells,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,Loss p26.1,LOH q11-qter; Loss q22.1-q24.3,None,WT,Amplified,WT,,,,,,,,,,,,7,10,7,6,40,06/05/2013,MG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-1691 Net-Luc,Net+Luc cells,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,Loss p26.1,LOH q11-qter; Loss q22.1-q24.3,None,WT,Amplified,WT,,,,,,,,,,,,7,10,7,7,34,05/18/2013,VB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-1691 Net-Luc,Net+Luc cells,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,Loss p26.1,LOH q11-qter; Loss q22.1-q24.3,None,WT,Amplified,WT,,,,,,,,,,,,7,10,7,8,34,05/18/2013,VB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-1691 Net-Luc,Net+Luc cells,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Unknown,None,Loss p26.1,LOH q11-qter; Loss q22.1-q24.3,None,WT,Amplified,WT,,,,,,,,,,,,7,10,7,9,,08/11/2012,JK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,7,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,8,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,8,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,8,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,8,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,8,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,8,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,8,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,8,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,8,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-573,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Suspension with foci clusters,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245I,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,10,9,1,5,08/15/2017,klc,"from LSH freeze, 3/1/2016, p4)",06/30/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-573,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Suspension with foci clusters,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245I,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,10,9,2,5,08/15/2017,klc,"from LSH freeze, 3/1/2016, p4)",06/30/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-573,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Suspension with foci clusters,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245I,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,10,9,3,5,08/15/2017,klc,"from LSH freeze, 3/1/2016, p4)",06/30/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-573,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Suspension with foci clusters,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245I,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,10,9,4,5,08/15/2017,klc,"from LSH freeze, 3/1/2016, p4)",06/30/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-573,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Suspension with foci clusters,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245I,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,10,9,5,5,08/15/2017,klc,"from LSH freeze, 3/1/2016, p4)",06/30/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-573,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Suspension with foci clusters,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245I,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,10,9,6,9,10/18/2019,KU,"from KLC, P5, 08/15/2017 (STR from thaw is good)",09/20/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-573,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Suspension with foci clusters,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245I,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,10,9,7,9,10/18/2019,KU,"from KLC, P5, 08/15/2017 (STR from thaw is good)",09/20/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-573,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Suspension with foci clusters,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245I,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,10,9,8,9,10/18/2019,KU,"from KLC, P5, 08/15/2017 (STR from thaw is good)",09/20/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-573,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Suspension with foci clusters,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245I,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,10,9,9,9,10/18/2019,KU,"from KLC, P5, 08/15/2017 (STR from thaw is good)",09/20/2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,9,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,10,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,10,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,10,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,10,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,10,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,10,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,10,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,10,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,10,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,10,10,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-440,Cell Bank,"IMDM Media, 20%FBS, 2 Mm L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,Grows primarily in clumps with some neurite projections,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,NA,NA,12,NA,NA,NA,NA,NA,NA,,7,11,1,1,16,08/15/2014,RS-Mosse Lab,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-440,Cell Bank,"IMDM Media, 20%FBS, 2 Mm L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,Grows primarily in clumps with some neurite projections,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,NA,NA,12,NA,NA,NA,NA,NA,NA,,7,11,1,2,16,08/15/2014,RS-Mosse Lab,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-440,Cell Bank,"IMDM Media, 20%FBS, 2 Mm L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,Grows primarily in clumps with some neurite projections,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,NA,NA,12,NA,NA,NA,NA,NA,NA,,7,11,1,3,16,08/15/2014,RS-Mosse Lab,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-440,Cell Bank,"IMDM Media, 20%FBS, 2 Mm L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,Grows primarily in clumps with some neurite projections,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,NA,NA,12,NA,NA,NA,NA,NA,NA,,7,11,1,4,4,03/03/2016,LSH,,,12/10/2019,Good,X,,15,17,,11,16,,11,14,13,15,,9,13,,13,21,,9,11,13,17,,17,19,,10,11,,12,13,,6,8,15,16,,28,,,11,12,11,12,8,,,,11,,,19,22,,13,14,,21,24,,14,17,,,Maris
COG-N-440,Cell Bank,"IMDM Media, 20%FBS, 2 Mm L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,Grows primarily in clumps with some neurite projections,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,NA,NA,12,NA,NA,NA,NA,NA,NA,,7,11,1,5,4,03/03/2016,LSH,,,12/10/2019,Good,X,,15,17,,11,16,,11,14,13,15,,9,13,,13,21,,9,11,13,17,,17,19,,10,11,,12,13,,6,8,15,16,,28,,,11,12,11,12,8,,,,11,,,19,22,,13,14,,21,24,,14,17,,,Maris
COG-N-440,Cell Bank,"IMDM Media, 20%FBS, 2 Mm L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,Grows primarily in clumps with some neurite projections,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,NA,NA,12,NA,NA,NA,NA,NA,NA,,7,11,1,6,7,05/28/2017,LS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-440,Cell Bank,"IMDM Media, 20%FBS, 2 Mm L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,Grows primarily in clumps with some neurite projections,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,NA,NA,12,NA,NA,NA,NA,NA,NA,,7,11,1,7,7,11/04/2019,KU,"From LSH, P4, 03/03/2016 (STR from thaw is good)",,10/19/2018,Good (STR of thaw is good),X,,15,17,,11,16,,11,14,13,15,,9,13,,13,21,,9,11,13,17,,17,19,,10,11,,12,13,,6,8,15,16,,28,,,11,12,11,12,8,,,,11,,,19,22,,13,14,,21,24,,14,17,,,Maris
COG-N-440,Cell Bank,"IMDM Media, 20%FBS, 2 Mm L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,Grows primarily in clumps with some neurite projections,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,NA,NA,12,NA,NA,NA,NA,NA,NA,,7,11,1,8,7,11/04/2019,KU,"From LSH, P4, 03/03/2016 (STR from thaw is good)",,10/19/2018,Good (STR of thaw is good),X,,15,17,,11,16,,11,14,13,15,,9,13,,13,21,,9,11,13,17,,17,19,,10,11,,12,13,,6,8,15,16,,28,,,11,12,11,12,8,,,,11,,,19,22,,13,14,,21,24,,14,17,,,Maris
COG-N-440,Cell Bank,"IMDM Media, 20%FBS, 2 Mm L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,Grows primarily in clumps with some neurite projections,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,NA,NA,12,NA,NA,NA,NA,NA,NA,,7,11,1,9,7,11/04/2019,KU,"From LSH, P4, 03/03/2016 (STR from thaw is good)",,10/19/2018,Good (STR of thaw is good),X,,15,17,,11,16,,11,14,13,15,,9,13,,13,21,,9,11,13,17,,17,19,,10,11,,12,13,,6,8,15,16,,28,,,11,12,11,12,8,,,,11,,,19,22,,13,14,,21,24,,14,17,,,Maris
COG-N-440,Cell Bank,"IMDM Media, 20%FBS, 2 Mm L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,Grows primarily in clumps with some neurite projections,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,NA,NA,12,NA,NA,NA,NA,NA,NA,,7,11,1,10,7,11/04/2019,KU,"From LSH, P4, 03/03/2016 (STR from thaw is good)",,10/19/2018,Good (STR of thaw is good),X,,15,17,,11,16,,11,14,13,15,,9,13,,13,21,,9,11,13,17,,17,19,,10,11,,12,13,,6,8,15,16,,28,,,11,12,11,12,8,,,,11,,,19,22,,13,14,,21,24,,14,17,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,2,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,2,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,2,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,2,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,2,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,2,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-557nb,Cell Bank,"Neurobasal-A plus, 50 ng/mL rhEGF, 50 ng/mL rhFGF, 4mM L-Glutamine, 1X B27, 1X N2",0.02% Versene,Adherent ,,Diagnosis,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245L,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,11,3,1,4,10/22/2015,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-557nb,Cell Bank,"Neurobasal-A plus, 50 ng/mL rhEGF, 50 ng/mL rhFGF, 4mM L-Glutamine, 1X B27, 1X N2",0.02% Versene,Adherent ,,Diagnosis,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245L,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,11,3,2,4,10/22/2015,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-557nb,Cell Bank,"Neurobasal-A plus, 50 ng/mL rhEGF, 50 ng/mL rhFGF, 4mM L-Glutamine, 1X B27, 1X N2",0.02% Versene,Adherent ,,Diagnosis,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245L,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,11,3,3,4,10/22/2015,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-557nb,Cell Bank,"Neurobasal-A plus, 50 ng/mL rhEGF, 50 ng/mL rhFGF, 4mM L-Glutamine, 1X B27, 1X N2",0.02% Versene,Adherent ,,Diagnosis,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245L,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,11,3,4,6,02/24/2016,LSH,,,12/10/19,Good,X,Y,14,16,,15,15.3,,11,,14,,,11,14,,5,8,,12,,15,16,,24,,,11,,,10,13,,7,9.3,17,18,,28,30,,8,10,11,12,8,11,,10,13,15,,18.3,23,,14,,,19,44.2,,11,16,,,Maris
COG-N-557nb,Cell Bank,"Neurobasal-A plus, 50 ng/mL rhEGF, 50 ng/mL rhFGF, 4mM L-Glutamine, 1X B27, 1X N2",0.02% Versene,Adherent ,,Diagnosis,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245L,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,11,3,5,6,02/24/2016,LSH,,,12/10/19,Good,X,Y,14,16,,15,15.3,,11,,14,,,11,14,,5,8,,12,,15,16,,24,,,11,,,10,13,,7,9.3,17,18,,28,30,,8,10,11,12,8,11,,10,13,15,,18.3,23,,14,,,19,44.2,,11,16,,,Maris
COG-N-557nb,Cell Bank,"Neurobasal-A plus, 50 ng/mL rhEGF, 50 ng/mL rhFGF, 4mM L-Glutamine, 1X B27, 1X N2",0.02% Versene,Adherent ,,Diagnosis,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245L,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,11,3,6,6,02/24/2016,LSH,,,12/10/19,Good,X,Y,14,16,,15,15.3,,11,,14,,,11,14,,5,8,,12,,15,16,,24,,,11,,,10,13,,7,9.3,17,18,,28,30,,8,10,11,12,8,11,,10,13,15,,18.3,23,,14,,,19,44.2,,11,16,,,Maris
COG-N-557nb,Cell Bank,"Neurobasal-A plus, 50 ng/mL rhEGF, 50 ng/mL rhFGF, 4mM L-Glutamine, 1X B27, 1X N2",0.02% Versene,Adherent ,,Diagnosis,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245L,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,11,3,7,6,02/24/2016,LSH,,,12/10/19,Good,X,Y,14,16,,15,15.3,,11,,14,,,11,14,,5,8,,12,,15,16,,24,,,11,,,10,13,,7,9.3,17,18,,28,30,,8,10,11,12,8,11,,10,13,15,,18.3,23,,14,,,19,44.2,,11,16,,,Maris
COG-N-557nb,Cell Bank,"Neurobasal-A plus, 50 ng/mL rhEGF, 50 ng/mL rhFGF, 4mM L-Glutamine, 1X B27, 1X N2",0.02% Versene,Adherent ,,Diagnosis,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245L,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,11,3,8,8,11/13/2019,KU,"From LSH, P6, 02/24/2016",10/25/2019,12/10/19,Good (STR of thaw is good),X,Y,14,16,,15,15.3,,11,,14,,,11,14,,5,8,,12,,15,16,,24,,,11,,,10,13,,7,9.3,17,18,,28,30,,8,10,11,12,8,11,,10,13,15,,18.3,23,,14,,,19,44.2,,11,16,,,Maris
COG-N-557nb,Cell Bank,"Neurobasal-A plus, 50 ng/mL rhEGF, 50 ng/mL rhFGF, 4mM L-Glutamine, 1X B27, 1X N2",0.02% Versene,Adherent ,,Diagnosis,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245L,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,11,3,9,8,11/13/2019,KU,"From LSH, P6, 02/24/2016 (STR from thaw is good)",10/25/2019,12/10/19,Good (STR of thaw is good),X,Y,14,16,,15,15.3,,11,,14,,,11,14,,5,8,,12,,15,16,,24,,,11,,,10,13,,7,9.3,17,18,,28,30,,8,10,11,12,8,11,,10,13,15,,18.3,23,,14,,,19,44.2,,11,16,,,Maris
COG-N-557nb,Cell Bank,"Neurobasal-A plus, 50 ng/mL rhEGF, 50 ng/mL rhFGF, 4mM L-Glutamine, 1X B27, 1X N2",0.02% Versene,Adherent ,,Diagnosis,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245L,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,11,3,10,8,11/13/2019,KU,"From LSH, P6, 02/24/2016 (STR from thaw is good)",10/25/2019,12/10/19,Good (STR of thaw is good),X,Y,14,16,,15,15.3,,11,,14,,,11,14,,5,8,,12,,15,16,,24,,,11,,,10,13,,7,9.3,17,18,,28,30,,8,10,11,12,8,11,,10,13,15,,18.3,23,,14,,,19,44.2,,11,16,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,4,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,4,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,4,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,4,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,4,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,4,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,4,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-557nb,Cell Bank,"Neurobasal-A plus, 50 ng/mL rhEGF, 50 ng/mL rhFGF, 4mM L-Glutamine, 1X B27, 1X N2",0.02% Versene,Adherent ,,Diagnosis,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1245L,Amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,11,4,10,8,11/13/2019,KU,"From LSH, P6, 02/24/2016 (STR from thaw is good)",10/25/2019,12/10/19,Good (STR of thaw is good),X,Y,14,16,,15,15.3,,11,,14,,,11,14,,5,8,,12,,15,16,,24,,,11,,,10,13,,7,9.3,17,18,,28,30,,8,10,11,12,8,11,,10,13,15,,18.3,23,,14,,,19,44.2,,11,16,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,5,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-415,Cell Bank,"IMDM Media, 20%FBS, 1% Pen/Strep, 2 mM L-Glutamine, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,"During the first few passages COG-N-415 will be a mix of adherent and non-adherent cells. As the passages progress, more of the cells will become adherent.",Unknown,Progressing ,Unknown,Unknown,Unknown,Unknown,None,Unknown,F1174L,Amplified,WT,NA,NA,NA,5,NA,NA,NA,NA,6,NA,,7,11,5,2,16,11/17/2017,klc,"Received and propagated from Mosse Lab, p15 RS 05/29/2015 (PReynolds p2+13)",11/14/2017,12/10/2019,Good (Drop out of 9 at D7S820),X,,14,15,,14,17,,11,14,14,15,,10,11,12,7,13,,11,,12,15,,19,21,,10,11,,9,12,,7,8,17,,,28,29,,9 (DO),10,11,,11,,,-,11,14,,15,21,,14,15,,19,22,,16,18,,,Maris
COG-N-415,Cell Bank,"IMDM Media, 20%FBS, 1% Pen/Strep, 2 mM L-Glutamine, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,"During the first few passages COG-N-415 will be a mix of adherent and non-adherent cells. As the passages progress, more of the cells will become adherent.",Unknown,Progressing ,Unknown,Unknown,Unknown,Unknown,None,Unknown,F1174L,Amplified,WT,NA,NA,NA,5,NA,NA,NA,NA,6,NA,,7,11,5,3,16,11/17/2017,klc,"Received and propagated from Mosse Lab, p15 RS 05/29/2015 (PReynolds p2+13)",11/14/2017,12/10/2019,Good (Drop out of 9 at D7S820),X,,14,15,,14,17,,11,14,14,15,,10,11,12,7,13,,11,,12,15,,19,21,,10,11,,9,12,,7,8,17,,,28,29,,9 (DO),10,11,,11,,,-,11,14,,15,21,,14,15,,19,22,,16,18,,,Maris
COG-N-415,Cell Bank,"IMDM Media, 20%FBS, 1% Pen/Strep, 2 mM L-Glutamine, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,"During the first few passages COG-N-415 will be a mix of adherent and non-adherent cells. As the passages progress, more of the cells will become adherent.",Unknown,Progressing ,Unknown,Unknown,Unknown,Unknown,None,Unknown,F1174L,Amplified,WT,NA,NA,NA,5,NA,NA,NA,NA,6,NA,,7,11,5,4,16,11/17/2017,klc,"Received and propagated from Mosse Lab, p15 RS 05/29/2015 (PReynolds p2+13)",11/14/2017,12/10/2019,Good (Drop out of 9 at D7S820),X,,14,15,,14,17,,11,14,14,15,,10,11,12,7,13,,11,,12,15,,19,21,,10,11,,9,12,,7,8,17,,,28,29,,9 (DO),10,11,,11,,,-,11,14,,15,21,,14,15,,19,22,,16,18,,,Maris
COG-N-415,Cell Bank,"IMDM Media, 20%FBS, 1% Pen/Strep, 2 mM L-Glutamine, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,"During the first few passages COG-N-415 will be a mix of adherent and non-adherent cells. As the passages progress, more of the cells will become adherent.",Unknown,Progressing ,Unknown,Unknown,Unknown,Unknown,None,Unknown,F1174L,Amplified,WT,NA,NA,NA,5,NA,NA,NA,NA,6,NA,,7,11,5,5,16,11/17/2017,klc,"Received and propagated from Mosse Lab, p15 RS 05/29/2015 (PReynolds p2+13)",11/14/2017,12/10/2019,Good (Drop out of 9 at D7S820),X,,14,15,,14,17,,11,14,14,15,,10,11,12,7,13,,11,,12,15,,19,21,,10,11,,9,12,,7,8,17,,,28,29,,9 (DO),10,11,,11,,,-,11,14,,15,21,,14,15,,19,22,,16,18,,,Maris
COG-N-415,Cell Bank,"IMDM Media, 20%FBS, 1% Pen/Strep, 2 mM L-Glutamine, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,"During the first few passages COG-N-415 will be a mix of adherent and non-adherent cells. As the passages progress, more of the cells will become adherent.",Unknown,Progressing ,Unknown,Unknown,Unknown,Unknown,None,Unknown,F1174L,Amplified,WT,NA,NA,NA,5,NA,NA,NA,NA,6,NA,,7,11,5,6,16,11/17/2017,klc,"Received and propagated from Mosse Lab, p15 RS 05/29/2015 (PReynolds p2+13)",11/14/2017,12/10/2019,Good (Drop out of 9 at D7S820),X,,14,15,,14,17,,11,14,14,15,,10,11,12,7,13,,11,,12,15,,19,21,,10,11,,9,12,,7,8,17,,,28,29,,9 (DO),10,11,,11,,,-,11,14,,15,21,,14,15,,19,22,,16,18,,,Maris
COG-N-415,Cell Bank,"IMDM Media, 20%FBS, 1% Pen/Strep, 2 mM L-Glutamine, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,"During the first few passages COG-N-415 will be a mix of adherent and non-adherent cells. As the passages progress, more of the cells will become adherent.",Unknown,Progressing ,Unknown,Unknown,Unknown,Unknown,None,Unknown,F1174L,Amplified,WT,NA,NA,NA,5,NA,NA,NA,NA,6,NA,,7,11,5,7,16,11/17/2017,klc,"Received and propagated from Mosse Lab, p15 RS 05/29/2015 (PReynolds p2+13)",11/14/2017,12/10/2019,Good (Drop out of 9 at D7S820),X,,14,15,,14,17,,11,14,14,15,,10,11,12,7,13,,11,,12,15,,19,21,,10,11,,9,12,,7,8,17,,,28,29,,9 (DO),10,11,,11,,,-,11,14,,15,21,,14,15,,19,22,,16,18,,,Maris
COG-N-415,Cell Bank,"IMDM Media, 20%FBS, 1% Pen/Strep, 2 mM L-Glutamine, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,"During the first few passages COG-N-415 will be a mix of adherent and non-adherent cells. As the passages progress, more of the cells will become adherent.",Unknown,Progressing ,Unknown,Unknown,Unknown,Unknown,None,Unknown,F1174L,Amplified,WT,NA,NA,NA,5,NA,NA,NA,NA,6,NA,,7,11,5,8,16,11/17/2017,klc,"Received and propagated from Mosse Lab, p15 RS 05/29/2015 (PReynolds p2+13)",11/14/2017,12/10/2019,Good (Drop out of 9 at D7S820),X,,14,15,,14,17,,11,14,14,15,,10,11,12,7,13,,11,,12,15,,19,21,,10,11,,9,12,,7,8,17,,,28,29,,9 (DO),10,11,,11,,,-,11,14,,15,21,,14,15,,19,22,,16,18,,,Maris
COG-N-415,Cell Bank,"IMDM Media, 20%FBS, 1% Pen/Strep, 2 mM L-Glutamine, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,"During the first few passages COG-N-415 will be a mix of adherent and non-adherent cells. As the passages progress, more of the cells will become adherent.",Unknown,Progressing ,Unknown,Unknown,Unknown,Unknown,None,Unknown,F1174L,Amplified,WT,NA,NA,NA,5,NA,NA,NA,NA,6,NA,,7,11,5,9,16,11/17/2017,klc,"Received and propagated from Mosse Lab, p15 RS 05/29/2015 (PReynolds p2+13)",11/14/2017,12/10/2019,Good (Drop out of 9 at D7S820),X,,14,15,,14,17,,11,14,14,15,,10,11,12,7,13,,11,,12,15,,19,21,,10,11,,9,12,,7,8,17,,,28,29,,9 (DO),10,11,,11,,,-,11,14,,15,21,,14,15,,19,22,,16,18,,,Maris
COG-N-415,Cell Bank,"IMDM Media, 20%FBS, 1% Pen/Strep, 2 mM L-Glutamine, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,"During the first few passages COG-N-415 will be a mix of adherent and non-adherent cells. As the passages progress, more of the cells will become adherent.",Unknown,Progressing ,Unknown,Unknown,Unknown,Unknown,None,Unknown,F1174L,Amplified,WT,NA,NA,NA,5,NA,NA,NA,NA,6,NA,,7,11,5,10,16,11/17/2017,klc,"Received and propagated from Mosse Lab, p15 RS 05/29/2015 (PReynolds p2+13)",11/14/2017,12/10/2019,Good (Drop out of 9 at D7S820),X,,14,15,,14,17,,11,14,14,15,,10,11,12,7,13,,11,,12,15,,19,21,,10,11,,9,12,,7,8,17,,,28,29,,9 (DO),10,11,,11,,,-,11,14,,15,21,,14,15,,19,22,,16,18,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,6,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,6,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-415,Cell Bank,"IMDM Media, 20%FBS, 1% Pen/Strep, 2 mM L-Glutamine, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,"During the first few passages COG-N-415 will be a mix of adherent and non-adherent cells. As the passages progress, more of the cells will become adherent.",Unknown,Progressing ,Unknown,Unknown,Unknown,Unknown,None,Unknown,F1174L,Amplified,WT,NA,NA,NA,5,NA,NA,NA,NA,6,NA,,7,11,6,3,17,11/20/2017,klc,"Received and propagated from Mosse Lab, p15 RS 05/29/2015 (PReynolds p2+13)",11/14/2017,12/10/2019,Good (Drop out of 9 at D7S820),X,,14,15,,14,17,,11,14,14,15,,10,11,12,7,13,,11,,12,15,,19,21,,10,11,,9,12,,7,8,17,,,28,29,,9 (DO),10,11,,11,,,-,11,14,,15,21,,14,15,,19,22,,16,18,,,Maris
COG-N-415,Cell Bank,"IMDM Media, 20%FBS, 1% Pen/Strep, 2 mM L-Glutamine, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,"During the first few passages COG-N-415 will be a mix of adherent and non-adherent cells. As the passages progress, more of the cells will become adherent.",Unknown,Progressing ,Unknown,Unknown,Unknown,Unknown,None,Unknown,F1174L,Amplified,WT,NA,NA,NA,5,NA,NA,NA,NA,6,NA,,7,11,6,4,17,11/20/2017,klc,"Received and propagated from Mosse Lab, p15 RS 05/29/2015 (PReynolds p2+13)",11/14/2017,12/10/2019,Good (Drop out of 9 at D7S820),X,,14,15,,14,17,,11,14,14,15,,10,11,12,7,13,,11,,12,15,,19,21,,10,11,,9,12,,7,8,17,,,28,29,,9 (DO),10,11,,11,,,-,11,14,,15,21,,14,15,,19,22,,16,18,,,Maris
COG-N-415,Cell Bank,"IMDM Media, 20%FBS, 1% Pen/Strep, 2 mM L-Glutamine, 1X ITS",0.02% Versene,Combination of adherent and non-adherent,"During the first few passages COG-N-415 will be a mix of adherent and non-adherent cells. As the passages progress, more of the cells will become adherent.",Unknown,Progressing ,Unknown,Unknown,Unknown,Unknown,None,Unknown,F1174L,Amplified,WT,NA,NA,NA,5,NA,NA,NA,NA,6,NA,,7,11,6,5,17,11/20/2017,klc,"Received and propagated from Mosse Lab, p15 RS 05/29/2015 (PReynolds p2+13)",11/14/2017,12/10/2019,Good (Drop out of 9 at D7S820),X,,14,15,,14,17,,11,14,14,15,,10,11,12,7,13,,11,,12,15,,19,21,,10,11,,9,12,,7,8,17,,,28,29,,9 (DO),10,11,,11,,,-,11,14,,15,21,,14,15,,19,22,,16,18,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,6,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,6,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,6,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,6,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,6,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-471nb,Cell Bank,"Neurobasal-A plus, 50 ng/mL rhEGF, 50 ng/mL rhFGF, 4mM L-Glutamine, 1X B27, 1X N2",0.02% Versene,Adherent,,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,5,NA,NA,6,NA,NA,NA,NA,NA,,7,11,7,1,4,10/28/2015,LSH,,,12/10/2019,Good,X,,16,18,,11,14,,12,14,,,,10,11,,,,,11,12,13,,,,,,,,,,,,6,7,14,15,,29,32.2,,8,9,10,12,,,,,11,13,,22,,,14,14.2,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,7,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-471nb,Cell Bank,"Neurobasal-A plus, 50 ng/mL rhEGF, 50 ng/mL rhFGF, 4mM L-Glutamine, 1X B27, 1X N2",0.02% Versene,Adherent,,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,5,NA,NA,6,NA,NA,NA,NA,NA,,7,11,7,3,11,07/12/2017,LS,,06/17/2017,12/10/2019,Good (Drop out of 14.2 in D19S1433),X,,16,18,,11,14,,12,14,13,14,,10,11,,14,15,,11,12,13,14,,17,22,,10,11,,9,12,,6,7,14,15,,29,32.2,,8,9,10,12,8,11,,,11,13,,22,,,14,14.2 (DO),,21,,,15,,,,Maris
COG-N-471nb,Cell Bank,"Neurobasal-A plus, 50 ng/mL rhEGF, 50 ng/mL rhFGF, 4mM L-Glutamine, 1X B27, 1X N2",0.02% Versene,Adherent,,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,5,NA,NA,6,NA,NA,NA,NA,NA,,7,11,7,4,11,07/12/2017,LS,,06/17/2017,12/10/2019,Good (Drop out of 14.2 in D19S1433),X,,16,18,,11,14,,12,14,13,14,,10,11,,14,15,,11,12,13,14,,17,22,,10,11,,9,12,,6,7,14,15,,29,32.2,,8,9,10,12,8,11,,,11,13,,22,,,14,14.2 (DO),,21,,,15,,,,Maris
COG-N-471nb,Cell Bank,"Neurobasal-A plus, 50 ng/mL rhEGF, 50 ng/mL rhFGF, 4mM L-Glutamine, 1X B27, 1X N2",0.02% Versene,Adherent,,Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,5,NA,NA,6,NA,NA,NA,NA,NA,,7,11,7,5,11,07/12/2017,LS,,06/17/2017,12/10/2019,Good (Drop out of 14.2 in D19S1433),X,,16,18,,11,14,,12,14,13,14,,10,11,,14,15,,11,12,13,14,,17,22,,10,11,,9,12,,6,7,14,15,,29,32.2,,8,9,10,12,8,11,,,11,13,,22,,,14,14.2 (DO),,21,,,15,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,7,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,7,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,7,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,7,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-519,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,"After thawing and splitting, it can take more than one day for all of the cells to settle to the plate and adhere.",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Amplified,Unknown,NA,NA,NA,3-4,NA,NA,NA,NA,NA,7,,7,11,7,10,7,06/09/2017,?,,,,Remove,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-519,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,"After thawing and splitting, it can take more than one day for all of the cells to settle to the plate and adhere.",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Amplified,Unknown,NA,NA,NA,3-4,NA,NA,NA,NA,NA,7,,7,11,8,1,4,10/15/2015,LSH,,08/22/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-519,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,"After thawing and splitting, it can take more than one day for all of the cells to settle to the plate and adhere.",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Amplified,Unknown,NA,NA,NA,3-4,NA,NA,NA,NA,NA,7,,7,11,8,2,4,03/01/2016,LSH,,,12/10/2019,Good,X,Y,17,,,11,12,,11,14,13,16,,8,12,,5,7,,11,13,13,15,,20,25,,10,12,,10,13,,6,7,16,,,29,30,,9,10,12,13,8,9,,11,14,,,17,21,,13,14.2,,20,21.2,,15,,,,Maris
COG-N-519,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,"After thawing and splitting, it can take more than one day for all of the cells to settle to the plate and adhere.",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Amplified,Unknown,NA,NA,NA,3-4,NA,NA,NA,NA,NA,7,,7,11,8,3,4,03/01/2016,LSH,,,12/10/2019,Good,X,Y,17,,,11,12,,11,14,13,16,,8,12,,5,7,,11,13,13,15,,20,25,,10,12,,10,13,,6,7,16,,,29,30,,9,10,12,13,8,9,,11,14,,,17,21,,13,14.2,,20,21.2,,15,,,,Maris
COG-N-519,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,"After thawing and splitting, it can take more than one day for all of the cells to settle to the plate and adhere.",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Amplified,Unknown,NA,NA,NA,3-4,NA,NA,NA,NA,NA,7,,7,11,8,4,4+2,08/21/2017,GEC,"from LSH freeze, 10/15/2015 p4 (STR of thaw is good)",08/22/2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-519,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,"After thawing and splitting, it can take more than one day for all of the cells to settle to the plate and adhere.",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Amplified,Unknown,NA,NA,NA,3-4,NA,NA,NA,NA,NA,7,,7,11,8,5,6,02/11/2020,KU,"from LSH, p4, 3/1/16 (STR of thaw is good)",02/07/2020,3/3/20,Good,X,Y,17,,,11,12,,11,14,13,16,,8,12,,5,7,,11,13,13,15,,20,25,,10,12,,10,13,,6,7,16,,,29,30,,9,10,12,13,8,9,,11,14,,,17,21,,13,14.2,,20,21.2,,15,,,,Maris
COG-N-519,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,"After thawing and splitting, it can take more than one day for all of the cells to settle to the plate and adhere.",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Amplified,Unknown,NA,NA,NA,3-4,NA,NA,NA,NA,NA,7,,7,11,8,6,6,02/11/2020,KU,"From KLC, P5, 05/24/2018",02/07/2020,3/3/20,Good,X,Y,17,,,11,12,,11,14,13,16,,8,12,,5,7,,11,13,13,15,,20,25,,10,12,,10,13,,6,7,16,,,29,30,,9,10,12,13,8,9,,11,14,,,17,21,,13,14.2,,20,21.2,,15,,,,Maris
COG-N-519,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,"After thawing and splitting, it can take more than one day for all of the cells to settle to the plate and adhere.",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Amplified,Unknown,NA,NA,NA,3-4,NA,NA,NA,NA,NA,7,,7,11,8,7,6,02/11/2020,KU,"From KLC, P5, 05/24/2018",02/07/2020,3/3/20,Good,X,Y,17,,,11,12,,11,14,13,16,,8,12,,5,7,,11,13,13,15,,20,25,,10,12,,10,13,,6,7,16,,,29,30,,9,10,12,13,8,9,,11,14,,,17,21,,13,14.2,,20,21.2,,15,,,,Maris
COG-N-519,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,"After thawing and splitting, it can take more than one day for all of the cells to settle to the plate and adhere.",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Amplified,Unknown,NA,NA,NA,3-4,NA,NA,NA,NA,NA,7,,7,11,8,8,6,02/11/2020,KU,"From KLC, P5, 05/24/2018",02/07/2020,3/3/20,Good,X,Y,17,,,11,12,,11,14,13,16,,8,12,,5,7,,11,13,13,15,,20,25,,10,12,,10,13,,6,7,16,,,29,30,,9,10,12,13,8,9,,11,14,,,17,21,,13,14.2,,20,21.2,,15,,,,Maris
COG-N-519,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,"After thawing and splitting, it can take more than one day for all of the cells to settle to the plate and adhere.",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Amplified,Unknown,NA,NA,NA,3-4,NA,NA,NA,NA,NA,7,,7,11,8,9,6,02/11/2020,KU,"From KLC, P5, 05/24/2018",02/07/2020,3/3/20,Good,X,Y,17,,,11,12,,11,14,13,16,,8,12,,5,7,,11,13,13,15,,20,25,,10,12,,10,13,,6,7,16,,,29,30,,9,10,12,13,8,9,,11,14,,,17,21,,13,14.2,,20,21.2,,15,,,,Maris
COG-N-519,Cell Bank,"IMDM Media, 20%FBS, 2 mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,"After thawing and splitting, it can take more than one day for all of the cells to settle to the plate and adhere.",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Amplified,Unknown,NA,NA,NA,3-4,NA,NA,NA,NA,NA,7,,7,11,8,10,6,02/11/2020,KU,"From KLC, P5, 05/24/2018",02/07/2020,3/3/20,Good,X,Y,17,,,11,12,,11,14,13,16,,8,12,,5,7,,11,13,13,15,,20,25,,10,12,,10,13,,6,7,16,,,29,30,,9,10,12,13,8,9,,11,14,,,17,21,,13,14.2,,20,21.2,,15,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,9,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,9,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,9,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,9,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,9,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,9,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,9,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-421,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Non-adherent,"Slow growing cell line, with a predominantly non-adherent, foci forming morphology. Some cells will settle and adhere. The cells tend to create a lot of debris in the plate as they continue to grow .",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,11,9,8,12,07/05/2019,KU,,02/15/2019,3/3/20,Good,X,Y,16,,,17.3,,,11,,13,14,,12,,,7,11,,9,,16,18,,17,25,,11,12,,10,12,,9.3,,17,,,29,32.2,,11,12,12,13,8,12,,11,13,,,19.3,21,,13,14,,22,25,,15,16,,,Maris
COG-N-421,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Non-adherent,"Slow growing cell line, with a predominantly non-adherent, foci forming morphology. Some cells will settle and adhere. The cells tend to create a lot of debris in the plate as they continue to grow .",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,11,9,9,12,07/05/2019,KU,,02/15/2019,3/3/20,Good,X,Y,16,,,17.3,,,11,,13,14,,12,,,7,11,,9,,16,18,,17,25,,11,12,,10,12,,9.3,,17,,,29,32.2,,11,12,12,13,8,12,,11,13,,,19.3,21,,13,14,,22,25,,15,16,,,Maris
COG-N-421,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Non-adherent,"Slow growing cell line, with a predominantly non-adherent, foci forming morphology. Some cells will settle and adhere. The cells tend to create a lot of debris in the plate as they continue to grow .",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,11,9,10,12,07/05/2019,KU,,02/15/2019,3/3/20,Good,X,Y,16,,,17.3,,,11,,13,14,,12,,,7,11,,9,,16,18,,17,25,,11,12,,10,12,,9.3,,17,,,29,32.2,,11,12,12,13,8,12,,11,13,,,19.3,21,,13,14,,22,25,,15,16,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,11,10,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-421,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Non-adherent,"Slow growing cell line, with a predominantly non-adherent, foci forming morphology. Some cells will settle and adhere. The cells tend to create a lot of debris in the plate as they continue to grow .",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,11,10,2,9,01/08/2018,klc,,11/17/2017,12/10/2019,Good,X,Y,16,,,17.3,,,11,,13,14,,12,,,7,11,,9,,16,18,,17,25,,11,12,,10,12,,9.3,,17,,,29,32.2,,11,12,12,13,8,12,,11,13,,,19.3,21,,13,14,,22,25,,15,16,,,Maris
COG-N-421,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Non-adherent,"Slow growing cell line, with a predominantly non-adherent, foci forming morphology. Some cells will settle and adhere. The cells tend to create a lot of debris in the plate as they continue to grow .",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,11,10,3,9,01/08/2018,klc,,11/17/2017,12/10/2019,Good,X,Y,16,,,17.3,,,11,,13,14,,12,,,7,11,,9,,16,18,,17,25,,11,12,,10,12,,9.3,,17,,,29,32.2,,11,12,12,13,8,12,,11,13,,,19.3,21,,13,14,,22,25,,15,16,,,Maris
COG-N-421,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Non-adherent,"Slow growing cell line, with a predominantly non-adherent, foci forming morphology. Some cells will settle and adhere. The cells tend to create a lot of debris in the plate as they continue to grow .",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,11,10,4,9,01/08/2018,klc,,11/17/2017,12/10/2019,Good,X,Y,16,,,17.3,,,11,,13,14,,12,,,7,11,,9,,16,18,,17,25,,11,12,,10,12,,9.3,,17,,,29,32.2,,11,12,12,13,8,12,,11,13,,,19.3,21,,13,14,,22,25,,15,16,,,Maris
COG-N-421,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Non-adherent,"Slow growing cell line, with a predominantly non-adherent, foci forming morphology. Some cells will settle and adhere. The cells tend to create a lot of debris in the plate as they continue to grow .",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,11,10,5,9,01/08/2018,klc,,11/17/2017,12/10/2019,Good,X,Y,16,,,17.3,,,11,,13,14,,12,,,7,11,,9,,16,18,,17,25,,11,12,,10,12,,9.3,,17,,,29,32.2,,11,12,12,13,8,12,,11,13,,,19.3,21,,13,14,,22,25,,15,16,,,Maris
COG-N-421,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Non-adherent,"Slow growing cell line, with a predominantly non-adherent, foci forming morphology. Some cells will settle and adhere. The cells tend to create a lot of debris in the plate as they continue to grow .",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,11,10,6,9,01/08/2018,klc,,11/17/2017,12/10/2019,Good,X,Y,16,,,17.3,,,11,,13,14,,12,,,7,11,,9,,16,18,,17,25,,11,12,,10,12,,9.3,,17,,,29,32.2,,11,12,12,13,8,12,,11,13,,,19.3,21,,13,14,,22,25,,15,16,,,Maris
COG-N-421,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Non-adherent,"Slow growing cell line, with a predominantly non-adherent, foci forming morphology. Some cells will settle and adhere. The cells tend to create a lot of debris in the plate as they continue to grow .",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,11,10,7,9,01/08/2018,klc,,11/17/2017,12/10/2019,Good,X,Y,16,,,17.3,,,11,,13,14,,12,,,7,11,,9,,16,18,,17,25,,11,12,,10,12,,9.3,,17,,,29,32.2,,11,12,12,13,8,12,,11,13,,,19.3,21,,13,14,,22,25,,15,16,,,Maris
COG-N-421,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Non-adherent,"Slow growing cell line, with a predominantly non-adherent, foci forming morphology. Some cells will settle and adhere. The cells tend to create a lot of debris in the plate as they continue to grow .",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,11,10,8,9,01/08/2018,klc,,11/17/2017,12/10/2019,Good,X,Y,16,,,17.3,,,11,,13,14,,12,,,7,11,,9,,16,18,,17,25,,11,12,,10,12,,9.3,,17,,,29,32.2,,11,12,12,13,8,12,,11,13,,,19.3,21,,13,14,,22,25,,15,16,,,Maris
COG-N-421,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Non-adherent,"Slow growing cell line, with a predominantly non-adherent, foci forming morphology. Some cells will settle and adhere. The cells tend to create a lot of debris in the plate as they continue to grow .",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,11,10,9,12,07/05/2019,KU,"From KM, P4, 02/03/2017 (STR of thaw is good)",02/15/2019,12/10/2019,Good ,X,Y,16,,,17.3,,,11,,13,14,,12,,,7,11,,9,,16,18,,17,25,,11,12,,10,12,,9.3,,17,,,29,32.2,,11,12,12,13,8,12,,11,13,,,19.3,21,,13,14,,22,25,,15,16,,,Maris
COG-N-421,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Non-adherent,"Slow growing cell line, with a predominantly non-adherent, foci forming morphology. Some cells will settle and adhere. The cells tend to create a lot of debris in the plate as they continue to grow .",Unknown,PD-PM,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,WT,Amplified,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,11,10,10,12,07/05/2019,KU,"From KM, P4, 02/03/2017 (STR of thaw is good)",02/15/2019,12/10/2019,Good,X,Y,16,,,17.3,,,11,,13,14,,12,,,7,11,,9,,16,18,,17,25,,11,12,,10,12,,9.3,,17,,,29,32.2,,11,12,12,13,8,12,,11,13,,,19.3,21,,13,14,,22,25,,15,16,,,Maris
CHP-134,shDACH1-1,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine + 25ng/ml puro",0.02% Versene,Adherent,,Unknown,Progressing,"Cisplatin, carboplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Sample was collected after bone marrow transplant.",Bone Marrow,LOH p32.3-pterm; Gain p34.3-p36.22; Loss p36.22-pterm,GaiNAl p26.3,None,Gain q12-qterm,WT,Amplified,WT,,,,,,,,,,,,7,12,1,1,4,07/15/2013,RMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHP-134,shCON,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine + 25ng/ml puro",0.02% Versene,Adherent,,Unknown,Progressing,"Cisplatin, carboplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Sample was collected after bone marrow transplant.",Bone Marrow,LOH p32.3-pterm; Gain p34.3-p36.22; Loss p36.22-pterm,GaiNAl p26.3,None,Gain q12-qterm,WT,Amplified,WT,,,,,,,,,,,,7,12,1,2,5,07/22/2014,RMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHP-134,shDACH1-1,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine + 25ng/ml puro",0.02% Versene,Adherent,,Unknown,Progressing,"Cisplatin, carboplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Sample was collected after bone marrow transplant.",Bone Marrow,LOH p32.3-pterm; Gain p34.3-p36.22; Loss p36.22-pterm,GaiNAl p26.3,None,Gain q12-qterm,WT,Amplified,WT,,,,,,,,,,,,7,12,1,3,6,07/22/2014,RMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHP-134,shDACH1-2,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine + 25ng/ml puro",0.02% Versene,Adherent,,Unknown,Progressing,"Cisplatin, carboplatin, cyclophosphamide, doxorubicin, etoposide, melphalan, and total body irradiation. Sample was collected after bone marrow transplant.",Bone Marrow,LOH p32.3-pterm; Gain p34.3-p36.22; Loss p36.22-pterm,GaiNAl p26.3,None,Gain q12-qterm,WT,Amplified,WT,,,,,,,,,,,,7,12,1,4,5,07/22/2014,RMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,1,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,1,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHP-212,GFP-Luc,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,,,,,,,,,,,,7,12,2,1,4,02/22/2013,RS/SC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHP-212,GFP-Luc,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,,,,,,,,,,,,7,12,2,2,4,02/22/2013,RS/SC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
CHP-212,GFP-Luc,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,Note the special media base.,Diagnosis,Diagnosis,No treatment was given to the patient prior to sample collection.,Solid Tumor (Kidney mass),Loss p13.2-pterm,GaiNAl p26.3 ,cnLOH 23.3,Gain q12-qterm,WT,Amplified,WT,,,,,,,,,,,,7,12,2,3,4,02/22/2013,RS/SC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,2,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,2,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,2,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,2,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,2,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,2,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C GFP-Luc,GFP-Luc,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,12,3,1,5,02/15/2013,SC,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C GFP-Luc,GFP-Luc,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,12,3,2,5,02/15/2013,SC,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C GFP-Luc,GFP-Luc,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,12,3,3,5,02/15/2013,SC,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C GFP-Luc,GFP-Luc,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,12,3,4,5,02/15/2013,SC,,10/26/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,shCON,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,12,3,5,5,07/07/2014,RK/PK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,shDACH1-5,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,12,3,6,5,07/07/2014,RK/PK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,shDACH1-3,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,12,3,7,5,07/07/2014,RK/PK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,shDACH1-4,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,12,3,8,5,07/07/2014,RK/PK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,delta500,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,12,3,9,9,06/30/2014,RMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,3,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly,43-1,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,12,4,1,21,06/18/2013,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
Kelly,42,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Unknown,Unknown,LOH p21.3-pter; Loss p36.32; Gain p36.33,Loss p26.2,Loss q23.3-qter,Gain q21.2-qter,F1174L,Amplified,P177T,,,,,,,,,,,,7,12,4,2,21,06/18/2013,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,4,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,4,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,4,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,4,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,4,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,4,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,4,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-16,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine + puro",,,,,,,,,,,,,,,,,,,,,,,,,,7,12,5,1,5,02/15/2013,SC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-16,,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine + puro",,,,,,,,,,,,,,,,,,,,,,,,,,7,12,5,2,5,02/15/2013,SC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-16,shCON,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine + puro",,,,,,,,,,,,,,,,,,,,,,,,,,7,12,5,3,3,07/19/2013,RMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-16,shDACH1-1,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine + puro",,,,,,,,,,,,,,,,,,,,,,,,,,7,12,5,4,3,07/19/2013,RMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NB-16,shDACH1-2,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine + puro",,,,,,,,,,,,,,,,,,,,,,,,,,7,12,5,5,3,07/19/2013,RMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,5,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,5,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,5,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,5,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,5,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,6,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,6,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,6,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,6,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,6,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,6,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,6,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,6,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,6,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,shCON,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine+50ng/ml puro",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,12,7,1,3,07/08/2013,RMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,shDACH1-1,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine+50ng/ml puro",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,12,7,2,3,07/08/2013,RMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,GFP+,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,12,7,3,6,09/02/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,GFP+,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,12,7,4,6,09/02/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,GFP+,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,12,7,5,6,09/02/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,shCON,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine+50ng/ml puro",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,12,7,6,9,10/03/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,shCON,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine+50ng/ml puro",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,12,7,7,9,10/03/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,shDACH1-5,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine+50ng/ml puro",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,12,7,8,10,10/03/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,shDACH1-5,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine+50ng/ml puro",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,12,7,9,10,10/03/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,"empty GFP, clone b","RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,12,7,10,4,10/14/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,"empty GFP, clone b","RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,12,8,1,4,10/14/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,"empty GFP, clone c","RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,12,8,2,4,10/14/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,"empty GFP, clone c","RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,12,8,3,4,10/14/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,"empty GFP, clone d","RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,12,8,4,4,10/14/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,"empty GFP, clone d","RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,12,8,5,4,10/14/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,"empty GFP, clone e","RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,12,8,6,4,10/14/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,"empty GFP, clone e","RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,12,8,7,4,10/14/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,"delta500, clone a","RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,12,8,8,8,12/05/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,"delta500, clone a","RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,12,8,9,8,12/05/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,"delta500, clone a","RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,12,8,10,8,12/05/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-FI,shDACH1-1,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine + 50ng/ml puro",0.02% Versene,Adherent,Has multiple morphologies,Unknown,Progressing,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,None,None,None,Gain q21.31-qterm,WT,Non-amplified,M246R,,,,,,,,,,,,7,12,9,1,2,07/24/2013,RMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-FI,shCON,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine + 50ng/ml puro",0.02% Versene,Adherent,Has multiple morphologies,Unknown,Progressing,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,None,None,None,Gain q21.31-qterm,WT,Non-amplified,M246R,,,,,,,,,,,,7,12,9,2,7,03/04/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-FI,shDACH1-2,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine + 50ng/ml puro",0.02% Versene,Adherent,Has multiple morphologies,Unknown,Progressing,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,None,None,None,Gain q21.31-qterm,WT,Non-amplified,M246R,,,,,,,,,,,,7,12,9,3,2,08/16/2013,RMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-FI,shDACH1-2,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine + 50ng/ml puro",0.02% Versene,Adherent,Has multiple morphologies,Unknown,Progressing,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,None,None,None,Gain q21.31-qterm,WT,Non-amplified,M246R,,,,,,,,,,,,7,12,9,4,4,08/30/2013,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-FI,shDACH1-1,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine + 50ng/ml puro",0.02% Versene,Adherent,Has multiple morphologies,Unknown,Progressing,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,None,None,None,Gain q21.31-qterm,WT,Non-amplified,M246R,,,,,,,,,,,,7,12,9,5,7,03/04/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-FI,shDACH1-2,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine + 50ng/ml puro",0.02% Versene,Adherent,Has multiple morphologies,Unknown,Progressing,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow,None,None,None,Gain q21.31-qterm,WT,Non-amplified,M246R,,,,,,,,,,,,7,12,9,6,7,03/04/2014,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,9,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,9,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,9,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,9,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,10,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,10,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,10,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,10,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,10,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,10,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,10,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,10,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,10,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,12,10,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-AS,MYCN-ER,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Bone Marrow,Loss p36.22-36.32,Loss p14.2-pterm,q13.4-qterm,Gain q21.31-qterm,WT,Non-amplified,H168R,,,,,,,,,,,,7,13,1,1,,12/07/2015,RTS,made by Hogarty Lab,November 2015,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-AS,MYCN-ER,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Bone Marrow,Loss p36.22-36.32,Loss p14.2-pterm,q13.4-qterm,Gain q21.31-qterm,WT,Non-amplified,H168R,,,,,,,,,,,,7,13,1,2,,12/07/2015,RTS,made by Hogarty Lab,November 2015,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-AS,MYCN-ER,"RPMI 1640 w/ 10 % FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Relapse,Progressing,Unknown,Bone Marrow,Loss p36.22-36.32,Loss p14.2-pterm,q13.4-qterm,Gain q21.31-qterm,WT,Non-amplified,H168R,,,,,,,,,,,,7,13,1,3,,12/07/2015,RTS,made by Hogarty Lab,November 2015,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,1,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,1,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-518hnb,cultured in 5% O2,"Neurobasal-A plus, 50 ng/mL rhEGF, 50 ng/mL rhFGF, 4mM L-Glutamine, 1X B27, 1X N2",,,,,,,,,,,,,,,,,,,,,,,,,,7,13,2,1,3,02/09/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-518hnb,cultured in 5% O2,"Neurobasal-A plus, 50 ng/mL rhEGF, 50 ng/mL rhFGF, 4mM L-Glutamine, 1X B27, 1X N2",,,,,,,,,,,,,,,,,,,,,,,,,,7,13,2,2,3,02/09/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,2,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,2,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,2,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,2,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,2,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,2,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,TRIPZ-NTC,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,13,3,1,10,12/08/2015,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,TRIPZ-NTC,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,13,3,2,10,12/08/2015,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,TRIPZ-MYCN-C1,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,13,3,3,10,12/08/2015,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,TRIPZ-MYCN-C1,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,13,3,4,10,12/08/2015,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,TRIPZ-MYCN-H9,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,13,3,5,10,12/08/2015,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,TRIPZ-MYCN-H9,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,,7,13,3,6,10,12/08/2015,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,3,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,3,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,3,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,3,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-564h,cultured in 5% O2,"IMDM Media, 20%FBS, 1% Pen/Strep, 4 mM L-Glutamine, 4X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,13,4,1,3,02/09/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-564h,cultured in 5% O2,"IMDM Media, 20%FBS, 1% Pen/Strep, 4 mM L-Glutamine, 4X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,13,4,2,3,02/09/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-564h,cultured in 5% O2,"IMDM Media, 20%FBS, 1% Pen/Strep, 4 mM L-Glutamine, 4X ITS",,,,,,,,,,,,,,,,,,,,,,,,,,7,13,4,3,3,02/09/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,4,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,4,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,4,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,4,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,4,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,4,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,TRIPZ-NTC,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,13,5,1,10,12/08/2015,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,TRIPZ-NTC,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,13,5,2,10,12/08/2015,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,TRIPZ-MYCN-C1,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,13,5,3,10,12/08/2015,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,TRIPZ-MYCN-C1,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,13,5,4,10,12/08/2015,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,TRIPZ-MYCN-H9,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,13,5,5,10,12/08/2015,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
SK-N-BE(2)-C,TRIPZ-MYCN-H9,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,"Cells will clump together, so it can be difficult to achieve a single-cell suspension",Relapse,Progressing,"Patient received multiple courses of chemotherapy and irradiation prior to sample collection. (Agents include: Cyclophosphamide, doxorubicin, vincristine, local irradiation)",Bone Marrow (Subclone of SK-N-BE(2)),cnLOH p21.3-pterm,Loss 14.2-pterm,Loss q11-qterm; Gain q13.4-qterm,Gain q12-qterm,WT,Amplified,C135F,,,,,,,,,,,,7,13,5,6,10,12/08/2015,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,5,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,5,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,5,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,5,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,6,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,6,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,6,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,6,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,6,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,6,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,6,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,6,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,6,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,TRIPZ.NTC.C,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,maintain with 200 ng/mL puro and induce shRNA with 250 ng/mL doxycycline,7,13,7,1,9,02/23/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,TRIPZ.NTC.C,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,maintain with 200 ng/mL puro and induce shRNA with 250 ng/mL doxycycline,7,13,7,2,9,02/23/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,TRIPZ.NTC.F,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,maintain with 200 ng/mL puro and induce shRNA with 250 ng/mL doxycycline,7,13,7,3,9,02/23/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,TRIPZ.NTC.F,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,maintain with 200 ng/mL puro and induce shRNA with 250 ng/mL doxycycline,7,13,7,4,9,02/23/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,TRIPZ.MYCN.C1.B,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,maintain with 200 ng/mL puro and induce shRNA with 250 ng/mL doxycycline,7,13,7,5,9,02/23/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,TRIPZ.MYCN.C1.B,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,maintain with 200 ng/mL puro and induce shRNA with 250 ng/mL doxycycline,7,13,7,6,9,02/23/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,TRIPZ.MYCN.C1.E,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,maintain with 200 ng/mL puro and induce shRNA with 250 ng/mL doxycycline,7,13,7,7,9,02/23/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,TRIPZ.MYCN.C1.E,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,maintain with 200 ng/mL puro and induce shRNA with 250 ng/mL doxycycline,7,13,7,8,9,02/23/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,TRIPZ.MYCN.C1.A,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,maintain with 200 ng/mL puro and induce shRNA with 250 ng/mL doxycycline,7,13,7,9,9,02/23/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,TRIPZ.MYCN.C1.C,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,maintain with 200 ng/mL puro and induce shRNA with 250 ng/mL doxycycline,7,13,7,10,9,02/23/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,TRIPZ.MYCN.C1.D,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,maintain with 200 ng/mL puro and induce shRNA with 250 ng/mL doxycycline,7,13,8,1,9,02/23/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,TRIPZ.MYCN.C1.F,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,maintain with 200 ng/mL puro and induce shRNA with 250 ng/mL doxycycline,7,13,8,2,9,02/23/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,TRIPZ.MYCN.H9.A,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,maintain with 200 ng/mL puro and induce shRNA with 250 ng/mL doxycycline,7,13,8,3,9,02/23/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,TRIPZ.MYCN.H9.A,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,maintain with 200 ng/mL puro and induce shRNA with 250 ng/mL doxycycline,7,13,8,4,9,02/23/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,TRIPZ.MYCN.H9.F,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,maintain with 200 ng/mL puro and induce shRNA with 250 ng/mL doxycycline,7,13,8,5,9,02/23/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,TRIPZ.MYCN.H9.F,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,maintain with 200 ng/mL puro and induce shRNA with 250 ng/mL doxycycline,7,13,8,6,9,02/23/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,TRIPZ.MYCN.H9.D,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,maintain with 200 ng/mL puro and induce shRNA with 250 ng/mL doxycycline,7,13,8,7,9,02/23/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
NGP,TRIPZ.MYCN.H9.E,"RPMI 1640 w/ 10 % tet-free FBS; 1 % of Pen/Strep, 2mM L-Glutamine",0.02% Versene,Adherent,,Unknown,Unknown,Patient had prior chemotherapy treatment (agents unknown).,Bone Marrow metatsis after treatment,cnLOH p32.3-pter,Gain p25.3-pterm,Loss q22.1-qterm,Gain q21.2-qterm,WT,Amplified,"A159D, C141W",,,,,,,,,,,maintain with 200 ng/mL puro and induce shRNA with 250 ng/mL doxycycline,7,13,8,8,9,02/23/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,8,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,8,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-549,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,Two main and distinct morphologies in this cell line. ,Progressing,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1174L,Non-amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,13,9,1,13,11/28/2017,klc,"From LS freeze, p11, 08/08/2017",11/14/2017,08/22/18,Good,X,Y,15,18,,14,17.3,,11,14,13,,,11,12,,12,15,,9,11,15,,,16,,,10,11,,12,,,7,9.3,15,16,,29,32.2,,9,10,11,12,8,11,,11,14,,,20,21,,13,,,20,,,14,15,,,Maris
COG-N-549,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,Two main and distinct morphologies in this cell line. ,Progressing,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1174L,Non-amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,13,9,2,6,03/01/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-549,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,Two main and distinct morphologies in this cell line. ,Progressing,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1174L,Non-amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,13,9,3,6,03/01/2016,LSH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-549,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,Two main and distinct morphologies in this cell line. ,Progressing,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1174L,Non-amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,13,9,4,11,08/08/2017,LS,,05/25/17,08/22/18,Good (STR of subsequent freeze is good),X,Y,15,18,,14,17.3,,11,14,13,,,11,12,,12,15,,9,11,15,,,16,,,10,11,,12,,,7,9.3,15,16,,29,32.2,,9,10,11,12,8,11,,11,14,,,20,21,,13,,,20,,,14,15,,,Maris
COG-N-549,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,Two main and distinct morphologies in this cell line. ,Progressing,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1174L,Non-amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,13,9,5,11,08/08/2017,LS,,05/25/17,08/22/18,Good (STR of subsequent freeze is good),X,Y,15,18,,14,17.3,,11,14,13,,,11,12,,12,15,,9,11,15,,,16,,,10,11,,12,,,7,9.3,15,16,,29,32.2,,9,10,11,12,8,11,,11,14,,,20,21,,13,,,20,,,14,15,,,Maris
COG-N-549,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,Two main and distinct morphologies in this cell line. ,Progressing,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1174L,Non-amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,13,9,6,11,08/08/2017,LS,,05/25/17,08/22/18,Good (STR of subsequent freeze is good),X,Y,15,18,,14,17.3,,11,14,13,,,11,12,,12,15,,9,11,15,,,16,,,10,11,,12,,,7,9.3,15,16,,29,32.2,,9,10,11,12,8,11,,11,14,,,20,21,,13,,,20,,,14,15,,,Maris
COG-N-549,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,Two main and distinct morphologies in this cell line. ,Progressing,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1174L,Non-amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,13,9,7,13,11/28/2017,klc,"From LS freeze, p11, 08/08/2017",11/14/2017,08/22/18,Good,X,Y,15,18,,14,17.3,,11,14,13,,,11,12,,12,15,,9,11,15,,,16,,,10,11,,12,,,7,9.3,15,16,,29,32.2,,9,10,11,12,8,11,,11,14,,,20,21,,13,,,20,,,14,15,,,Maris
COG-N-549,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,Two main and distinct morphologies in this cell line. ,Progressing,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1174L,Non-amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,13,9,8,13,11/28/2017,klc,"From LS freeze, p11, 08/08/2017",11/14/2017,08/22/18,Good,X,Y,15,18,,14,17.3,,11,14,13,,,11,12,,12,15,,9,11,15,,,16,,,10,11,,12,,,7,9.3,15,16,,29,32.2,,9,10,11,12,8,11,,11,14,,,20,21,,13,,,20,,,14,15,,,Maris
COG-N-549,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,Two main and distinct morphologies in this cell line. ,Progressing,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1174L,Non-amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,13,9,9,13,11/28/2017,klc,"From LS freeze, p11, 08/08/2017",11/14/2017,08/22/18,Good,X,Y,15,18,,14,17.3,,11,14,13,,,11,12,,12,15,,9,11,15,,,16,,,10,11,,12,,,7,9.3,15,16,,29,32.2,,9,10,11,12,8,11,,11,14,,,20,21,,13,,,20,,,14,15,,,Maris
COG-N-549,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,Two main and distinct morphologies in this cell line. ,Progressing,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1174L,Non-amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,13,9,10,13,11/28/2017,klc,"From LS freeze, p11, 08/08/2017",11/14/2017,08/22/18,Good,X,Y,15,18,,14,17.3,,11,14,13,,,11,12,,12,15,,9,11,15,,,16,,,10,11,,12,,,7,9.3,15,16,,29,32.2,,9,10,11,12,8,11,,11,14,,,20,21,,13,,,20,,,14,15,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,10,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,10,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,10,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,10,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
COG-N-549,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,Two main and distinct morphologies in this cell line. ,Progressing,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1174L,Non-amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,13,10,5,15,03/23/2018,klc,"from KLC, p13, 11/28/17 (STR of thaw is good)",03/13/2018,08/22/18,Good (STR of thaw is good),X,Y,15,18,,14,17.3,,11,14,13,,,11,12,,12,15,,9,11,15,,,16,,,10,11,,12,,,7,9.3,15,16,,29,32.2,,9,10,11,12,8,11,,11,14,,,20,21,,13,,,20,,,14,15,,,Maris
COG-N-549,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,Two main and distinct morphologies in this cell line. ,Progressing,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1174L,Non-amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,13,10,6,15,03/23/2018,klc,"from KLC, p13, 11/28/17 (STR of thaw is good)",03/13/2018,08/22/18,Good (STR of thaw is good),X,Y,15,18,,14,17.3,,11,14,13,,,11,12,,12,15,,9,11,15,,,16,,,10,11,,12,,,7,9.3,15,16,,29,32.2,,9,10,11,12,8,11,,11,14,,,20,21,,13,,,20,,,14,15,,,Maris
COG-N-549,Cell Bank,"IMDM Media, 20%FBS, 2mM L-glutamine, 1% Pen/Strep, 1X ITS",0.02% Versene,Adherent ,Two main and distinct morphologies in this cell line. ,Progressing,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,F1174L,Non-amplified,Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,7,13,10,7,15,03/23/2018,klc,"from KLC, p13, 11/28/17 (STR of thaw is good)",03/13/2018,08/22/18,Good (STR of thaw is good),X,Y,15,18,,14,17.3,,11,14,13,,,11,12,,12,15,,9,11,15,,,16,,,10,11,,12,,,7,9.3,15,16,,29,32.2,,9,10,11,12,8,11,,11,14,,,20,21,,13,,,20,,,14,15,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,10,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,10,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,7,13,10,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Maris
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,